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At the threshold of the 21st centry, a new set of challenges is defined by the need 
to develop sustainable means of preparing chemical commodities demanded by society. 
Hence, such concepts as atom economy, step economy, and ‘green chemistry’ have 
become the requirements for the development of synthetic reactions. Hydrogenation is 
one of the most powerful catalytic methods which successfully satisfy the stated 
requirements of modern chemistry. Accordingly, catalytic hydrogenation has been 
tremendously utilized in industrial settings. The profound impact of hydrogenation 
portended a powerful approach to reductive carbon-carbon bond formation under 
hydrogenation conditions, resulting in the discovery of the Fischer-Tropsch process and 
hydroformylation. However, since this discovery, processes have restricted to the 
incorporation of a single carbon monoxide unit. Even though there are a few seminal 
contributions, systematic efforts toward the development of hydrogen-mediated carbon-
carbon bond forming processes beyond hydroformylation have been absent from the 
 vii
literature. In an exciting advance, the Krische group has shown that it is possible to 
reductively couple two or more organic molecules simply through their exposure to 
gaseous hydrogen in the presence of a metal catalyst. This finding has led to the 
development of a broad, new family of hydrogen-mediated C-C bond formation. Herein, 
related to hydrogen-mediated C-C bond formation, the overview of metal catalyzed 
intermolecular reductive coupling in the presence of reducing agents such as borane, 
silane, alane, metal, and hydrogen is presented. Chapter 2 describes systematic 
approaches to the development of hydrogen-mediated C-C bond formation and successful 
preliminary results achieved by our research group. Chapters 3 and 4 will describe the 
further extension of these hydrogen-mediated C-C bond formations including (1) 
hydrogen-mediated reductive couplings of conjugated alkynes with iminoacetates, (2) 
hydrogen-mediated reductive couplings of 1,3-enynes with α-ketoesters, and (3) 
hydrogen-mediated multicomponent reductive couplings.  
The development of catalytic systems for the nucleophilic activation of enones 
using phosphine catalysts has received attractive attention. Recently, an intramolecular 
variant of the Rauhut-Currier reaction was developed in our lab. To further extend 
nucleophilic phosphine catalysis, we have sought to develop new catalytic methodology 
via phosphine conjugate addition. Chapter 5 describes two new methodologies related to 
their area: (1) catalytic cycloallylation via nucleophilic phosphine catalysis and (2) allylic 
amination of Morita-Baylis-Hillman acetates.  
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Chapter 1 Metal-Catalyzed Intermolecular Reductive Coupling 
1.1 INTRODUCTION AND SCOPE 
The catalytic reductive coupling is one of the most important methods for carbon-
carbon bond formation. The representative catalytic reductive coupling reactions such as 
the Fischer-Tropsch process (1922)1 and hydroformylation (1938)2 are industrially 
important methods of carbon-carbon bond formation3. The concept of reductively 
coupling two or more small molecules to form larger or complex molecule has been 
appealing to synthetic chemists due to its atom ecomomy4 and environmentally friendly 
nature. The Takahashi group (1969)5a and the Tsuji group (1971)5b independently 
discovered a novel palladium catalyzed hydrosilylation of butadiene, making the first 
“non-hydrogen-mediated” reductive coupling reaction. Since this discovery, catalytic 
reductive coupling reactions have only recently attracted a high level of interest in the 
formation of carbon-carbon bonds in synthetic as well as industrial circles. Progress has 
been made with regard to the nucleophilic activation of diverse precursors containing π-
bonds such as alkenes, alkynes, enones, dienes, and enynes, then catalytically reductively 
coupling those to other partners containing π-bonds. 
Some of important examples of reductive couplings include the Fischer-Tropsch 
reaction and hydroformylation6, the reductive Heck reaction7, the reductive aldol 
reaction8-11, Nozaki-Hiyama-Kishi coupling12, reductive cyclization13, reductive coupling 
of two π components, and pinacol coupling14. Recently, catalytic intermolecular reductive 
coupling reactions have received substantial attention. The following review will discuss 
the advent and development of one of the most attractive synthetic methods. This review 
is organized by catalyst system and substrate functionality. 
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Classical reactions such as the Fischer-Tropsch process and hydroformylation 
however, will not be covered. Reductive cyclizations (intramolecular reductive coupling) 
and the reductive aldol reaction will also not be covered. Additionally, reactions 
including the activation of a carbon-halogen bond such as the Nozaki-Hiyama-Kishi 
coupling and reductive Heck coupling are beyond the scope of this review. 
 
1.2 REDUCTIVE COUPLING OF ALKENES WITH ALKENES, ALKYNES, OR ANHYDRIDES 
1.2.1 Alkene-Alkene Coupling 
Transition metal-catalyzed dimerization of olefins is useful for synthesizing 
important intermediates for fine and industrial chemicals.15 In 2004, the Cheng group 
reported the cobalt-catalyzed reductive dimerization of alkenes. Butyl acrylate in the 
presence of CoI2(PPh3)2, PPh3, zinc metal powder and water in acetonitrile at 80 oC 
underwent tail-to-tail reductive dimerization to give dibutyl adipate 1.2 in 90% yield with 
complete regioselectivity.16 Acrylonitrile, phenyl vinyl sulfone, and acrylamide were also 





CoI2(PPh3)2/ Zn / PPh3













Scheme 1.1 Co-catalyzed reductive dimerization of alkenes. 
 
It was found that the choice of solvent is vital to the catalytic reaction. Upon 
screening of a variety of solvents, acetonitrile proved most effective. Dichloromethane, 
THF, and DMF are less effective providing 1.2 in 63%, 33%, and 26% yields, 
respectively. Interestingly, toluene is completely ineffective providing no reductive 
 3
dimerization product. Based on the deuterium labeling study, a plausible mechanism was 
proposed. The catalytic cycle is initiated by the reduction of the Co(III) complex to a 
Co(I) complex. Protonation of Co(I) species by water generates a Co(III) hydride 1.6. 
The insertion of an acrylate gives five-membered ring species 1.7. Insertion into a second 
acrylate molecule provides intermediate 1.8. Finally, protonation of Co-enolate 1.8 



































Scheme 1.2 Proposed catalytic cycle for Co-catalyzed reductive dimerization of alkenes. 
 
1.2.2 Alkene-Alkyne Coupling 
Intermolecular coupling of a carbon-carbon triple bond and double bond provides 
a convenient route for carbon-carbon bond formation. Due to the regio- and 
stereoselectivity problems and potential side reactions such as cyclotrimerization17 and 
polymerization, there was no catalytic intermolecular reductive ene-yne coupling until 
2002. Here, the Cheng group reported a cobalt-catalyzed highly regioselective and 
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stereoselective intermolecular reductive coupling of alkynes with conjugated alkenes in 
2002.18 Treatment of alkyne 1.10 with a variety of activated alkenes 1.11 in the presence 
of Co(Ph3)2I2, PPh3, water, and zinc metal powder in acetonitrile at 80 oC led to reductive 
coupling of alkyne and activated alkene to give products 1.12 – 1.17 in good to excellent 
yields (Scheme 1.3). 
 




CoI2(PPh3)2/ Zn / PPh3
























Scheme 1.3 Co-catalyzed reductive cupling of alkenes and alkynes. 
 
The author proposed two possible mechanisms based on the known 
organometallic chemistry that relates to acrylates and alkynes as well as a deuterium 
isotope-labeling experiment. The first proposed mechanism includes the formation of 
cobaltacyclopentene intermediate 1.18 from oxidative coupling of an alkyne and an 
alkene to the cobalt(I) center followed by protonation of the intermediate 1.1819 by water 
(Scheme 1.4 (a)). Another possible mechanism involves a cobalt(III) hydride 1.19 
generated from protonation of cobalt(I) by water. Insertion of an acrylate molecule into 
the cobalt hydride 1.19 gives five-membered ring species 1.20. Further insertion of an 
alkyne molecule gives cobalt(III) intermediate 1.21. Subsequent protonation of 1.21 
produces the reductive coupling product 1.12 and regenerates the Co(I) complex (Scheme 





















































Scheme 1.4 Proposed catalytic cycles for reductive coupling of alkenes and alkynes. 
 
In 2005, the Yamamoto group reported a cationic palladium-catalyzed hydro-
silylative cross-coupling of alkynes with alkenes.20 Exposure of the mixture of phenyl 
acetylene and 1-hexene (3 equiv.) to trichlorosilane in the presence of catalytic cationic 
palladium (II) 1.22 afforded the coupling products 1.23 and 1.24 in 70% combined yield 
as triethoxysilyl derivatives after a usual work-up (Scheme 1.5 (a)). Additionally, they 
discovered that triphenylphosphine greatly affected the regioselectivity of the reaction. 
Once triphenylphosphine (1equiv.) was added to catalyst 1.22, the same reaction shown 
in Scheme 1.5 (a) exhibited a different reaction pattern to afford a single coupling 




cat. 1.22 (1 mol%)














( 1.23:1.24 = 60:40)
Bu
PPh3 (1 mol%)






58% yield (a single isomer)





(a) Without PPh3 Additive
(b) With PPh3 Additive
[(    -C3H5)Pd(cod)]+[PF6]-η




Scheme 1.5 Cationic Pd-catalyzed hydrosilylative cross-coupling. 
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Mechanistically, the reaction with cationic palladium and trichlorosilane would 
produce a palladium hydride complex 1.26. Next, hydropalladation of a given alkyne 
would afford alkenylpalladium intermediate 1.27, which would undergo rapid and 
regioselective alkene insertion to generate homoallylic organopalladium intermediate 
1.28. Finally, the resulting organopalladium 1.28 would terminate one catalytic cycle by 























Scheme 1.6 Proposed catalytic cycle for Pd-catalyzed hydrosilylative cross-coupling. 
 
1.2.3 Alkene-Anhydride Coupling 
In 1995, the Miura group reported rhodium-catalyzed reaction of benzoic 
anhydride with styrene at atmosphere of molecular hydrogen.21 The reaction of benzoic 
anhydride with styrene in the presence of [RhCl(COD)]2, (PhO)3P, and 
diisopropylethylamine in 2-methoxyethyl ether at 65 oC under 1 atm of molecular 
hydrogen gave 1,2-diphenyl-1-propaneone 1.29 as the major product along with 1,3-















1.29 1.30H2 (1 atm)
 
Scheme 1.7 Rh-catalyzed reductive coupling of alkenes and anhydrides.  
 
On the basis of the deuterium labeling study and the product ratio analysis, a 
plausible mechanism was proposed. The catalytic cycle is initiated by reaction of 
[RhCl(COD)]2 with hydrogen in the presence of (PhO)3P and a base to generate a 
hydridorhodium species 1.31. Insertion of styrene to intermediate 1.31 affords two 
different rhodium complexes 1.32 and 1.32’, each undergoes oxidative addition of 
benzoic anhydride to produce two rhodium complexes 1.33 and 1.33’. Reductive 
elimination of rhodium complexes 1.33 and 1.33’ would produce the corresponding 
products (1.29 and 1.30) and benzoyloxyrhodium species 1.34 which may react with 














































Scheme 1.8 Proposed catalytic cycle for reductive coupling of alkenes and anhydrides.  
 8
Recently, the Krische group reported an advanced catalyst system for hydrogen-
mediated alkene-anhydride coupling. They found that cationic rhodium catalysts ligated 
by triphenylarsine (Ph3As) enable formation of branched hydroacylation products (1.35 -
1.37) with exceptionally high levels of regiocontrol. For more precious carboxylic acids, 
they also showed that selective acyl transfer from mixed anhydrides 1.38 was possible to 
produce completely branch-selective hydroacylation product 1.39 in good yields. In 
addition, reductive coupling of ethylene in the presence of carboxylic anhydride 1.40 

































































Scheme 1.9 Cationic Rh-catalyzed reductive coupling of alkenes and anhydrides.  
 
On the basis of a deuterium labeling study, two possible mechanisms were 
proposed. In catalytic mechanism A, the catalytic cycle is initiated by the reaction of the 
cationic rhodium complex with molecular hydrogen in the presence of Ph3As and a base 
to generate a hydridorhodium species 1.42. Subsequent hydrometallation of styrene 
 9
delivers organorhodium intermediate 1.43 which engages in formal acyl substitution to 
produce intermediate 1.44. Finally, C-C reductive elimination produces the 
hydroacylation product 1.35 and rhodium carboxylate complex 1.45. In catalytic 
mechanism B, oxidative addition of anhydride followed by insertion of styrene affords 
organorhodium intermediate 1.46. Subsequent hydrogenolysis of intermediate 1.46 
delivers hydridorhodium complex 1.47. C-H reductive elimination produces the 
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Scheme 1.10 Proposed mechanisms for cationic Rh-catalyzed reductive coupling. 
 
1.3 REDUCTIVE COUPLING OF ALKYNES WITH CARBONYLS 
Allylic alcohols are organic substructures which are exceptionally valuable in 
many synthetic applications.23 Perhaps the most commonly used method involves 
coupling of alkenyl halides and aldehydes either by metallation/addition or Nozaki-
Hiyama-Kishi coupling12. More recently, Wipf and Oppolzer demonstrated alkyne 
 10
hydrozirconation or hydroboration followed by addition to aldehydes.24 However, many 
of these strategies for preparing allylic alcohols require the use of stoichiometric 
reagents.25 Recent progress has shown that these versatile intermediates can be prepared 
via catalytic intermolecular reductive coupling technology. 
 
1.3.1 Ni-Borane System 
In 2000, Jamison and coworkers reported the first catalytic intermolecular 
reductive coupling of alkynes and aldehydes.26 Optimal conditions to control the 
reactivity, stereoselectivity, and regioselectivity were determined to be reaction of 1 
equiv. of aldehyde with 1 equiv. of the alkyne and a low-valent nickel catalyst along with 
tributylphosphine and triethylborane. The efficiency, substrate scope, and selectivity of 






















77 85 49 76
92:8 92:8 >98:2 96:4
100 mol% 100 mol%
 
Scheme 1.11 Ni-Catalyzed reductive coupling of alkynes and aldehydes. 
 
Chiral allylic alcohols are useful starting materials and are prevalent in complex 
natural products.23c, 27 In 2003, the Jamison group reported the first highly enantio-
selective catalytic intermolecular reductive coupling of alkynes and aldehydes.28 From 
extensive evaluations of chiral ligands, transition metals, and reducing agents, they found 
that NMDPP, Ni(COD)2, and triethylborane provided superior results. Yield and 
enantioselectivity were further improved by using a solvent composed of equal volumes 
of ethyl acetate and 1,3-dimethylimidazolidinone (DMI) in conjunction with slow 
 11
addition of the aldehyde. The catalytic system afforded trisubstitued allylic alcohols 
corresponding to exclusive cis addition to the alkyne in excellent regioselectivity and 
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91:9 >95:5 >95:5 >95:5








Scheme 1.12 Ni-catalyzed asymmetric reductive coupling of alkynes and aldehydes. 
 
The stereochemical outcome of the asymmetric coupling with NMDPP as the 
chiral ligand has been rationalized by a cooperative effect between steric properties of the 
ligand and electronic differences of the alkyne substituents. Among four possible modes 
of aldehyde coordination, A and C are inconsistent with the sense and degree of 






























































Scheme 1.13 Proposed steric and electronic control in asymmetric reaction. 
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To achieve the regioselective coupling reactions between aldehydes and alkynes 
with two linear aliphatic groups, the Jamison group examined ligand-switchable directing 
effects29 of tethered alkenes (1.48-1.51) in nickel-catalyzed additions to alkynes (Table 
1.1, entries 1-4).30 Remarkably, they found that a tether of three methylene units provided 
complete selectivity for allylic alcohol regioisomer 1.53 (Table 1.1, entry 3). The 
directing effects of tethered alkenes were further supported by a control experiment with 
the corresponding alkyne 1.52 lacking the pendant alkene, which gave no regioselectivity 
(Table 1.1, entry 4).30a  
 
Table 1.1 Directing effects of tethered alkenes. 
 
H












entry alkyne n yield (%) regioselectivity(1.53 : 1.54)
1 1.48 1 <5 nd
2 1.49 2 <5 nd
3 1.50 3 53 >95:5
4 1.51 4 <5 nd
5 n.a. 28 50:50C Cn-pentyl n-hexyl (1.52)




Additionally, they found that the sense of regioselectivity was completely 
reversed upon the addition of catalytic amount of tricyclopentylphosphine (Cyp3P). The 
ligand effects provided significant insight into the mechanistic framework for the nickel-
catalyzed reductive coupling reaction of alkynes in general. When Cyp3P is employed in 
the reaction, the alkenyl H is installed prior to carbon-carbon bond formation to form the 
regioisomer 1.54 exclusively. On the other hand, in the absence of Cyp3P, carbon-carbon 
bond formation occurs prior to alkenyl H introduction to produce the regioiosmer 1.53 
predominantly (Table 1.2). 
 13































Recently, the Jamison group developed a nickel-catalyzed reductive coupling of 
alkynes and easily accessible, enantiomerically enriched α-oxyaldehydes 1.55. The 
reductive coupling reaction provides efficient access to a variety of differentially 



























3 Et >95:5Cy PMB 74
4 Et >95:5Ph MOM 39
R1 R2 R3
1.55 1.56  
Scheme 1.14 Ni-catalyzed reductive coupling of alkynes and chiral aldehydes. 
 
The anti-diastereoselectivity could be rationalized by the “dipolar” model because 




























Figure 1.1 Possible interpretation of the diastereoselectivity. 
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1.3.2 Ni-Silane System 
In 2004, the Montgomery group reported the nickel-catalyzed intermolecular 
reductive coupling of alkynes and aldehydes using an imidazolium carbene ligand 1.57 
and triethylsilane.32 Optimized conditions involved syringe drive addition of the alkyne 
(typically over 15 min). The scope of this reductive coupling method was broad, and 
good to excellent yields and regioselectivities were observed across a broad range of 
substrates 1.58. Aromatic (1.59, 1.61, and 1.62) and aliphatic aldehydes (1.60) were 
excellent participants in the procedure. However, an internal aliphatic alkyne provided 
the coupling product 1.62 with low dr. It is noteworthy that this terminal alkynyl 
compounds were coupled to produce product 1.61 in 71% yield. Terminal alkynes were 
previously problematic due to alkyne trimerization (Scheme 1.15).  
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Scheme 1.15 Ni-catalyzed reductive coupling of alkynes, aldehydes, and organosilanes. 
 
A particularly intriguing feature of these studies is the significant difference in 
scope of catalysts derived from PBu3 and the imidazolium carbene ligand. Accordingly, 
they examined crossover experiments between Et3SiD and Pr3SiH to gain insight into a 
mechanistic probe. With Ni(COD)2 and carbene ligand complex, non-crossover products 
1.59b and 1.59c were produced in comparable amounts, and < 1% of crossover products 
was observed (Scheme 1.16 (a)). In addition, the crossover experiment was applied to the 
 15
intramolecular reductive coupling of an ynal 1.63.33 In case of Ni(COD)2 with a carbene 
ligand, the results were very similar to those of intermolecular reductive coupling. 
However, significant crossover was observed in the case of Ni(COD)2 with PBu3 
(Scheme 1.16 (b)).  
 























































(a) Intermolecular Crossover Experiment











Based on the crossover experiment results, the author suggested the mechanisms 
of the two catalyst systems are fundamentally different. The author proposed two 
possible mechanisms for Ni(COD)2 and carbene ligand system which are consistent with 
the lack of crossover. The first scenario is the formation of metallacycle 1.64 via 
oxidative coupling followed by a σ-bond metathesis with silane. The second scenario 
involves a nickel hydride species 1.65 (Scheme 1.16 (a)). However, the extensive 
crossover observed in the reductive cyclization catalyzed by Ni(COD)2/Bu3P is clearly 
inconsistent with either of the aforementioned mechanisms. In order to explain the 
observed extensive crossover, the author proposed two other possible mechanisms. The 
first mechanism includes the formation of nickel hydride species 1.66 which undergoes 
sequential alkyne and aldehyde insertions via intermediate 1.67 which would lead to 
 16
crossover. Alternatively, a nickel hydride species 1.68 mediates oxidative coupling in the 
formation of metallacycle 1.69 which would also lead to crossover (Scheme 1.16(b)).  
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1.68 1.69  
Scheme 1.16 Possible mechanisms. 
 
The Montgomery group extended the Ni catalyzed reductive coupling of alkynes 
and aldehydes to the intermolecular diastereoslective coupling of alkynes and α-silyloxy- 
aldehydes.34 Optimal conditions were found utilizing (i-Pr)3SiH as the reducing agent, 
TBS as the α-hydroxy protection group on the aldehyde, and trimethylsilyl alkynes at 
room temperature. Under optimized conditions, both aliphatic and aromatic alkynyl 
silanes smoothly underwent reductive coupling to afford the anti-1,2-diols in high yields 
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Scheme 1.17 Reductive coupling of alkynes and α-silyloxyaldehydes. 
 
1.3.3 Ni-Cr System 
It is well known that 3-alkyl-substituted allylic alcohols can be prepared via 
hydrometallation methods24 or Ni-catalyzed intermolecular reductive couplings.26,32 
However, it is not easy to prepare 2-alkyl-substituted allylic alcohols from a terminal 
alkyne and an aldehyde. In 2003, the Takai group reported Ni-catalyzed regioselective 
coupling of terminal alkynes and aldehydes leading to 2-alkyl-substituted allylic alcohol 
products.35 Upon exposure of an aldehyde to terminal alkyne 1.70 in the presence of 
excess CrCl2, catalytic NiCl2, catalytic PPh3, and H2O in DMF, a mixture of the two 
allylic alcohols 1.71 and 1.72 was obtained in 78% yield. The 2-alkyl-substituted allylic 
alcohol 1.71 was produced selectively. The key to the success of these reactions is the 
addition of a small amount of water to the reaction mixture. It was also found that the 
addition of triphenylphosphine to the reaction was necessary to stabilize the nickel 
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Scheme 1.18 Regioselective reductive coupling of alkynes and aldehydes. 
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Two possible reaction pathways were proposed for the formation of the alkenyl 
nickel intermediate 1.74 from terminal alkynes. In Path A, the coordination of a terminal 
alkyne to Ni(0) generated by the reduction of nickel(II) with 2 equiv. of chromium (II) 
produces a nickel-alkyne complex 1.73. A reaction of the complex 1.73 with water gives 
the alkenylnickel species 1.74, which transmetallates to afford alkenylchromium reagent 
1.75. In Path B, nickel(0) reacts immediately with water to give a nickel-hydride species 
1.76. Insertion of the nickel-hydride species into the terminal alkyne gives the 




















Scheme 1.19 Proposed catalytic cycles. 
 
1.3.4 Ir-H2 System 
The Krische group has developed the reductive couplings of conjugated dienes36, 
enynes,37 and diynes38 to carbonyl partners using a cationic rhodium catalyst under 
hydrogenation conditions. However, under the conditions of rhodium catalysis, simple 
nonconjugated alkyl substituted alkynes fail to react. In order to overcome this limitation, 
the group assayed cationic iridium complexes. Upon exposure of alkyne 1.77 to α-
ketoester 1.78 under 1 atm of hydrogen in the presence of Ir(COD)2BARF, DPPF, and 
triphenylacetic acid, α-hydroxyesters 1.79-1.83 were obtained in excellent yields as a 
single alkene geometrical isomer. The nonsymmetric alkyl-substituted alkynes coupled 
 19
regioselectively proximal to the methyl terminus to produce the corresponding products 
1.82 and 1.83 in excellent yields. Furthermore, regioselectivity and olefin geometry are 



































1.79 (93%) 1.80 (82%) 1.82 (88%) 1.83 (87%)
1.77 1.78 OR=O(CH2)Ph
 
Scheme 1.20 Ir-catalyzed reductive coupling of alkynes and carbonyls. 
 
The author proposed a possible mechanism based on the deuterium-labeling study 
and the regioselectivity analysis. Alkyne-carbonyl oxidative coupling would furnish an 
oxametallacyclic intermediate 1.84, which undergoes protonolytic cleavage by the 
Brønsted acid co-catalyst to produce a cationic iridium carboxylate 1.85. Hydrogenolysis 
of the Ir-O bond followed by C-D reductive elimination of 1.86 would deliver deuterio-

















































Scheme 1.21 Plausible catalytic cycle as supported by 2H-labeling.  
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1.4 REDUCTIVE COUPLING OF 1,3-DIENES WITH CARBONYLS 
Homoallylation of carbonyl compounds is an important carbon-carbon bond 
forming reaction for the preparation of bishomollylic alcohols. However, this process has 
received little attention, presumably due to the limited homoallylating agents and the low 
nucleophilicity of homoallylic transition metal species. Recently, metal catalyzed 
intermolecular reductive homoallylations have received increasing attention as an 
efficient homoallylation method to avoid using stoichiometric homoallylating reagents. 
 
1.4.1 Ni-Borane System 
In 1998, the Tamaru group reported the highly regio- and stereoselective Ni-
catalyzed reductive homoallylation of 1,3-dienes and aldehydes.40 It was found that 
Ni(acac)2 combined with triethylborane catalyzed the homoallylation of benzaldehyde 
with 1,3-dienes (1.87, 1.89, and 1.91) to provide bishomoallylic alcohols (1.88, 1.90, and 
1.92) in excellent yields and with high regio- and stereoselectivities (Scheme 1.22).40a 
The reaction is remarkable in many respects. First, carbon-carbon bond formation only 
occurred at the C1 position of the diene moiety with an exclusive delivery of hydrogen at 
C2 position. Second, the reaction exhibits high 1,2- and 1,3-diastereoselectivity providing 
1,2-anti-products (from E-1,3-diene) and 1,3-anti-products. Economically, the low cost 
of the reagents [Ni(acac)2 and Et3B] and a 1:1 stoichiometry of the reaction partners 
(diene and benzaldehyde) are quite attractive. It is noteworthy to add that for the first 
time, Et3B played an important role as a reducing agent in maintaining the catalytic cycle 
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Scheme 1.22 Ni-catalyzed homoallylation of benzaldehyde with dienes. 
 
The author proposed the most plausible reaction pathway that accommodates both 
stereoselectivity leading to 1,3-anti-product over 1,3-syn-product and regioselectivity 
which gives homoallylation products over the allylation products where isoprene is 
representative of dienes. The regioselectivity of dienes (reacting either at C1 or C4 with 
an aldehyde) might be predominantly controlled by the electron densities on the diene 
termini, and the reaction occurs at the termini bearing the highest electron density. The 
1,3-anti-diastereoselectivity might be explained by the relative stability of the two 
intermediates 1.94 and 1.94’. Since intermediate 1.94’ suffers from 1,3-diaxial repulsion 
between an aldehyde R group and isoprene methyl group, the reaction should proceed 
selectively through intermediate 1.94. Moreover, the route leading to intermediate 1.97 is 
expected to be favored over the one leading to intermediate 1.97’ since the β-agostic 
interaction of the Et group with the vacant site on Ni, cis to the Et group. This vacant site 












































































Scheme 1.23 Plausible reaction pathways selectively leading to 1,3-anti-product. 
 
Generally, reactions with homoallylic metals (e.g. Li, Mg) should be performed 
with care under anhydrous conditions, and are generally not effective with acidic 
compounds. In 2001, the Tamaru group found that the Ni-catalyzed reductive coupling of 
dienes and aldehydes could be performed in the presence of water and alcohols.41 
Isoprene reacted with glutaraldehyde (available as a 50% aqueous solution) 
regioselectively at the C1 position and stereoselectively to furnish 1,3-anti-product 1.99 
in 57% yield as a single isomer. Hemiacetal 1.100 also participated in this reaction to 




















100 mol%  
Scheme 1.24 Ni-catalyzed homoallylation in the presence of water and hemiacetal. 
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1.4.2 Ni-Zn System 
In 1999, the Tamaru group developed a Ni/Et2Zn system for the reductive 
homoallylation reaction. The Ni/Et2Zn combination is particularly effective for the 
homoallylation of saturated aldehydes and ketones, which were unreactive with the 
Ni/Et3B system. Treatment of cyclohexane carboxaldehyde with excess isoprene in the 
presence of a catalytic amount of Ni(acac)2 and 2.4 equiv. of Et2Zn generated the 
coupling product 1.102 in 83% yield with good 1,3-anti-selectivity. Ketones were 
entirely unreactive with the Ni/BEt3 catalyst system. However, the Ni/Et2Zn system 
proved to be advantageous for reactions with ketones. In the reaction with ketones, partial 
loss of regioselectivity was observed and mixtures of 1.103 (the C1 addition product) and 
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Scheme 1.25: Ni-catalyzed homoallylation of aldehydes and ketones. 
 
The proposed mechanism for the homoallylation of aldehydes with the Ni/Et2Zn 
is illustrated in Scheme 1.26. The s-trans-isoprenenickel(0) complex 1.105 selectively 
reacts at the C1 position bearing the highest electron density, and the carbonyl group of 
the aldehyde is activated by Et2Zn via 1.106. In the transition state 1.107, the aldehyde 
may be arranged in such a way to avoid a quasi-1,3-diaxial repulsion to furnish the 1,3-
 24
anti-product. With a ketone however, a 1,3-diaxial repulsion is inevitable in transition 
state 1.108. As a result, a sterically less demanding C4 addition of isoprene may compete 











































Scheme 1.26 Proposed transition state models. 
 
In 2002, the Loh group reported Ni-catalyzed homoallylation of cyclic diene (1,3-
cyclohexadiene) and aldehydes in the presence of Et2Zn as the reducing reagent. 1,3-
Cyclohexadiene reacted with the chiral steroidal aldehyde 1.109 to afford the desired 
product 1.110 and 1.111 in 61% combined yield and a moderate 3:1 1,2-
diastereoselectivity. The author proposed that a less rigid, open-chain transition state may 
be responsible for the low 1,2-diastereoselectivity observed with the cyclic diene 
(Scheme 1.27).43 
 





61% (anti:syn = 75:25)
(400 mol%)
1.109 1.110 (anti) 1.111 (syn)
 
Scheme 1.27 Ni-catalyzed homoallylation of aldehydes with cyclic 1,3-dienes.  
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In 2007, the Zhou group reported the first asymmetric reductive coupling of 1,3-
dienes and aldehydes. To achieve high enantioselectivity, the group examined nickel 
complexes ligated with bulky spirobiindane phosphoramidite ligands, and employed 
Et2Zn as a reducing reagent. With ligand 1.112, enantiomerically enriched bishomoallylic 
alcohols were produced in high yields with excellent diastereoselectivities and 








































Scheme 1.28 Asymmetric reductive coupling of 1,3-dienes and aldehydes.  
 
1.4.3 Ni-Silane System 
In 1998, the Mori group introduced the Ni(COD)2/PPh3/Et3SiH catalyst system 
for intermolecular reductive coupling of 1,3-dienes and aldehyde. Upon exposure of 
diene 1.113 to benzaldehyde in the presence of Ni(COD)2, PPh3, and Et3SiH in toluene at 
50 oC, triethylsilyl protected alcohol 1.114 was obtained in 84% yield as sole product in a 















Scheme 1.29 Ni-Catalyzed homoallylation of aldehydes with organosilane. 
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The proposed reaction pathways are outlined in Scheme 1.30. In this reaction, 
nickel hydride complex 1.115 generated by the oxidative addition of Et3SiH to Ni(0) is 
coordinated by diene 1.113 to give complex 1.116. The insertion of the diene into the 
nickel-hydride bond produces nickel π-allyl complexes anti-1.117 and anti-1.118, which 
would be in equilibrium with the more stable syn-1.119 and syn-1.120. Then, syn-1.119 







































Scheme 1.30 Proposed reaction pathways. 
 
The Mori group also developed a Ni/carbene/Et3SiH catalyst system for the 
reductive coupling of 1,3-dienes and aldehydes.46 It was found that Ni-carbene complex 
1.121 showed a unique property in the ability to couple 1,3-dienes and aldehydes to 
afford coupling product 1.122, possessing the (Z)-olefin exclusively in good yield in a 
highly stereoselective manner (Scheme 1.31).45 This indicates that the reactivity of Ni-
 27
carbene complex 1.121 is quite different from those of the traditional Ni(0)-phosphine 



















Scheme 1.31 Ni-catalyzed homoallylation of aldehydes with a carbene ligand. 
 
1.4.4 Rh-H2 System 
In 2003, the Krische group reported the rhodium-catalyzed reductive coupling of 
cyclohexadiene and carbonyls under hydrogenation conditions. It is noteworthy that 
hydrogenation of conjugated alkenes in the presence of phenyl glyoxal provided 
reductive carbonyl-ene type coupling products. Under optimum conditions, 1,3-
cyclohexadiene coupled to a range of α-ketoaldehydes 1.123 to produce the 

























Scheme 1.32 Rh-catalyzed reductive coupling of 1,3-dienes and carbonyls. 
 
Based on a deuterium labeling study, a plausible mechanism was proposed. Initial 
oxidative coupling of diene and glyoxal would furnish an oxarhodacyle 1.127, which then 
reacts with deuterium via σ-bond metathesis to afford rhodium alkoxide complex 1.128. 
Subsequent abstraction of an allylic hydrogen provides a rhodium π-allyl complex 1.129, 
 28
which upon C-D reductive elimination delivers the dideuterated products as an equimolar 














































Scheme 1.33 Plausible catalytic cycle supported by 2H-labeling. 
 
1.5 REDUCTIVE COUPLING OF CONJUGATED ALKYNES WITH CARBONYLS 
1,3-Dienes are important and useful intermediates in synthetic chemistry. Since 
they can be used in an array of cycloaddition reactions such as Diels-Alder reaction, there 
are a variety of efficient methods for their preparation.47 Recently, a new method for the 
synthesis of 1,3-dienes via metal-catalyzed reductive coupling of 1,3-enyne and carbonyl 
compounds has been developed by several groups.32, 37, 48 
 
1.5.1 Ni-Borane System 
In 2004, the Jamison group reported the Ni-catalyzed reductive coupling of 1,3-
enynes and aldehydes to produce 1,3-diene compounds. In the nickel catalyzed coupling 
reaction of aryl alkyl acetylene (Ar-C≡C-alkyl), the regioselectivity is generally very 
high (>95:5), favoring carbon-carbon bond formation distal to the aromatic group. 
Interestingly, electronically similar and smaller vinyl groups cause a complete reversal in 
 29
sense of regioselectivity. In these cases, carbon-carbon bond formation proximal to the 
aryl substituent (1.132) is favored. Additionally, the alkene substituent provided a 
remarkable increase in reactivity. For instance, sterically demanding t-Bu-C≡C-CH=CH2 
underwent reductive coupling, favoring carbon-carbon bond formation adjacent to the 
tert-Bu group (1.133). It is important to note that the directing ability of the alkene 
depends neither on the nature or size of the other alkyne substitution (aryl, akyl (1o, 2o, 
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Scheme 1.34 Ni-Catalyzed reductive coupling of 1,3-enynes and aldehydes.  
 
The Jamison group also developed an enantioselective variant of nickel-catalyzed 
reductive coupling of 1,3-enynes and aldehydes by employing P-chiral ferrocenyl mono-
phosphine ligand. Among monodentate phosphine ligands assayed, ferrocenylphosphine 
1.135 provided high levels of regioselectivity (>95:5) with moderate enantioselectivities 
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Scheme 1.35 Asymmetric reductive coupling of 1,3-enynes with aldehydes. 
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The Jamison group extended this reaction to the asymmetric reductive coupling of 
1,3-enynes with ketones. The catalytic reductive coupling of alkyl 1,3-enynes with 
acetophenone produced the tertiary alcohol product 1.136 in 62% yield with excellent 
regioselectivity. In addition, the reaction of commercially available 2-methyl-1-hexene-3-
yne with acetophenone gave coupling product 1.137 in good yield with complete 
regiocontrol. In addition to acetophenone, a heteroaromatic ketone and a α,β-unsaturated 
ketone successfully participated in the reaction to give the corresponding coupling 
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Scheme 1.36 Asymmetric reductive coupling of 1,3-enynes with ketones. 
 
1.5.2 Rh-H2 System 
In 2003, the Krische group reported the rhodium-catalyzed reductive coupling of 
diynes and activated aldehydes under hydrogenation conditions.38 Treatment of 
diphenylbutadiyne with phenyl glyoxal and catalytic [Rh(COD)2]OTf in dichloroethane 
afforded the conjugated diene product 1.140 in good yield as a single regio- and 
stereoisomer. To explore the feasibility of an enantioselective variant, a variety of 
commercially available chiral triarylphosphine ligands were screened. Among those 
assayed, (R)-Cl-MeO-BIPHEP proved superior, providing 1.140 in 74% yield and 76% 
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ee. Through variation of the reaction medium, benzene was identified as the ideal solvent, 
affording a 74% yield of 1.140 in 91% ee. Heteroaryl glyoxal and alkyl glyoxal also 
participated in the reaction to produce the corresponding products 1.141 and 1.142 in 


































Scheme 1.37 Asymmetric reductive coupling under hydrogenation conditions. 
 
The reductive coupling of 1,3-diynes and activated aldehydes was further 
extended to the reductive coupling of 1,3-enynes and α-ketoaldehydes. Exposure of 1-
phenyl but-3-en-1-yne 1.143 to phenyl glyoxal in the presence of Rh(COD)2OTf and 
BIPHEP in DCE under an atmosphere of hydrogen provided the highly unsaturated 
diene-containing product 1.144 in 86% yield as a single regio- and stereoisomer. In 
addition, the reaction of heteroaryl and alkyl glyoxal gave the corresponding products 
1.145 and 1.146 in good yields. Similar to Jamison’s Ni-catalyzed reductive coupling of 
1,3-enynes with carbonyls,48 the regioselectivity is generally very high (>95:5), favoring 




















1.146 (61%)1.143  
Scheme 1.38 Rh-catalyzed reductive coupling of 1,3-enynes and carbonyls. 
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To gain insight into the origins of chemo- and regioselectivity observed for the 
intermolecular reductive coupling of 1,3-diynes and 1,3-enynes with α-ketoaldehydes, a 
series of competition experiments were performed. As a result, it was found that the 
diyne is the most reactive. Additionally, the enyne is more reactive than the diene for the 
reductive coupling reaction. Chemoselective coupling to the more highly unsaturated 
pronucleophile suggests preferential coordination of the most π-acidic reacting partner by 
low-valent rhodium and pronucleophile complexation to the metal center might control 






















































Scheme 1.39 Competition experiments. 
 
In 2006, the Krische group reported a Rh-catalyzed enantioselective reductive 
coupling of 1,3-enynes with pyruvates as a means of accessing enantiomerically enriched 
α-hydroxy acids. It was found that the reductive coupling of 1,3-phenylenyne with ethyl 
pyruvate in the presence of Rh(COD)2OTf and (R)-xylyl-WALPHOS produced the 
coupling product 1.147 in good enantiomeric excess but only moderate yield. It was 
thought that hydrogenolytic cleavage of the Rh-O bond in the catalytic cycle might be the 
rate determining step. Indeed, it is known that the Rh-O bond is easily cleaved in 
presence of protic additives such as H2O.49 Additionally, computational studies suggest 
 33
that four-centered transition structures for hydrogenolysis of Rh-O bonds are higher in 
energy than those occurring by way of six-centered transition structures involving 
rhodium carboxylates.50 It was hypothesized that an acid cocatalyst might enhance 
reaction rate, a variety of acids were screened. Gratefully, triphenylacetic acid 
dramatically influenced the rate of conversion without decreasing enantioselectivity. 
Under optimized reaction conditions, a variety of 1,3-enynes were tested. Aryl, 
heteroaryl, alkyl substituted 1,3-enynes coupled very well to give products 1.147-1.149 in 


































Scheme 1.40 Asymmetric reductive coupling of 1,3-enynes and activated ketones. 
 
The results of the reductive coupling employing ac acid additive provided 
significant insight into the mechanistic framework of the rhodium-catalyzed reductive 
coupling of enynes and diynes. Based on the deuterium labeling study and acid additive 
effect, a plausible mechanism was proposed. The catalytic cycle is initiated by oxidative 
coupling of enyne and pyruvate to form oxarhodacyclopentene 1.150. Subsequently, 
hydrolytic cleavage of Rh-O bond through 1.151 produces rhodium carboxylate 1.152. 
Hydrogenolysis of Rh-O bond in 1.152 through six-centered transition structure 1.153 via 
σ-bond metathesis with deuterium gas generates alkenyl rhodium intermediate 1.154, 






























































Scheme 1.41 Proposed catalytic cycle. 
Recently, the Krishce group disclosed a Rh-catalyzed reductive coupling of 1,3-
enynes with heterocyclic aromatic aldehydes and ketones. In case of the reductive 
coupling of 1,3-phenyenyne to 2-pyridinecarboxaldehyde 1.155, a chiral Brønsted acid 
co-catalyst 1.15651 derived from BINOL produced the optically enriched coupling 
product 1.157 in 82% ee. This result strongly suggests that carbon-carbon coupling is 
accelerated by substrate protonation via a LUMO lowering effect, and that the chiral acid 
co-catalyst is associated with 2-pyridine-carboxaldehyde during the enantiodeterming 
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Scheme 1.42 Plausible catalytic mechanism as supported by chiral acid effect. 
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1.6 REDUCTIVE COUPLING OF CARBONYLS WITH CARBONYLS 
Reductive coupling of carbonyl compounds have found extensive use in organic 
synthesis.52 In particular, stereoselective pinacol couplings have received much attention 
since enantiomerically pure diols can be used for asymmetric syntheses.53 In addition, the 
pinacol coupling has been employed as a key step in the syntheses of many natural 
products and pharmaceuticals.54 In 1973, two research groups, Mukaiyama55a and 
Tyrilik,55b independently reported this coupling reaction mediated by metal. Later, in 
1974, the McMurry group studied the pinacol coupling reaction in detail using either a 
TiCl3-LiAlH4 system or TiCl3-Zn/Cu system.55c The importance of this reaction and the 
utility of the pinacol product warranted extensive studies employing other transition 
metals as reducing reagents in this coupling. 
 
1.6.1 Titanium Catalysts 
The Sato group reported that aliphatic aldehydes or ketones were reduced by 
Cp2TiCl2-catalyzed Grignard reagents to form the corresponding alcohols.56 In the course 
of studying Ti-catalyzed reduction of aryl ketones, the Zhang group observed that when 
the reaction of Grinard reagents with diaryl ketones was carried out in the presence of a 
catalytic amount of Cp2TiCl2, reductive coupling was observed and usual 1,2-addition 
was suppressed. The author proposed that the principle intermediate of the catalytic 
reductive coupling could be [Cp2TiH], and the unpaired electron on Ti is transferred to 
the ketones inducing some radical character at the ketone carbon atom (Scheme 1.43).57  
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Scheme 1.43 Ti-catalyzed pinacol coupling of diaryl ketones. 
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Later, highly diastereoselective Ti-catalyzed reductive coupling was developed by 
Gansäuer in 1997. To convert the known stoichiometric pinacol reaction58 to a catalytic 
reaction, Gansäuer introduced Zn as a reductant and TMSCl as a promoter. The reductive 
coupling of benzaldehyde in the presence of Zn and Me2SiCl2 with 10 mol% of Cp2TiCl2 
gave pinacol conversion to produce coupling product 1.158 in good yield but with low 
diastereoselectivity. The diastereoselectivity was improved by adding 1 equiv. of MgBr2. 
It is believed that Mg would replace Zn to give a tighter dimeric titanium catalyst (Figure 
1.2). 4-Chlorobenzaldehyde and 2-furanecarboxaldehyde participated in the reaction to 
give the corresponding pinacol products 1.159 and 1.160 in good yields with high 
diastereoselectivies (Scheme 1.44).59 
 
MgBr2, Me3SiCl




















Scheme 1.44 Pinacol coupling of aldehydes catalyzed by a titanocene complex.  
 
Mechanistically, it was assumed that the catalytically active species could be a 
dimeric titanium complex binding both ketyl radicals. The observed syn-selectivity could 
be explained by minimization of steric interference through anti-orientation of the Ar 







































Figure 1.2 Catalytically active species controlling diastereoselectivity. 
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In 1998, the Gansäuer group demonstrated that catalytic turnover of titanium in 
the catalytic pinacol coupling could be achieved by protonation of a metal-oxygen bond 
in buffered protic media by properly adjusting the pKa of the employed acid additive. 
The use of 2,4,6-collidine hydrochloride (pKa value in water 7.43) as an acid additive 
improved both diastereoselectivity and reactivity in the Ti-catalyzed pinacol coupling. In 
addition, it was found that using manganese as a stoichiometric reductant in the coupling 
vastly superior to zinc in respect to both yield and diastereoselectivity. The proposed 























Scheme 1.45 Proposed catalytic cycle under protic conditions. 
 
The Nelson group reported the use of organic-soluble Ti(III) complexes as highly 
efficient catalysts for pinacol homocoupling reactions. In the course of these studies, they 
discovered that the organic-soluble TiCl3(THF)3 was applicable to the pinacol coupling of 
enolization-prone aldehydes. Optimal conditions were determined to be reaction of the 
aldehyde with 1.2 equiv. of Zn, 1.2 equiv. of TMSCl, and 5 mol% of TiCl3(THF)3-t-
BuOH. Alkyl aldehyde 1.162 was subjected to the reaction conditions to produce pinacol 
coupling products 1.163 and 1.164 in 76% yield with moderate diastereo-selectivity 
(Scheme 1.46).61 
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 Me3SiCl (120 mol%)























Scheme 1.46 Ti-catalyzed pinacol coupling of enolization-prone aldehydes. 
 
The Nicholas group reported the first titanium-catalyzed enantioselective pinacol 
coupling using chiral Brintzinger’s catalyst, (R,R)-ethylenebis(tetrahydroindenyl)titanium 
dichloride. Under optimized conditions, the reductive homocoupling of benzaldehyde 
catalyzed by the chiral Ti-complex gave pinacol 1.165 in 60% ee. This result 
demonstrated the first catalytic asymmetric pinacol coupling and the viability of this 

















Scheme 1.47 Enantioselective pinacol coupling with Brintzinger’s catatalyst. 
 
In 2001, the Riant group reported a catalytic enantioselective pinacol coupling of 
aldehydes catalyzed by chiral titanium complexes. To achieve asymmetric induction, an 
air-stable, nonhygroscopic catalyst 1.166 derived from tridentate salen ligands and TiCl4 
was prepared and the feasibility of this catalyst for enantioselective pinacol coupling was 
investigated. A survey of various reductants indicated manganese to be the best choice at 
-10 oC. While electron-donating substituents gave a noticeable increase in the ee of the 
pinacol products (4-methoxybenzaldehyde and 4-methyl-benzaldehyde), the introduction 
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of an electron-withdrawing group strikingly decreased enantioselectivity (4-bromo-





































Scheme 1.48 Enantioselective Pinacol coupling by the Riant group.  
 
1.6.2 Vanadium Catalysts 
In 1996, the Hirao group reported the first vanadium-catalyzed reductive coupling 
of aldehydes. Treatment of hexanal with a catalytic amount of CpV(CO)4 in the presence 
of zinc powder and chlorotrimethylsilane in DME at room temperature led to high yields 
of 2,4,5-tripentyl-1,3-dioxolanes 1.167-1.169 via the reductive coupling and acetalization 
of the 1,2-diol derivative (Scheme 1.49 (a)).64a Later, the group found that use of THF as 
solvent and Cp2VCl2 as catalyst led to the highly diastereoselective formation of the dl-
1,2-diols 1.170 and 1.171 from secondary aliphatic aldehydes without formation of any 
olefinic products and 1,3-dioxolane 1.172. In particular, this catalyst system was 
applicable to the pinacol coupling of a variety of secondary aliphatic aldehydes to give 
the desired products in good to excellent yields and with high diastereoselectivities. 
However, the pinacol coupling of primary aliphatic aldehydes and ketones still suffered 































96          :           4         :             0
(b)
1.167 1.168 1.169
100 % combined yield
1.170 1.171 1.172
 
Scheme 1.49 Vanadium-catalyzed pinacol coupling of aliphatic aldehydes. 
 
Recently, the catalytic pinacol coupling reaction in water was reported by the 
Hirao group.65 It was demonstrated that the reaction successfully proceeded with VCl3-Al 
catalyst system in water even in the absence of a chlorosilane, which was previously 
required as an essential additive in organic media. This catalyst system (VCl3-Al-water) 
is considered to be of synthetic potential as an environmentally harmonious system. 
 
1.6.3 Chromium Catalysts 
In the course of the study on chromium-catalyzed Nozaki-Hiyama-Kishi reaction, 
the Fürstner group observed that the use of electron deficient aldehydes afforded the 
pinacol as the major product.66 Inspired by the Fürstner group’s result, the Boland group 
systematically investigated the chromium-catalyzed reductive pinacol coupling of 
aromatic carbonyl compounds. Treatment of benzaldehyde in a binary solvent mixture of 
THF/DMF with CrCl3 (5 mol%) and trimethylsilyl chloride in the presence of Mn-dust 












1.182 (dl):1.183 (meso) = 47:53
1.173
+
70 % combined yield
1.174
 
Scheme 1.50 Cr-catalyzed reductive pinacol coupling of aromatic carbonyls. 
 
Most of catalytic pinacol coupling methods reported were limited to the 
homocoupling of aldehydes affording symmetrically substituted 1,2-diols. In 2001, the 
Takai group reported the cross pinacol-type coupling reaction between α,β-unsaturated 
carbonyl compounds and aldehydes using 4 equiv. of chromium(II) chloride.68a The 
catalytic variant of Takai’s method was developed by Groth in 2002. They observed that 
the couplings of vinyl ketones 1.175 with aliphatic aldehydes proceed with only 10 mol% 
of chromium(II) chloride affording the desired products 1.176-1.178 in up to 80% yield 



























Scheme 1.51 Cr-catalyzed diastereoselective pinacol-type cross coupling. 
 
A postulated catalytic cycle is illustrated in Scheme 1.52 based on the mechanism 
of Takai.68a It should be noted that this reaction does not proceed through ketyl radicals. 
Instead, a nucleophilic attack of a chromium allyl apecies onto an aldehyde is proposed. 
The reduction of an α,β-unsaturated ketone with chromium(II) would generate the radical 
enolate 1.179, which could be trapped with Me3SiCl to give the allylic radical 1.180. 
Such an allylic radical could be easily reduced with chromium(II) to afford the 
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corresponding allylic chromium species 1.181. The coupling of allylic chromium 



































Scheme 1.52 Postulated catalytic cycle. 
 
Highly enantioselective chromium-catalyzed pinacol couplings have been 
developed by the Yamamoto group using a new tethered bis(8-quinolinolato) ligand 
1.182. Treatment of benzaldehyde with co-reducing reagent (Mn), the product scavenger 
(TMSCl), and the precatalyst [TBSOxCr(III)Cl] 1.183 in CH3CN under an atmosphere of 
argon at room temperature generated the pinacol coupling product 1.184 in 94% yield 
and 97% ee after acidic work-up. Additionally, the scope of this method was found not to 
be limited to aromatic aldehyde derivatives, as cyclohexanecarboxaldehyde underwent 
pinacolization (1.185, 44% yield, dl:meso=93:7, 84% ee). In catalytic pinacol coupling 
reactions, the role of chlorosilane is generally considered to cleavage the metal-oxygen 
bond of a putative pinacol formed to recycle the catalyst. However, they observed that 
TESCl provided better stereoselectivities than TMSCl in the catalyst system. This 
catalyst system represents the first example of the asymmetric catalysis of an aliphatic 










1) TBOxCrCl (1.183, 3 mol%)
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TBOxH + CrCl2       TBOxCrCl (1.183)  
Scheme 1.53 Cr-catalyzed enantioselective pinacol coupling. 
 
1.6.4 Samarium Catalysts 
In 1996, the Endo group reported that Sm-catalyzed reductive coupling of 
aldehydes and ketones. In order to incorporate SmI2 into the catalytic cyle, it is first 
required that samarium species must be reduced. Due to the similar reduction potential 
between Sm and Mg (-2.41 and -2.37 V, respectively), the possibility of Mg as reducing 
agent of trivalent samarium was investigated. Optimal conditions were found to be 
reaction of the aldehyde with a catalytic amount of SmI2 in the presence of Mg/Me3SiCl 
in THF. Aldehydes as well as ketones participated in the reaction to produce the 


























On the basis that reactions employing both catalytic and stoichiometric SmI2 
exhibited the same level of diastereoselectivity, it was proposed that the carbon-carbon 
bond formation proceeds prior to silylation of the alkoxide. The possible reaction 
pathway involves the reduction of carbonyl compounds by SmI2 to give Sm(III) 
alcoholates 1.189 followed by silylation of the alcoholates by TMSCl to provide the 
corresponding silyl ether and SmI2Cl. SmI2 or SmClI would be regenerated by the 













(X = Cl or I)
1.189  
Scheme 1.55 Proposed catalytic cycle for Sm-catalyzed pinacol coupling.  
 
In 2005, the Greeves group reported the samarium-catalyzed diastereoselective 
pinacol coupling. To achieve high diastereoselectivity, a variety of potentially chelating 
ligands were screened. In the catalytic reaction, it is necessary for the chelating ligand to 
be sufficiently flexible to bind both the very large Sm2+ ion (eight-coordinate with radius 
of 141 pm) and the smaller Sm3+ ion (eight-coordinate with radius of 124 pm). It turned 
out that tetraglyme fulfilled this requirement to increase diastereoselectivity up to 90%. 
The author proposed the active catalyst for the pinacol coupling is Sm-tetraglyme 
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2
 SmI2 (10 mol%)
62 - 83% yield
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Scheme 1.56 Sm-catalyzed pinacol coupling using chelating ligand. 
 
1.6.5 Other Catalysts (Nickel and Cesium) 
The Tu group found that Rieke Ni generated in situ was able to efficiently 
promote the pinacol coupling of various carbonyls. Additionally, the group examined the 
cheaper and more convenient NiCl2(cat.)/Mg/TMSCl system for the pinacol coupling. 
Slow addition of a solution of the carbonyl compounds and TMSCl to the mixture of 
catalytic NiCl2 and Mg afforded the pinacol coupling product 1.191 in 70% yield with a 
moderate diastreoselectivity. Heteroaryl aldehyde (1.192), alkyl aldehyde (1.193), and 
ketone (1.194) also participated in the reaction to produce dimerized products in good 
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Scheme 1.57 Ni-catalyzed pinacol coupling. 
 
In 2000, the Groth group demonstrated that cerium(III) isopropanolate catalyzed 
pinacol couplings of carbonyl compounds where diethylzinc is used as reducing agent. 
The advantages of this method are numerous. First, both aliphatic aldehydes and aromatic 
aldehydes can be coupled with high diastereoselectivities. Additionally, this method 
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allows pinacol preparation on a large scale which is of great interest for industrial 
applications. It is noteworthy that this reaction represents the first cerium-catalyzed 




























Scheme 1.58 Ce-catalyzed pinacol coupling. 
 
1.7 MICELLANEOUS 
1.7.1 Reductive Cycloaddition 
In 2000, Montgomery reported the stoichiometric nickel-promoted reductive 
[3+2] cycloaddition of tethered alkynes and enals.74 The development of a catalytic 
variant of the reaction was found to be problematic due to competitive alkyne 
trimerization and difficulty in the reduction of Ni(II) to Ni(0) required to close the 
catalytic cycle. Upon screening various ligands and reaction conditions, it was found that 
a simple catalytic system involving triethylborane as a stoichiometric reductant, 
tributylphosphine as ligand, and a methanol/THF cosolvent system allowed the desired 
reductive [3+2] cycloaddition to proceed efficiently. The key for success requires that a 
Ni(0) species, a reducing agent (Et3B), and a weak Brønsted acid (MeOH) can all coexist 
under the reaction conditions. A wide range of conjugated enals 1.195 underwent 
catalytic diastereo-selective and regioselective [3+2] cycloaddition with internal alkynes 
1.196 to produce the reductive cycloaddition products 1.197-1.201 in good yields and 













































Scheme 1.59 Ni-catalyzed reductive cycloaddition of alkynes and enals. 
 
More recently, Cheng reported a cobalt-catalyzed diastereoselective reductive 
[3+2] cycloaddition of allenes and enones. Treatment of allenes 1.202 with α,β-
unsaturated ketones 1.203 in the presence of CoI2(dppe), Zn, ZnI2, and water in CH3CN 
gave cyclopentanol derivatives 1.204-1.207 in very good yields with excellent chemo- 
and regioselectivity. In all cases, the cycloaddition took place exclusively at the terminal 
double bond placed at the 3-position of cyclopentanol. (Scheme 1.60).76  
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Scheme 1.60 Co-catalyzed reductive cycloaddition of allenes and enones. 
 
To understand the role of water and to elucidate the mechanism of the reaction, an 
isotope labeling using D2O was carried out. The results showed that the 5-position on the 
cyclopentanol ring and the alcohol were both deuterated. Based on the deuterium labeling 
results, a plausible mechanism was proposed. The catalytic cycle is initiated by the 
reduction of Co(II) to Co(I) by zinc dust. Next, the chemoselective cyclometallation of 
Co(I) with allene and enone forms cobaltacyclopentane intermediate 1.208. Selective 
protonation of 1.209 followed by carbonyl insertion into the cobalt-carbon bond produces 
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the cobaltalkoxide 1.210. Subsequent protonation of alkoxide 1.211 leads to the observed 










































Scheme 1.61 Proposed catalytic cycle for Co-catalyzed reductive cycloaddition.  
 
1.7.2 Reductive Coupling of Alkynes and Epoxides 
In 2003, Jamison reported a Ni-catalyzed reductive coupling of alkynes and 
epoxides. Exposure of alkyne and chiral epoxide to nickel(0) in the presence of Et3B 
provided homoallylic alcohols in moderate yields with high regioselectivity. While there 
was little dependence of yield upon solvent choice, maximum yield was obtained in the 
absence of traditional organic solvent. In addition, it was noteworthy that the optical 





























Scheme 1.62 Ni-catalyzed reductive coupling of alkynes and epoxides. 
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1.7.3 Reductive Coupling of Allenes and Aldehydes 
In 2005, Jamison reported a highly enantioselective and regioselective Ni-
catalyzed reductive coupling of allenes and aldehydes. In examining combinations of 
allenes, aldehydes, and reducing agents, a Ni(COD)2-Cyp3P-Et3SiH system turned out to 
be excellent for chemoselectivity (the ratio of allylic and homoallylic products was 
>95:5), but the enantioselectivity was seriously decreased from 95 to 62% ee. However, 
it was found that the use of Ni(COD)2-imidazolinyl carbene-R3SiH system completely 
eliminated this limitation to give the coupling product in good yields and excellent 
enantioselectivies. Additionally, they documented full transfer of allene axial chirality in 


















































Scheme 1.63 Ni-catalyzed reductive coupling of allenes, aldehydes, and silanes. 
 
Mechanistically, it is believed that there is a direct link between the selectivity for 
the (Z)-alkene geometry and the sense of induction of deuterium labeling. σ-Bond 
metathesis between 1.213 and Et3SiD could afford η3-allyl-Ni complex 1.214. Reductive 
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elimination with retention leads to the observed (Z)-alkene and (R)-configuration at the 
labeled carbon (1.215). On the other hand, the alternative complex 1.216 gives the 
opposite sense of selectivity in both cases ((E)and (S), respectively). The absence of 
(E,S)-product 1.217 can be explained by the severe 1,3-interaction between the Me and 















































Scheme 1.64 Plausible reaction pathways supported by 2H-labeling. 
 
1.7.4 Multicomponent Reductive Coupling of Acetylene and Carbonyls 
More recently, the Krische group demonstrated the multicomponent reductive 
coupling of acetylene with carbonyl compounds. Exposure of phenethyl glyoxalate to 
equal volumes of hydrogen and acetylene gas in the presence of Rh(COD)2OTf (5 
mol%), triphenylacetic acid (TPAA, 5 mol%) as cocatalyst, and BIPHEP as a ligand 
produced carbonyl (Z)-butadienylation product 1.218 in 32% yield. It was found that the 
cationic rhodium(I) counterion played a decisive role. As expected, precatalysts 
possessing chloride counterions provided none of the reductive coupling product. 
However, in the series Rh(COD)2X, where the counterion X is OTf, BF4, SbF6, and 
BARF (B(3,5-(CF3)2C6H3)4, counterions that coordinate to the rhodium metal less 
strongly than OTf uniformly provided the coupling product 1.218 in higher yield. These 
 51
optimized conditions were applied successfully to a diverse set of carbonyl partners. α-
Ketoester and aromatic aldehydes successfully participated in the reductive coupling to 
produce the corresponding products 1.219 and 1.220 in good yields. Moreover, 
enantioselective (Z)-butadienylation of aldehydes using (R)-MeO-BIPHEP as a chiral 
ligand produced the corresponding coupling products 1.221 and 1.222 in 88% ee and 













































Scheme 1.65 Reductive coupling of acetylene and carbonyls. 
 
As corroborated by deuterium labeling studies, the catalytic mechanism likely 
involves oxidative dimerization of two acetylene molecules to form a rhodacyclo-
pentadiene 1.223 followed by carbonyl insertion. Subsequent protonolytic cleavage of the 
oxarhodacycloheptadiene 1.224 by the acid co-catalyst gives rise to a vinyl rhodium 
carboxylate 1.225, which upon hydrogenolysis through a six-centered transition structure 
and C-D reductive elimination of rhodium deuteride 1.226 delivers the coupling product 
(Scheme 1.66). In order to further confirm the mechanistic probe, ESI-MS studies were 
conducted. As shown in Figure 4.2, the most abundant ions, as assigned on the basis of 
their m/z values, correspond to species postulated to arise in the proposed catalytic cycle 














































































1.8 SUMMARY AND OUTLOOK 
Over the past decade, catalytic intermolecular reductive couplings have evolved 
into a broadly useful strategy for assembling synthetically versatile substructures and 
complex molecules. In this regard, the reductive coupling technology has added valuable 
processes to the synthetic toolbox. Yet, we have barely scratched the surface of immense 
possibilities afforded by catalytic intermolecular reductive coupling technology. Future 
challenges will be the development of cross coupling of alkenes, cross coupling of 
alkynes, and coupling of simple alkenes (not conjugated alkene) with aldehydes. Finally, 
the further evolution of catalytic intermolecular reductive couplings will provide a robust 
technology to obtain useful organic compounds from easily accessible starting materials, 
while using more “green” chemistry and addressing issues of atom economy, cost 
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Chapter 2 Hydrogen-Mediated Carbon-Carbon Bond Formation:        
Discovery and Development  
2.1 INTRODUCTION 
At the threshold of the 21st centry, a new set of challenges was defined by the 
need to develop a sustainable means of preparing the chemical commodities demanded 
by our society. Hence, such concepts as atom economy,1 step economy, and “green 
chemistry”2 have become essential requirements for the development of any synthetic 
reaction. Additionally, the utilization of a set of principles that avoids the use of 
stoichiometric reagents and creation of wasteful chemical byproducts is of importance. 
Hydrogenation is one of the most powerful catalytic methods that can statisfy these 
requirements.3 Accordingly, catalytic hydrogenation has been tremendously utilized 
industrially, accounting for over half of the chiral compounds made by man not produced 
via physical or enzymatic resolution.4 The profound impact of hydrogenation portended a 
powerful approach to reductive carbon-carbon bond formation under hydrogenation 
conditions and resulted in the discovery of the Fischer-Troph process5 and 
hydroformylation.6 However, these processes are restricted to the incorporation of carbon 
monoxide. Therefore, the field of the reductive C-C bond formation under hydrogenation 
conditions has lain fallow for several decades. Even though there have been a few 
seminal contributions,7 systematic efforts toward the development of hydrogen-mediated 
carbon-carbon bond formation process beyond hydroformylation have been absent from 
the literature. Given the profound potential impact of the hydrogen-mediated C-C bond 
formation, the Krische group has initiated systematic efforts towards the development of 
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Scheme 2.1 Hydrogen-mediated C-C bond formation. 
 
2.2 HYDROGENATIVE C-C BOND FORMATION BEYOND HYDROFORMYLATION 
To investigate the feasibility of hydrogen-mediated C-C bond formations, it is 
necessary to review conventional hydrogenation.3 Among catalysts for conventional 
hydrogenation, rhodium catalysts have been studied in greatest detail. For conventional 
hydrogenation, there are three fundamental steps: (1) oxidative addition of hydrogen to 
metal complex (2) hydrometallation of substrate (3) C-H reductive elimination. The 
mechanism of alkene hydrogenation catalyzed by the neutral rhodium complex 
RhCl(PPh3)3 (Wilkinson’s catalyst) has been studied in detail by Halpern.8 In the 
catalytic cycle, the oxidative addition of hydrogen to rhodium complex 2.1 generates a 
dihydrido rhodium complex 2.2. Then hydrometallation of the alkene produces 
organomonohydrido rhodium complex 2.3. It is believed that the hydrogen oxidative 
addition step is a reversible process and the turnover-limiting step. Finally, rapid C-H 
reductive elimination produces the hydrogenation product 2.4 and regenerates the catalyst 
2.1. To achieve carbon-carbon bond formation under hydrogenation conditions, it is 
necessary to intercept the hydrometallated intermediate 2.3 arising transiently in the 
course of catalytic hydrogenation. However, the possibility of C-C coupling is very low 



















Scheme 2.2: Hydrogenation catalyzed by Wilkinson’s catalyst. 
 
Cationic rhodium complexes however, exhibit different characteristics under 
hydrogenation conditions. The hydrogenation of simple alkenes using cationic rhodium 
precatalysts has been studied in detail by Osborn and Schrock.9 Although there is no 
kinetic data, their collective experimental data suggest that both monohydride-based and 
dihydride-based catalytic cycles are operative. It was also documented that monohydride-
based and dihydride-based catalytic cycles may be partitioned by virtue of an acid-base 
reaction involving deprotonation of cationic rhodium(III) dihydride 2.5 to furnish a 
neutral rhodium (I) monohydride species 2.6 (Scheme 2.3). In addition, it was also 
observed that alkene isomerization occurred under hydrogenation conditions using a 
cationic rhodium complex.9(a) From Osborn and Schrock’s studies, the Krische group 
extracted two important facts concerning cationic rhodium complexes. First of all, 
rhodium monohydride-based catalytic cycle may operate in presence of base additives. 
Secondly, substrate hydrometallation from the rhodium monohydride complex 2.7 
furnishes organometallic intermediate 2.8 which lacks hydride ligands. This should 
disable direct C-H reductive elimination manifolds, and extend the lifetime of the 
resulting organometallic intermediate 2.8 to facilitate its capture by electrophilic partners. 
 64
These two pieces of information strongly support the possibility of C-C bond formation 
under hydrogenation conditions using cationic rhodium complexes in the presence of 










































Scheme 2.3: Hydrogenation catalyzed by a cationic rhodium complex. 
 
An alternative pathway involves oxidative coupling of two or more organic 
molecules to furnish a metallocycle 2.9, an intermediate which is well known in other 
rhodium catalyzed coupling reactions.10 In this pathway, C-C bond formation precedes 
hydrogen activation to form the metallocycle 2.9. Subsequently, σ-bond metathesis11 with 
hydrogen provides the reductive coupling product and regenerates the catalyst. This 
hypothesis is further supported by the fact that cationic rhodium complexes are slow to 
activate hydrogen, so oxidative coupling of the reactants may precede hydrogen 
activation leading to carbon-carbon bond formation products (Scheme 2.4(b)). 
On the basis of the mechanistic analysis of rhodium catalyzed conventional 
hydrogenation and the general properties of cationic rhodium complexes, the Krische 
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group identified two possible pathways for hydrogen-mediated C-C bond formation: (1) 
the rhodium monohydride strategy and (2) the oxidative coupling-hydrogenative 

































(a) Rhodium Monohydride Strategy




Scheme 2.4 Potential pathways for hydrogen-mediated C-C bond formation. 
 
2.3 RHODIUM MONOHYDRIDE STRATEGY 
2.3.1 Intramolecular Reductive Aldol Cyclization 
To investigate the idea of the rhodium monohydride strategy, the Krische group 
examined an intramolecular reductive aldol reaction under hydrogenation conditions. As 
expected, hydrogenation of the phenyl-substituted mono-enone mono-aldehyde 2.10 
using neutral rhodium (I) catalyst Rh(PPh3)3Cl furnished the conventional enone 
hydrogenation product 2.12. However, cationic rhodium(I) complexes with the electron 
deficient phosphine (p-CF3Ph)3P, and the base additive KOAc smoothly catalyzed the 
reductive aldol cyclization to produce syn-aldol product 2.11 in 89% yield and good 
diastereoselectivity. The pronounced effect of basic additives on partitioning of the 
aldolization and 1,4-reduction manifolds suggests that the enolate-hydrogen reductive 
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elimination pathway are suppressed through deprotonation of the (hydrido)metal 
intermediates LnRhIIIX(H)2 or (enolate)RhIIIX(H)Ln. Thus, as observed by Osborn and 
Schrock, deprotonation mediated by base additives changes the catalytic mechanism from 
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Scheme 2.5 Reductive aldol cyclization of mono-enone mono-aldehyde. 
 
This intramolecular reductive aldol reaction12 was further extended to the 
reductive cyclization of monoenone monoketone substrates. The Rh-catalyzed reductive 
aldol cyclization of monoenone monoketone 2.13 provided the desired product 2.14 in 
72% yield and with excellent diastereoselectivity. In general, for the reductive aldol 
cyclization of keto-enones, the competitive 1,4-reduction product 2.15 was observered in 
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Scheme 2.6 Reductive aldol cyclization of mono-enone mono-ketone. 
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2.3.2 Intermolecular Reductive Aldol Coupling 
Intermolecular reductive aldol coupling using triphenylphosphine (Ph3P) ligated 
cationic rhodium catalysts provided aldol products in good yields, but with poor levels of 
diastereoselectivity.12 Upon screening of monodentate phosphine ligands, it was found 
that tri-2-furylphosphine ligated cationic rhodium catalysts gave the reductive aldol 
coupling products 2.16 in good yield and with high levels of syn-diastereoselectivity. 
Additionally, it was observed that the basic additive Li2CO3 played a critical role for high 
syn-diastereoselectivity. Under the optimized conditions, commercially available methyl 
and ethyl vinyl ketone 2.17 and divinyl ketones such as crotyl vinyl ketone 2.24 engaged 
in highly diastereoselective reductive aldol coupling with a diverse collection of 
aldehydes to produce the reductive aldol coupling products 2.18-2.23 and 2.25-2.27 in 
good to excellent yields and with excellent diastereoslectivities (Scheme 2.7).14  
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2.18, R1 = Me, 91% (16:1 dr)
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Scheme 2.7 Hydrogen-mediated intermolecular reductive aldol coupling. 
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Inspired by the high stereoselectivity of reductive aldol couplings, the Krische 
group studied the generation of stereotriads by way of reductive aldol couplings to 
optically enriched α-chiral aldehydes. Hence, the hydrogenation of vinyl ketones in the 
presence of N-Boc-α-aminoaldehydes 2.28 at ambient temperature resulted in the 
formation of aldol stereotriads 2.29-2.31 that embody high levels of syn-aldol 
diastereoselectivity accompanied by high levels of anti-Felkin-Ahn control. Presumably, 
intramolecular hydrogen bonding of N-Boc-α-aminoaldehydes might be responsible for 
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> 20:1, anti-Felkin-Anh Selectivity
2.28
 
Scheme 2.8 Hydrogen-mediated reductive aldol coupling to α-aminoaldehydes. 
 
2.4 OXIDATIVE COUPLING-HYDROGENATIVE TERMINATION STRATEGY 
2.4.1 Reductive Cyclization 
To investigate the idea of the oxidative coupling-hydrogenative termination 
strategy, the Krische group examined the reductive cyclization of 1,6-diynes under 
hydrogenation conditions. Catalytic hydrogenation of 1,6-diynes 2.32 employing cationic 
rhodium precatalysts at ambient hydrogen pressure enabled the reductive 
carbocyclization to produce 1,2-dialkylidene cyclopentanes 2.33-2.35 in good to 



























Scheme 2.9 Reductive cyclization of 1,6-diynes. 
 
This method has successfully extended to the reductive cyclization of 1,6-enynes. 
Moreover, the entantioselective reductive cyclization of 1,6-enynes was investigated by 
employing chiral phosphine ligands. Among the chiral triarylphosphines assayed, the 
reductive cyclization of 1,6-enyne 2.36 using (R)-Cl-MeO-BIPHEP provided the desired 
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Scheme 2.10 Enantioselective reductive cyclization of 1,6-enynes. 
 
To gain mechanistic insight, deuterium labeling studies and H/D crossover 
experiments were conducted. Based on deuterium labeling studies, the formal heterolytic 
activation mechanism (rhodium monohydride mechanism) could be ruled out. It is 
assumed that oxidative coupling of a cationic rhodium complex with 1,6-enyne 2.40 
preceed hydrogen activation to afford a metallocycle intermediate 2.42, and subsequent 
hydrogenaction via σ-bond metathesis followed by C-H reductive elimination produces 
the desired products 2.41a-2.41d (Scheme 2.11). Indeed, the rhodacyclopentadiene 





































































Scheme 2.11 Crossover experiments in the absence of base. 
 
 
2.4.2 Intermolecular Reductive Coupling 
To investigate the possibility of an oxidative coupling-hydrogenative termination 
strategy in the intermolecular system, the reductive coupling of diynes and activated 
aldehydes was examined as a model system. Treatment of diphenylbutadiyne with phenyl 
glyoxal in the presence of catalytic [Rh(COD)2]OTf in dichloroethane afforded the 
conjugated diene product in good yield as a single regio- and stereoisomer. To explore 
the feasibility of an enantioselective variant, a variety of commercially available chiral 
triarylphosphine ligands were screened. Among the chiral triarylphosphines assayed, (R)-
Cl-MeO-BIPHEP proved superior, providing the coupling product 2.43 in 74% yield and 
76% ee. Through variation of the reaction medium, benzene was identified as the ideal 
solvent, affording a 74% yield of 2.43 in 91%ee. Heteroaryl glyoxal and alkyl glyoxal 
also participated in the reaction to produce the corresponding products 2.44 and 2.45 in 


































Scheme 2.12 Asymmetric reductive coupling of 1,3-diynes and glyoxals. 
 
The reductive coupling of 1,3-diynes and activated aldehydes was further 
extended to the reductive coupling of 1,3-enynes and α-ketoaldehydes. Exposure of 1,3-
enyne 2.46 to phenyl glyoxal under an atmosphere of hydrogen in the presence of 
Rh(COD)2OTf and BIPHEP in DCE provided the highly unsaturated diene-containing 
product 2.47 in 86% yield as a single regio- and stereoisomer. In addition, the reductive 
coupling to heteroaryl and alkyl glyoxal provided the corresponding products 2.48 and 
























Scheme 2.13 Reductive coupling of 1,3-enynes and glyoxals. 
 
To gain insight into the origin of the chemo- and regioselectivity observed for the 
intermolecular reductive coupling of conjugated alkynes with α-ketoaldehydes, a series of 
competition experiments were performed. It was found that the diyne is the most reactive, 
and the enyne is more reactive than the diene (Scheme 2.14). Chemo-selective coupling 
to the more highly unsaturated pronucleophile suggests preferential coordination of the 
most π-acidic reacting partner by low-valent rhodium, as explained by the Dewar-Chatt-






















































Scheme 2.14 Competition experiments.  
 
2.5 SUMMARY AND CONCLUDING REMARKS 
The results of reductive aldol reaction via rhodium monohydride strategy and 
results of reductive coupling of conjugated alkynes with a set of activated aldehydes via 
oxidative coupling-hydrogenative termination strategy proved the feasibility of carbon-
carbon bond formation under hydrogenation conditions. This novel reductive coupling 
methodology involves the electrophilic trapping of organometallic intermediates during 
the course of catalytic hydrogenation, forming π-unsaturated products without over-
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Chapter 3 Rh-Catalyzed Reductive Coupling of Conjugated Alkynes 
with Iminoacetates and α-Ketoesters 
3.1 INTRODUCTION 
The results of hydrogen mediated reductive coupling of conjugated alkynes with a 
set of activated aldehydes prove the feasibility of the oxidative coupling-hydrogenative 
termination strategy.1 This novel reductive coupling methodology involves the 
electrophilic trapping of organometallic intermediates during the course of catalytic 
hydrogenation, forming π-unsaturated products without over-reduction. The use of 
elemental hydrogen in this class of reactions has potentially overcome the disadvantages 
of many hydrometallative reductive coupling methods which generate stoichiometric 
byproducts.2 These preliminary findings stimulated efforts toward related transformations 
involving imines and ketones as electrophilic partners. In this section, we report three 
different types of hydrogen-mediated reductive couplings: (1) intermolecular reductive 
coupling of 1,3-enynes with iminoacetates, (2) intermolecular reductive coupling of 1,3-
diynes with iminoacetates, (3) intermolecular reductive coupling of 1,3-enynes with α-
ketoesters. 
 
3.2 REDUCTIVE COUPLING OF 1,3-ENYNES WITH IMINOACETATES 
3.2.1 Optimization 
To investigate the possibility of Rh-catalyzed reductive coupling of 1,3-enynes to 
imines under hydrogenation conditions, our initial efforts focused on the hydrogen-
mediated reductive coupling of 1,3-enyne 3.1 (200 mol%) to assorted (N-sulfinyl)-
iminoacetates 3.2 (100 mol%) at ambient pressure and temperature in the presence of 
Rh(COD)2OTf (5 mol%) and BIPHEP (5 mol%) in dichloromethane (0.1M). It was found 
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that hydrogenation of 3.1 in the presence of ethyl (N-para-toluenesulfinyl)iminoacetate 
3.2a3 (100 mol%) provided the desired reductive coupling product 3.3a in 95% yield, but 
with poor diastereoselectivity. A further decrease in diastereoselectivity is observed in 
conjunction with the use of the corresponding mesityl derivative 3.2b. However, 
hydrogenation of 1,3-enyne in the presence of ethyl (N-tert-butanesulfinyl)iminoacetate 
3.2c4 furnished the desired reductive coupling product 3.3c in 55% yield as a single 
regio- and stereoisomer. When the reaction was conducted at higher concentration 
(0.3M), the yield was increased to 92% without loss of selectivity. Finally, at a slightly 
elevated temperature (35 oC), the desired product was obtained in 99% yield as a single 
diastereomer (Table 3.1). 
 





















entry R concentration temp (oC) yield (%) dr
1 Tolyl (3.2a) 0.1 24 95 (3.3a) 3.4:1
2 Mesityl (3.2b) 0.1 24 96 (3.3b) 1.2:1
3 tert-Butyl (3.2c) 0.1 24 55 (3.3c) >95:5
4 tert-Butyl (3.2c) 0.3 24 92 (3.3c) >95:5




3.2.2 Substrate Scope 
Using optimized conditions in Table 3.1, various conjugated alkynes were tested 
with ethyl (N-tert-butanesulfinyl)iminoacetate 3.2c. As indicated in Table 3.2, aryl 
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enynes and heteroaryl enynes worked very well to produce the corresponding products 
3.3-3.6 in good to excellent yields and with >95:5 regio- and diastereoselecitvity. In 
addition, alkyl enynes smoothly underwent the reductive coupling to produce the desired 
products 3.7-3.10 in good yields with high diastereoselectivities. The chemoselectivity of 
the hydrogen-mediated coupling of enynes to iminoacetates underscored by the fact that 
over-reduction of the diene-containing products was not observed.  
 




































































The regio- and stereochemical assignment of reductive coupling products was 
confirmed by a single crystal X-ray analysis of a derivative of compound 3.6 prepared 
from the exhaustive hydrogenation of the coupling product 3.6 using Crabtree’s catalyst 
[Ir(COD)(Pyr)(PCy)3]PF3 at ambient pressure and temperature (Figure 3.1). 
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Figure 3.1 X-ray structure of a derivative of compound 3.6. 
 
3.2.3 Elaboration of Reductive Coupling Products 
In a preliminary effort to explore further manipulation of the coupling products, 
compound 3.3 was exposed to Rh(PPh3)3Cl (Wilkinson’s catalyst) at ambient pressure 
and temperature. In the event, regioselective hydrogenation of the coupling product 3.3 
occurred cleanly to afford the β,γ-unsaturated α-amino esters 3.11 in 74% yield. These 
regioselective hydrogenation conditions were applied to all diene-containing products. 
Under optimized conditions, the β,γ-unsaturated α-amino esters 3.12-3.18 were obtained 
in 70-93% yields (Table 3.3).  
Conversion of the coupling product 3.3 to the corresponding Boc-derivative was 
explored next. The conversion worked excellently to produce the compound 3.19 in 94% 
yield. Similarly, conversion to Fmoc was conducted to give the compound 3.21 in 92% 
yield. Next, exhaustive hydrogenation of the diene side chain was explored. 
Hydrogenation of 3.19 using Crabtree’s catalyst (5 mol%) at ambient pressure and 
temperature provided the fully saturated Boc-protected amino acid ester 3.20 in 99% 








protected amino acid ester 3.22 was obtained in 95% yield as a 2.4:1 mixture of 
diastereomers (Scheme 3.1). 
 












































































































3.19, 94% 3.20, 99% (2:1 dr)







DCM (0.1M), 25 oC
Crabtree's catalyst
 
Scheme 3.1 Exhaustive hydrogenation of coupling products. 
 
Unlike the reductive coupling of enynes with glyoxal,1(c) the reductive coupling of 
enynes with iminoacetate do not tolerate vinylic substitution. Hence, functionalization of 
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the diene terminus via cross-metathesis was explored. Exposure of the Boc-protected 
reductive coupling product 3.19 to cis-1,4-diacetoxy-2-butene in the presence of 5 mol% 
of second generation Grubbs catalyst provided the allylic acetate 3.23 in 80% yield as a 




























Scheme 3.2 Cross-metathesis of the coupling product 3.19. 
 
3.2.4 Mechanistic Studies  
To gain mechanistic insight, the reductive coupling of 1,3-phenylenyne 3.1 with 
iminoacetate 3.2c was performed under an atmosphere of deuterium. As expected, 
monodeuterated product deuterio-3.3 was observed by 1H-NMR. These results are 
consistent with a catalytic mechanism involving alkyne-imine oxidative coupling 
followed by hydrogenolytic cleavage of the resulting metallacycle. Based on the 
deuterium labeling study, a plausible mechanism was proposed. The catalytic cycle is 
initiated by oxidative coupling of the alkyne and imine to form metallacycle intermediate 
3.24. The following step incorporates deuterium via σ-bond metathesis7 to generate the 
intermediate 3.25. Finally, alkenyl rhodium monohydride complex 3.25 undergoes C-D 















































Scheme 3.3 Plausible catalytic cycle. 
 
Given the observed sense of stereoinduction, two stereochemical models A and B 
are proposed. In each case, the iminoacetate is bound to rhodium(I) in a five-membered 
chelate. This type of chelating model has been established for late transition metal 
complexes with α-iminoketones and α-iminoesters.8 Upon oxidative coupling, the alkyne 
is delivered to the less hindered π-face of the imine. This is the opposite face of the bulky 
tert-butyl group in its most stable s-cis conformation.9 The resulting metallacycle C 
possesses a unoccupied coordinate site L, which should facilitate subsequent hydrogen 






























A B C  
Figure 3.2 Proposed models for asymmetric induction. 
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3.3 REDUCTIVE COUPLING OF 1,3-DIYNES WITH IMINOACETATES 
3.3.1 Optimization 
The hydrogen-mediated reductive coupling of 1,3-diynes to (N-sulfinyl) imino-
acetates was explored next. Interestingly, under conditions established for the reductive 
coupling of enynes, coupling of diyne 3.26 (200 mol%) to ethyl (N-tert-butanesulfinyl) 
iminoacetate 3.2c did not produce the desired reductive coupling product. It was 
suspected that the diminished electrophilicity of the alkyl substituted sulfinyl imine 
decreased the reactivity of the reductive coupling. In contrast, hydrogenation of diyne 
3.26 in the presence of ethyl (N-para-toluenesulfinyl) iminoacetate 3.2a delivered the 
desired product 3.27a in 94% yield as a 1.2:1 mixture of diastereomers. Remarkably, the 
use of the corresponding mesityl derivative 3.2b provided the coupling product 3.27b in 
94% yield with >95:5 regio- and diastereoslectivity. Additionally, comparable results 
were obtained using ethyl N-(2,4,6-triisopropylbenzenesulfinyl) iminoacetate 3.2d,10 
which was chosen as the standard coupling partner due to its enhanced chromatographic 
stability and ease of purification (Table 3.4). 
 





















entry R yield (%) dr
1 tert-Butyl (3.2c) No Reaction NA
2 Tolyl (3.2a) 94 (3.27a) 1.2:1
3 Mesityl (3.2b) 96 (3.27b) >95:5






3.3.2 Substrate Scope 
Under optimized conditions, the coupling of a variety of 1,3-diynes to ethyl N-
(2,4,6-triisopropylbenzenesulfinyl)iminoacetate provided the enyne-containing α-amino 
acid ethyl esters 3.27-3.32 as single regio- and stereoisomers in good to excellent yield. 
In each case, the regioselectivity was perfect, favoring carbon-carbon bond formation 
proximal to the aryl substituent. The regioisomeric products, which resulted from the 
coupling of alkyl terminus to imine partner, were not observed. Remarkably, the 
unprotected diol substrate smoothly underwent the reductive coupling to provide the 
desired product 3.32 in good yield with excellent selectivity (Table 3.5). The 
stereochemical assignment of 3.27-3.32 was made in analogy for a derivative of enyne 
coupling product 3.6, as shown in Figure 3.1. 
 

























































3.29, 91% (>95:5 d.r.)
3.31, 76% (>95:5 d.r.)  
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3.3.3 Elaboration of Reductive Coupling Products 
The protecting group conversion was examined first. Under acidic condition, the 
sulfinyl protecting group was smoothly removed. Subsequent Boc protection provided 
the corresponding Boc-derivative 3.33 in excellent yield. Next, exhaustive hydrogenation 
of the Boc-derivative 3.33 using Crabtree’s catalyst provided the saturated amino acid 































HCl (500 mol%) Crabtree's catalyst
 
Scheme 3.4 Exhaustive Hydrogenation of compound 3.33. 
 
 
3.4 REDUCTIVE COUPLING OF 1,3-ENYNES WITH ACTIVATED KETONES 
3.4.1 Introduction 
The enantioselective generation of quaternary stereocenters is generally a 
formidable challenge. Recently, several catalytic, asymmetric methods that achieve this 
goal have been developed,11 and addition reactions to ketones have attracted significant 
attention, as they provide access to enantiomerically enriched tertiary alcohols.12 The 
Walsh group has reported highly enantioselective, catalytic addition of alkenylzirconium 
reagents to ketones.13,14 However, this approach requires stoichiometric use of two 
metallic reagents. Here, we report that hydrogenation of conjugated enynes in the 
presence of α-ketoesters using a chirally modified rhodium catalyst enables formation of 
enantiomerically enriched tertiary alcohols. 
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3.4.2 Optimization 
To investigate the possibility of the hydrogen-mediated reductive coupling of 1,3-
enynes to ketone partners, we chose 1,3-phenylenyne and ethyl pyruvate as nucleophilic 
and electrophilic partner, respectively. Upon exposure of 1,3-phenylenyne to ethyl 
pyruvate in the presence of a cationic rhodium complex and BIPHEP ligand, the desired 
product 3.35 (Table 3.7) was obtained in 64% yield with high levels of stereo- and 
regioselectivity. This remarkable result prompted us to explore the enantioselective 
reductive coupling utilizing commercially available chiral bidentate phosphine ligands. 
For optimization of the asymmetric variant of this reaction, enyne 3.36 was adopted as 
the standard coupling partner due to its enhanced stability and relative ease of use (i.e. 
solid is easier to handle than oil). Initially, asymmetric induction was assayed under 
hydrogenation conditions employing Rh(COD)2OTf and (R)-BINAP in DCE (0.1M). The 
desired product 3.37 was obtained in 35% yield with 50% ee. Through an assay of 
commercially available chiral ligands, (R)-xylyl-WALPHOS provided excellent levels of 
asymmetric induction. However, chemical yields varied dramatically in response to aging 
of the solvent 1,2-dichloroethane (DCE). Older batches of solvent provided better results. 
It was reasoned that adventitious HCl might promote reductive coupling. Indeed, an assay 
of Brønsted acid additives revealed that reactions with substoichiometric amount of 
triphenylacetic acid (5 mol%) in freshly distilled DCE reproducibly gave the coupling 
product 3.37 in 67% yield and 78% ee. At an elevated temperature (60oC), the coupling 
product was obtained in 82% yield and 89% ee. Finally, the use of methyl pyruvate 
instead of ethyl pyruvate provided the desired product 3.37 in 88% yield and 90% ee. In 
the absence of a Brønsted acid additive, but under otherwise identical conditions, the 
coupling product 3.37 was produced in only 42% yield and 87% ee (Table 3.6).  
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entry R Ligand temp (oC) yield (%)
1 Et (R)-BINAP 24 35
2 Et 24 24
3 Et (R)-xylyl-WALPHOS 24 67
4 Et (R)-xylyl-WALPHOS 60 82






















3.4.3 Substrate Scope 
The optimized conditions were applied to the reductive coupling of a variety of 
conjugated enynes to methyl or ethyl pyruvate. Aryl substituted enynes underwent 
reductive coupling to produce the corresponding products 3.35 and 3.39 in excellent 
yields with high enantioselectivities. Alkyl substituted enynes also smoothly participated 
in the reductive coupling to give the coupling products 3.37-3.38 and 3.40-3.42. When an 
unprotected propargylic alcohol derivative was employed, the lactone product 3.40 was 
obtained in 80% yield and 91% ee. Interestingly, in the case of alkyl substituted enynes, 
coupling with methyl pyruvate gave a little higher asymmetric induction than with ethyl 
pyruvate (Table 3.7). 
To further broaden the asymmetric reductive coupling of enynes and activated 
ketones, a variety of α-ketoesters were investigated. Gratifyingly, the coupling of enyne 
with several different activated ketones afforded the corresponding products 3.43-3.46 in 
good to excellent yields and enantiomeric excesses. In all cases, the diene containing 
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coupling products are not subject to over-reduction under the standard conditions, and the 
the trisubstituted alkene is formed as a single geometrical isomer (Table 3.8). 
 
Table 3.7 Reductive coupling of 1,3-enynes with methyl or ethyl pyruvate.15 
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Table 3.8 Reductive coupling of the enyne with a set of α-ketoesters.  
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3.4.4 Elaboration of Reductive Coupling Products 
In a preliminary effort to explore further manipulation of the coupling products, 
compound 3.35 was exposed to Rh(PPh3)3Cl (Wilkinson’s catalyst) at ambient pressure 
and temperature. In the event, regioselective hydrogenation of the terminal alkene 
occurred cleanly to afford the β,γ-unsaturated α-hydroxy ester 3.47 in 97% yield. 
Ozonoloysis of compound 3.47 provided compound 3.48 in 93% yield. Next, exhaustive 
hydrogenation of compound 3.35 using Crabtree’s catalyst provided the saturated α-
hydroxy ester 3.49 in excellent yield as a 12:1 mixture of diastereomers. It was assumed 
that the high diastereoselective hydrogenation of compound 3.35 resulted from a 
directing effect by the hydroxy functional group during hydrogenation using Crabtree’s 
catalyst.16 To further investigate the hydroxyl group directing effect, we explored 
directed metal-catalyzed epoxidation. Upon exposure of the reductive coupling product 
3.35 in the presence of VO(acac)2 and tert-BuO2H, the epoxide 3.50 was obtained in 94% 













































3.50, 94% yield (7:1 dr)3.35
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Scheme 3.5 Elaboration of reductive coupling products. 
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To determine the absolute and relative stereochemistry, the compound 3.49 and 
3.50 were converted to amide compounds 3.51 and 3.52, respectively (Scheme 3.6). The 
absolute and relative stereochemical assignment was determined by X-ray diffraction 




















































Figure 3.3 A single crystal X-ray structure of 3.52. 
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Additionally, site selective oxidative cleavage of compound 3.35 under Johnson-
Lemieux conditions17 provided aldehyde 3.53 in 84% yield without isomerization of 
alkene geometry. Finally, functionalization of the diene terminus via cross-metathesis 
was explored. Exposure of the reductive coupling product 3.35 to cis-1,4-diacetoxy-2-
butene in the presence of 5 mol% of the second generation Grubbs’ catalyst provided the 








































Scheme 3.7 Functionalization of compound 3.35. 
 
3.4.5 Mechanistic Studies  
To gain insight into the role of the Brønsted acid co-catalyst, the reductive 
coupling of 1,3-phenylenyne and ethyl pyruvate was performed under a deuterium 
atmosphere to provide deuterio-3.35. This result is consistent with a catalytic mechanism 
involving oxidative coupling followed by hydrogenolytic cleavage of the resulting 
metallacycle via σ-bond metathesis. Even when a 50 mol% loading of Brønsted acid is 
used under otherwise standard conditions, with a 2 mol% loading of rhodium catalyst, 
clean monodeuteration persists. This result excludes mechanisms involving protonolytic 
cleavage of the rhodium-carbon bond of the oxametallacycle and suggests a plausible role 
for the acid additive might involve protonolytic cleavage of the rhodium-oxygen bond of 
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the oxametallacycle. Indeed, the protonolytic cleavage of the rhodium-oxygen bond in 
protic media (i.e. H2O) has been studied by Hartwig.18 Protonolysis may occur through 
six-membered transition state (A). Recent studies by Musashi and Sakaki19 suggest that 
Brønsted acid cocatalysts may accelerate the reductive coupling by circumventing four-
centered transition structures for σ-bond metathesis. High energy structure, (B) obtained 
by direct hydrogenolysis of the putative oxametallacyclic intermediateis compared to six-
centered transition structure (C) from hydrogenolysis of rhodium carboxylates derived 
































Scheme 3.8 Proposed models accounting the role of Brønsted acid cocatalyst. 
 
Based on deuterium labeling studies and other experimental data, a plausible 
catalytic mechanism was proposed. Without acid cocatalyst, Cycle A will be operative 
resulting in a relatively slower reaction. With acid cocatalyst, Cycle B will be operative. 
In Cycle B, oxidative coupling of enyne to ethyl pyruvate furnishes an oxametallacyclic 
intermediate 3.55, which is protonolytically cleaved by the Brønsted acid cocatalyst to 
produce a cationic rhodium carboxylate 3.56. Hydrogenolysis of the Rh-O bond followed 
by C-D reductive elimination of intermediate 3.57 delivers deuterio-3.35, along with the 































































































3.5 SUMMARY AND CONCLUDING REMARKS 
The reductive coupling of conjugated alkynes and iminoacetates has been 
achieved through catalytic hydrogenation, representing the first use of imines as 
electrophilic partners in simple hydrometallative reductive coupling. Good to excellent 
yields and exceptional levels of regiocontrol are observed. Moreover, the high levels of 
relative stereocontrol with respect to the N-sulfinyl moiety allow the absolute 
stereochemical course of the reductive coupling to be controlled. The requirement of π-
unsaturated reactants in the form of activated imines and conjugated alkynes suggests a 
weakly nucleophilic metallocyclopropane is formed through alkyne coordination with 
low valent rhodium. For low valent late transition metals, this pattern of reactivity may 
represent a driving force that assists the oxidative coupling of alkyne to C=O π-bonds.  
The reductive coupling of 1,3-enynes and α-ketoesters has been achieved under 
rhodium-catalyzed hydrogenation conditions. This transformation is highly regioselective 
and affords synthetically useful 1,3-dienes with an adjacent quaternary carbinol 
stereogenic center in high enantioselectivity. Moreover, during the optimization of this 
reaction, we observed that Brønsted acid cocatalysts played a critical role in the reaction. 
This acid effect could be applicable to more challenging catalytic hydrogen-mediated 









3.6 EXPERIMENTAL SECTION 
3.6.1 GENERAL  
All reactions were run under an atmosphere of argon, unless otherwise indicated. 
Anhydrous solvents were transferred by an oven-dried syringe. Flasks were flame-dried 
and cooled under a stream of nitrogen. Dichloromethane (DCM) was distilled from 
calcium hydride. Analytical thin-layer chromatography (TLC) was carried out using 0.2-
mm commercial silica gel plates (DC-Fertigplatten Kieselgel 60 F254). Preparative 
column chromatography employing silica gel was performed according to the method of 
Still. Solvents for chromatography are listed as volume/volume ratios. Infrared spectra 
were recorded on a Perkin-Elmer 1600 spectrometer. High-resolution mass spectra 
(HRMS) were obtained on a Karatos MS9 and are reported as m/z (relative intensity). 
Accurate masses are reported for the molecular ion (M + 1) or a suitable fragment ion. 
Proton nuclear magnetic resonance (1H-NMR) spectra were recorded with a Varian 
Gemini (400 MHz or 300MHz) spectrometer. Chemical shifts are reported in delta (δ) 
units, parts per million (pip) downfield from trimethylsilane. Coupling constants are 
reported in Hertz (Hz). Carbon-13 nuclear magnetic resonance (13C-NMR) spectra were 
recorded with a Varian Gemini 400 (100 MHz) spectrometer. Chemical shifts are 
reported in delta (δ) units, ppm relative to the center of the triplet at 77.0 ppm for 
deuteriochloroform. 13C NMR spectra were routinely run with broadband decoupling. 
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3.6.2 Hydrogen-Mediated Reductive coupling of 1,3-Enynes and Iminoacetes 
Representative Procedure for the Coupling of 1,3-phenyl enyne and N-(tert-Butane 
sulfinyl) iminoacetate. 
To a solution of N-(tert-Butanesulfinyl)iminoacetate 3.2c (41 mg, 0.20 mmol, 100 
mol%) and 3-buten-1-ynyl-benzene 3.1 (50.9 mg, 0.40 mmol, 200 mol%) in DCM (0.67 
mL, 0.3M) at 35 oC was added Rh(COD)2OTf (4.7 mg, 0.01 mmol, 5 mol%) and 
BIPHEP (5.3 mg, 0.01 mmol, 5 mol%). The system was purged with argon gas followed 
by hydrogen gas. The reaction was allowed to stir at 35 oC under 1 atm of hydrogen for 8 
hours. The title compound was purified by flash silical chromatography (Rf = 0.3, 25% 











2-(2-methyl-propane-2-sulfinylamino)-3-phenyl-hexa -3,5-dienoic acid ethyl ester 
(3.3). Rf = 0.3, 25% EtOAc/hexane; colorless oil; 1H NMR (400 MHz, CDCl3): 7.34 - 
7.26 (m, 3H), 7.19 - 7.16 (m, 2H), 6.42 (d, J = 10.8 Hz, 1H), 6.30 (dt, J = 16.8, 10.4 Hz, 
1H), 5.15 (dd, J = 10.0, 1.6 Hz, 1H), 5.14 (dd, J = 10.0, 1.6 Hz, 1H), 4.80 (d, J = 4.0 Hz, 
1H), 4.34 (d, J = 4.0, 1H), 4.17 (q, J = 7.2 Hz, 2H), 1.19 (s, 9H), 1.18 (t, J = 7.0 Hz, 3H). 
13C NMR (100 MHz, CDCl3): 171.0, 137.9, 137.0, 133.3, 132.6, 129.3, 128.0, 127.6, 
120.1, 62.8, 62.0, 55.9, 22.5, 13.9. HRMS Calcd. for C18H26N1O3S1 (M+1): 336.1633, 
Found: 336.1632. FTIR (neat): 3285, 3072, 2980, 1738, 1602, 1494, 1474, 1444, 1366, 











deuterio-2-(2-methyl-propane-2-sulfinylamino)-3-phenyl-hexa-3,5-dienoic acid ethyl 
ester (deuterio-3.3). Rf = 0.3, 25% EtOAc/hexane; colorless oil; 1H NMR (400 MHz, 
CDCl3): 7.34 - 7.25 (m, 3H), 7.18 - 7.15 (m, 2H), 6.29 (dd, J = 16.8, 10.0 Hz, 1H), 5.35 
(dd, J = 17.0, 1.8 Hz, 1H), 5.13 (dd, J = 10.2, 1.8 Hz, 1H), 4.79 (d, J = 4.8 Hz, 1H), 4.34 
(d, J = 4.4, 1H), 4.16 (q, J = 7.2 Hz, 2H), 1.17 (s, 9H), 1.17 (t, J = 7.0 Hz, 3H). 13C NMR 
(100 MHz, CDCl3): 171.0, 137.8, 137.0, 133.2, 129.3, 128.0, 127.6, 120.1, 62.8, 62.1, 
55.9, 22.5, 13.9. HRMS Calcd. for C18H25D1N1O3S1 (M+1): 337.1696, Found: 337.1692. 
FTIR (neat): 3285, 3056, 2980, 2870, 1732, 1601, 1493, 1473, 1444, 1412, 1391, 1366, 











2-(2-methyl-propane-2-sulfinylamino)-3-naphthalen-2-yl-hexa-3,5-dienoic acid ethyl 
ester (3.4). Rf = 0.3, 25% EtOAc/hexane; colorless oil; 1H NMR (400 MHz, CDCl3): 7.84 
- 7.78 (m, 3H), 7.66 (s, 1H), 7.51 - 7.46 (m, 2H), 7.30 (dd, J = 8.4, 1.6 Hz, 1H), 6.51 (d, J 
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= 11.2 Hz, 2H), 6.35 (t, J = 10.4 Hz, 1H), 6.51 (d, J = 11.2 Hz, 1H), 6.30 (dt, J = 17.2, 
10.4 Hz, 1H), 5.40 (dd, J = 16.8, 1.4 Hz, 1H), 5.16 (dd, J = 10.2, 1.4 Hz, 1H), 4.90 (d, J = 
4.4 Hz, 1H), 4.41 (d, J = 4.0, 1H), 4.20 - 4.15 (m, 2H), 1.19 (s, 9H), 1.17 (t, J = 7.2 Hz, 
3H). 13C NMR (100 MHz, CDCl3): 171.0, 137.9, 134.5, 133.3, 133.0, 132.9, 132.6, 
128.5, 127.9, 127.6, 127.2, 126.2, 126.2, 120.3, 62.8, 62.1, 56.0, 22.5, 14.0. HRMS 
Calcd. for C22H28N1O3S1 (M+1): 386.1790, Found: 386.1786. FTIR (neat):  3283, 2979, 












2-(2-methyl-propane-2-sulfinylamino)-3-furan-2-yl-hexa-3,5-dienoic acid ethyl ester 
(3.5). Rf = 0.3, 30% EtOAc/hexane; colorless oil; 1H NMR (400 MHz, CDCl3): 7.42 (d, J 
= 1.2, 1H), 7.12 (dt, J = 17.6, 10.7, 1H), 6.42 (d, J = 3.2 Hz, 1H), 6.40 - 6.38 (m, 1H), 
6.30 (d, J = 11.2 Hz, 1H), 5.46 (d, J = 8.4 Hz, 1H), 5.36 (dd, J = 10.0, 1.2 Hz, 1H), 4.80 
(d, J = 3.2 Hz, 1H), 4.44 (d, J = 2.8 Hz, 1H), 4.21 (q, J = 7.1 Hz, 2H), 1.19 (t, J = 7.2 Hz, 
3H), 1.15 (s, 9H). 13C NMR (100 MHz, CDCl3): 171.0, 150.8, 142.2, 133.4, 132.4, 125.9, 
111.0, 110.8, 62.2, 61.4, 55.7, 22.4, 13.9. HRMS Calcd. for C16H24N1O4S1 (M+1): 
326.1426, Found: 326.1426. FTIR (neat): 3287, 2980, 1737, 1467, 1366, 1260, 1224, 













3-(1H-Indol-2-yl)-2-(2-methyl-propane-2-sulfinyl amino)-hexa-3,5-dienoic acid ethyl 
ester (3.6). Rf = 0.3, 40% EtOAc/hexane; white 1H NMR (400 MHz, CDCl3): 8.90 (s, 
1H), 7.56 (d, J = 8.0 Hz, 1H), 7.31 (d, J = 8.4 Hz, 1H), 7.16 (td, J = 7.6, 1.1 Hz, 1H), 
7.07 (t, J = 7.4 Hz, 1H), 6.90 (dt, J = 17.2, 10.6 Hz, 1H), 6.55 (d, J = 1.6 Hz, 1H), 6.48 
(d, J = 10.8, 1H), 5.50 (d, J = 16.0 Hz, 1H), 5.33 (d, J = 10.0 Hz, 1H), 4.85 (d, J = 3.6, 
1H), 4.46 (d, J = 3.2 Hz, 1H), 4.15 (q, J = 7.2 Hz, 2H), 1.20 (s, 9H), 1.11 (t, J = 7.2 Hz, 
3H). 13C NMR (100 MHz, CDCl3): 172.2, 136.0, 134.8, 133.4, 133.2, 127.9, 127.8, 
122.5, 122.0, 120.5, 120.0, 110.9, 105.2, 62.4, 61.8, 56.0, 22.5, 13.7. HRMS Calcd. for 
C20H27N2O3S1 (M+1): 375.1742, Found: 375.1747. FTIR (neat): 3274, 2978, 1731, 1455, 












3-Allylidene-2-(2-methyl-propane-2-sulfinylamino)-octanoic acid ethyl ester (3.7). Rf 
= 0.4, 25% EtOAc/hexane; colorless oil; 1H NMR (400 MHz, CDCl3): 6.58 (dt, J = 16.8, 
10.4 Hz, 1H), 6.11 (d, J = 11.2 Hz, 1H), 5.27 (dd, J = 16.8, 1.6 Hz, 1H), 5.19 (dd, J = 9.8, 
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1.4 Hz, 1H), 4.45 (d, J = 4.0, 1H), 4.32 (d, J = 4.0 Hz, 1H), 4.27 -4.17 (m, 2H), 2.19 (t, J 
= 8.0, 2H), 1.44 - 1.36 (m, 2H), 1.29 - 1.26 (m, 7H), 1.26 (s, 9H), 0.88 (t, J = 2.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): 171.6, 138.0, 132.1, 130.6, 118.9, 62.0, 62.0, 55.8, 31.9, 
28.6, 28.6, 22.6, 22.4, 14.0, 14.0. HRMS Calcd. for C17H32N1O3S1 (M+1): 330.2103, 
Found: 330.2090. FTIR (neat):  3452, 2956, 2869, 1734, 1465, 1365, 1255, 1182, 1078, 












hexa-3,5-dienoic acid ethyl ester (3.8) Rf = 0.3, 25% EtOAc/hexane; colorless oil; 1H 
NMR (400 MHz, CDCl3): 6.62 (dt, J = 16.8, 10.5 Hz, 1H), 6.13 (d, J = 10.8 Hz, 1H), 
5.32 (dd, J = 15.2, 1.4 Hz, 1H), 5.24 (dd, J = 10.0, 1.6 Hz, 1H), 4.59 (d, J = 4.4 Hz, 1H), 
4.44 - 4.38 (m, 2H), 4.32 -4.23 (m, 2H), 4.17 - 4.41 (m, 1H), 1.27 (t, J = 1.2, 3H), 1.25 (s, 
9H), 0.09 (s, 9H), 0.062 (s, 6H). 13C NMR (100 MHz, CDCl3): 171.4, 136.4, 131.2, 
131.1, 120.3, 61.8, 60.1, 58.6, 55.8, 25.8, 22.6, 18.3, 14.0, -5.52. HRMS Calcd. for 
C19H38N1O4Si1S1 (M+1): 404.2291, Found: 404.2299. FTIR (neat): 3418, 2956, 2925, 














hexa-3,5-dienoic acid ethyl (3.9) Rf = 0.3, 25% EtOAc/hexane; colorless oil; 1H NMR 
(400 MHz, CDCl3): 6.55 (dt, J = 16.8, 10.6 Hz, 1H), 6.12 (d, J = 10.8, 2H), 5.24 (dd, J = 
16.8, 1.6 Hz, 1H), 5.17 (dd, J = 10.2, 1.6 Hz, 1H), 4.45 (d, J = 4.8 Hz, 1H), 4.32 (d, J = 
4.4, 1H), 4.25 -4.11 (m, 2H), 3.63 - 3.53 (m, 2H), 2.48 - 2.34 (m, 2H), 1.24 (t, J = 6.4 Hz, 
3H), 1.21 (s, 9H), 0.84 (s, 9H), 0.018 (s, 6H). 13C NMR (100 MHz, CDCl3): 171.4, 134.1, 
132.3, 132.1, 119.5, 62.4, 62.1, 62.0, 55.9, 32.2, 25.9, 22.6, 18.2, 14.0, -5.37. HRMS 
Calcd. for C20H40N1O4Si1S1 (M+1): 418.2447, Found: 418.2447. FTIR (neat):  3447, 













3,5-dienoic acid ethyl ester (3.10). Rf = 0.3, 30% EtOAc/hexane; colorless oil; 1H NMR 
(400 MHz, CDCl3): 6.67 (dt, J = 16.4, 10.4 Hz, 1H), 6.26 (d, J = 11.2 Hz, 1H), 5.39 (d, J 
= 16.4 Hz, 1H), 5.32 (d, J = 10.0 Hz, 1H), 4.58 (s, 1H), 4.53 (d, J = 3.6 Hz, 1H), 4.45 (s, 
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1H), 4.23 (q, J = 7.1 Hz, 2H), 3.94 (d, J =5.2 Hz, 1H), 1.43 (s, 9H), 1.29 (t, J = 7.2 Hz, 
3H), 1.27 (s, 9H). 13C NMR (100 MHz, CDCl3): 170.9, 155.3, 134.5, 132.9, 131.1, 121.4, 
79.4, 62.2, 61.2, 55.8, 37.3, 28.2, 22.5, 14.0. HRMS Calcd. for C18H33N2O5S1 (M+1): 
389.2110, Found: 389.2108. FTIR (neat): 3384, 2978, 1734, 1707, 1507, 1457, 1391, 
1366, 1251, 1170, 1064, 917, 734 cm-1.  
 
Representative Procedure for the Selective Hydrogenation of the Diene 3.3 
To a solution of diene 3.3 (33.5 mg, 0.1 mmol, 100 mol%) in toluene (1 mL, 
0.1M) was added RhCl(PPh3)3 (9.3 mg, 0.01 mmol, 10 mol%). The system was purged 
with argon gas followed by hydrogen gas. The reaction was allowed to stir at ambient 
temperature under 1 atm of hydrogen for 24 hours. The title compound was purified by 
flash silica chromatography (Rf = 0.3, 25% EtOAc/hexane) to afford 24.9 mg as a 











2-(2-Methyl-propane-2-sulfinylamino)-3-phenyl-hex-3-enoic acid ethyl ester (3.11). 
Rf = 0.3, 25% EtOAc/hexane; colorless oil; 1H NMR (400 MHz, CDCl3): 7.32 - 7.23 (m, 
3H), 7.13 - 7.10(m, 2H), 5.83 (t, J = 7.4 Hz, 1H), 4.72 (d, J = 4.4 Hz, 2H), 4.23 (d, J = 
4.0 Hz, 1H), 4.20 - 4.12 (m, 2H), 1.99 (qt, J = 7.4 Hz, 2H), 1.19 (t, J = 7.0 Hz, 3H), 1.19 
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(s, 9H), 0.95 (t, J = 7.6 Hz, 3H). 13C NMR (100 MHz, CDCl3): 171.4, 137.3, 136.0, 
135.6, 129.1, 127.9, 127.2, 63.1, 61.8, 55.8, 22.5, 22.3, 14.0, 13.9. HRMS Calcd. for 
C18H28N1O3S1 (M+1): 338.1790, Found: 338.1792. FTIR (neat): 3279, 2964, 2930, 2871, 












2-(2-Methyl-propane-2-sulfinylamino)-3-naphthalen-2-yl-hex-3-enoic acid ethyl 
ester (3.12). Rf = 0.3, 25% EtOAc/hexane; colorless oil; 1H NMR (400 MHz, CDCl3): 
7.83 - 7.76 (m, 3H), 7.60 (s, 1H), 7.49 - 7.45 (m, 2H), 7.25 (d, J = 8.6, 1H), 5.90 (t, J = 
7.6 Hz, 1H), 4.81 (s, 1H), 4.33 (s, 1H), 4.21 - 4.13 (m, 2H), 2.02 (qt, J = 7.5 Hz, 2H), 
1.20 (s, 9H), 1.18 (t, J = 7.2 Hz, 3H), 0.96 (t, J = 7.4 Hz, 3H). 13C NMR (100 MHz, 
CDCl3): 171.3, 136.5, 135.6, 134.9, 133.0, 132.4, 128.0, 127.5, 127.5, 127.4, 126.0, 
125.9, 63.1, 61.9, 29.6, 22.7, 22.6, 22.4, 14.0. HRMS Calcd. for C22H30N1O3S1 (M+1): 
388.1946, Found: 388.1953. FTIR (neat): 3285, 3054, 2961, 2870, 1734, 1597, 1503, 













3-Furan-2-yl-2-(2-methyl-propane-2-sulfinylamino)-hex-3-enoic acid ethyl ester 
(3.13). Rf = 0.3, 30% EtOAc/hexane; colorless oil; 1H NMR (400 MHz, CDCl3): 7.36 (t, 
J = 2.0 Hz, 1H), 6.37 - 6.36 (m, 1H), 6.30 (d, J = 3.2 Hz, 1H), 5.77 (t, J = 7.2 Hz, 1H), 
4.75 (s, 1H), 4.41 (s, 1H), 4.23 - 4.15 (m, 2H), 2.42 (qt, J = 7.5 Hz, 2H), 1.20 (t, J = 7.0 
Hz, 3H), 1.14 (s, 9H), 1.09 (t, J = 7.6 Hz, 3H). 13C NMR (100 MHz, CDCl3): 171.3, 
150.7, 141.3, 137.4, 125.6, 110.7, 109.6, 62.0, 61.8, 29.7, 22.8, 22.4, 14.0, 13.9. HRMS 
Calcd. for C16H26N1O4S1 (M+1): 328.1583, Found: 328.1573. FTIR (neat): 3288, 2966, 












3-(1H-Indol-2-yl)-2-(2-methyl-propane-2-sulfinylamino)-hex-3-enoic acid ethyl ester 
(3.14). Rf = 0.3, 40% EtOAc/hexane; yellow solid; 1H NMR (400 MHz, CDCl3): 8.84 (s, 
1H), 7.55 (d, J = 7.6 Hz, 1H), 7.30 (d, J = 7.6 Hz, 1H), 7.14 (td, J =  7.6, 1.1 Hz, 1H), 
7.06 (t, J = 7.4 Hz, 1H), 6.45 (d, J = 1.2, 1H), 5.94 (t, J = 7.4 Hz, 1H), 4.78 (d, J = 3.2 
Hz, 2H), 4.41 (d, J = 2.4 Hz, 1H), 4.14 (qd, J = 7.2, 1.2 Hz, 2H), 2.45 - 2.37 (m, 2H), 
 104
1.21 (s, 9H), 1.10 (t, J = 7.0 Hz, 3H), 1.08 (t, J = 7.6 Hz, 3H). 13C NMR (100 MHz, 
CDCl3): 171.5, 140.1, 136.6, 133.4, 127.9, 126.1, 122.1, 120.3, 119.8, 110.9, 103.9, 62.3, 
62.1, 55.9, 22.1, 22.6, 22.5, 14.0, 13.9. HRMS Calcd. for C20H29N2O3S1 (M+1): 
377.1900, Found: 377.1900. FTIR (neat): 3403, 3276, 2965, 2861, 1732, 1653, 1456, 












2-(2-Methyl-propane-2-sulfinylamino)-3-propylidene -octanoic acid ethyl ester 
(3.15). Rf = 0.4, 25% EtOAc/hexane; colorless oil; 1H NMR (400 MHz, CDCl3): 5.47 (t, 
J = 7.2 Hz, 1H), 4.38 (d, J = 4.4 Hz, 1H), 4.25 - 4.16 (m, 1H + 2H), 2.22 – 2.01 (m, 4H), 
1.37 – 1.25 (m, 6H), 1.25 (s, 9H), 0.98 (t, J = 7.6 Hz, 3H), 0.88 (t, J = 6.8 Hz, 3H). 13C 
NMR (100 MHz, CDCl3): 172.2, 134.6, 133.7, 62.3, 61.7, 55.7, 32.0, 28.3, 30.0, 22.6, 
22.5, 21.3, 14.1, 14.0, 13.9. HRMS Calcd. for C17H34N1O3S1 (M+1): 332.2259, Found: 















hex-3-enoicacid ethyl ester (3.16). Rf = 0.3, 25% EtOAc/hexane; colorless oil; 1H NMR 
(400 MHz, CDCl3): 5.55 (t, J = 7.4 Hz, 1H), 4.52 (d, J = 4.4 Hz, 1H), 4.27 (d, J = 4.4 Hz, 
1H), 4.29 - 4.09 (m, 2H + 2H), 2.11 (qd, J = 7.5, 2.4 Hz, 2H), 2.78 (t, J = 4.4 Hz, 3H), 
1.25 (s, 9H), 0.99 (t, J = 7.4 Hz, 3H), 0.89 (s, 9H), 0.05 (s, 6H). 13C NMR (100 MHz, 
CDCl3): 171.8, 134.4, 134.2, 61.5, 60.4, 58.2, 55.6, 25.9, 22.6, 21.0, 18.3, 14.0, -5.5. 
HRMS Calcd. for C19H40N1O4Si1S1 (M+1): 406.2447, Found: 406.2448. FTIR (neat): 













hex-3-enoic acid ethyl ester (3.17). Rf = 0.3, 25% EtOAc/hexane; colorless oil; 1H 
NMR (400 MHz, CDCl3): 5.51 (t, J = 7.2 Hz, 1H), 4.38 (d, J = 5.2 Hz, 1H), 4.24 (d, J = 
5.2 Hz, 1H), 4.22 - 4.11 (m, 2H), 3.60 - 3.48 (m, 2H), 2.36 - 2.21 (m, 2H), 2.07 (qt, J = 
7.5 Hz, 2H), 1.24 (t, J = 7.2 Hz, 3H), 1.22 (s, 9H), 0.95 (t, J = 7.6 Hz, 3H), 0.85 (s, 9H), 
0.01 (s, 6H). 13C NMR (100 MHz, CDCl3): 171.9, 135.6, 130.9, 62.6, 61.9, 61.8, 55.7, 
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31.7, 25.9, 22.6, 21.4, 18.3, 14.0, 13.9, -5.3. HRMS Calcd. for C20H40N1O4Si1S1 (M+1): 
418.2447, Found: 418.2447. FTIR (neat): 2958, 2857, 1736, 1472, 1364, 1255, 1188, 












enoic acid ethyl ester (3.18). Rf = 0.3, 30% EtOAc/hexane; colorless oil; 1H NMR (400 
MHz, CDCl3): 5.71 (t, J = 7.2 Hz, 1H), 4.55 (s, 1H), 4.46 (d, J = 2.8 Hz, 1H), 4.38 (s, 
1H), 4.22 (q, J = 7.1, 2H), 3.81 (d, J = 5.2, 2H), 2.19 (qt, J = 7.6, 2H), 1.42 (s, 9H), 1.29 
(t, J = 7.2 Hz, 3H), 1.26 (s, 9H), 1.02 (t, J = 7.6, 3H). 13C NMR (100 MHz, CDCl3): 
171.5, 155.4, 138.5, 130.8, 79.3, 62.2, 61.6, 55.7, 37.2, 29.7, 28.4, 22.6, 21.3, 14.0, 13.9. 
HRMS Calcd. for C18H35N2O5S1 (M+1): 391.2267, Found: 391.2278. FTIR (neat):  
3301, 2975, 2927, 1738, 1713, 1509, 1459, 1391, 1360, 1248, 1174, 1075 cm-1. 
 
Rpresentative Procedure for Desulfinylation and N-Protection of the Diene 3.3 
The diene 3.3 (1.14 g, 3.4 mmol, 100 mol%) was dissolved in MeOH (340 mL, 
0.01M) and treated with HCl in dioxane (4.25 mL, 4.0 M in dioxane, 500 mol%). The 
reaction was allowed to stir at ambient temperature for 10 hours. The reaction mixture 
was concentrated and coevaporated with MeOH. The residue was dissolved in DCM (340 
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mL, 0.01M) followed by addition of DiPEA (1.8 mL, 300 mol%) and Boc2O (1.12 g, 5.1 
mmol, 150 mol%). The reaction mixture was stirred for 12 hours before diluting with 
DCM and H2O. The organic phase was washed with an aqueous solution of citric acid (10 
wt%), a saturated aqueous solution of NaHCO3 and with H2O. After drying (Na2SO4), the 
organic phase was evaporated in vacuo and the residue was purified by silica gel column 







2-tert-Butoxycarbonylamino-3-phenyl-hexa-3,5-dienoic acid ethyl ester (3.19). Rf = 
0.5 15% EtOAc/hexane; colorless oil; 1H NMR (400 MHz, CDCl3): 7.17 – 7.26 (m, 3H), 
7.17 (s, J = 7.2 Hz, 2H), 6.39 (d, J = 11.2 Hz, 1H), 6.23(dt, J = 16.8, 10.5 Hz, 1H), 5.34 
(d, J = 1.6 Hz, 1H), 5.30 (d, J = 1.6 Hz, 1H), 5.10 (d, J = 10.0 Hz, 1H), 5.06 (d, J = 8.0 
Hz, 1H), 4.14 (m, 2H), 1.43 (s, 9H), 1.17 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, 
CDCl3): 170.5, 154.7, 138.3, 137.0, 133.3, 131.0, 129.2, 128.2, 127.7, 119.6, 79.9, 61.6, 
59.7, 28.2, 13.7. HRMS Calcd. for C19H26N1O4 (M+1): 332.1862, Found: 332.1862. 
FTIR (neat):  3439, 2978, 2933, 1740, 1717, 1492, 1367, 1323, 1248, 1162, 1058, 1026, 








2-(9H-Fluoren-9-ylmethoxycarbonylamino)-3-phenyl -hexa-3,5-dienoic acid ethyl ester 
(3.21). Rf = 0.3 10% EtOAc/hexane;  colorless oil; 1H NMR (400 MHz, CDCl3): 7.77 (d, 
J  = 7.6 Hz, 2H), 7.60 – 7.55 (m, 2H), 7.42 – 7.29 (m, 7H), 7.20 (d, J = 6.8 Hz, 2H), 6.44 
(d, J = 10.8 Hz, 1H), 6.23 (dt, J = 17.2, 10.5 Hz, 1H), 5.68 (d, J = 8.0 Hz, 1H), 5.36 (d, J 
= 17.2 Hz, 1H),  5.15 (d, J = 7.2 Hz, 1H),  5.14 (d, J = 10.4 Hz, 1H), 4.44 (dd, J = 10.2, 
7.0 Hz, 1H), 4.26 (dd, J = 10.4, 6.8 Hz, 1H), 4.25 – 4.17 (m, 3H), 1.21 (t, J = 7.2, 3H). 
13C NMR (100 MHz, CDCl3): 170.2, 155.2, 143.7, 143.6, 141.2, 138.0, 136.9, 133.2, 
131.2, 129.2, 128.2, 127.8, 127.6, 127.0, 125.1, 125.0, 120.0, 119.9, 67.0, 61.8, 60.0, 
47.1, 14.0. HRMS Calcd. for C29H28N1O4 (M+1): 454.2018, Found: 454.2015. FTIR 
(neat):  3344, 2979, 1720, 1498, 1449, 1321, 1194, 1047, 912, 758, 740, 703 cm-1. 
 
Representative Procedure for the Exhaustive Hydrogenation of Diene Products. 
To a solution of diene 3.19 (44 mg, 0.13 mmol, 100 mol%) in DCM (1.3 mL, 
0.1M) at ambient temperature was added Ir(COD)(Pyr)[P(c-Hex)3]PF6 (5.2 mg, 0.03 
mmol, 5 mol%). The system was purged with argon gas followed by hydrogen gas. The 
reaction was allowed to stir at ambient temperature under 1 atm of hydrogen for 24 hours. 
The title compound was purified by flash silica chromatography (Rf = 0.6, 15% 







2-tert-Butoxycarbonylamino-3-phenyl-hexanoic acid ethyl ester (3.20). Rf = 0.4, 10% 
EtOAc/hexane; colorless oil; 1H NMR (300MHz, CDCl3); Major: 7.33 -7.24 (m, 3H), 
7.18 – 7.15 (m, 2H), 5.06 (d, J = 9.3 Hz, 1H), 4.47 (t, J = 8.1 Hz, 1H), 3.98 (q, J = 7.1 
Hz, 2H), 2.93 (q, J = 7.4 Hz, 1H), 1.78 (q, J = 7.5 Hz, 2H), 1.45 (s, 9H), 1.27 – 1.12 (m, 
2H), 1.05 (t, J = 7.0, 3H), 0.87 (t, J = 7.4 Hz, 3H); Minor: 7.30 -7.11 (m, 3H), 7.11 – 7.09 
(m, 2H), 4.77 (d, J = 8.7 Hz, 1H), 4.55 (dd, J = 9.3, 5.1 Hz, 1H), 4.11 (q, J = 7.0 Hz, 2H), 
3.16 (dd, J = 16.2, 7.5 Hz, 1H), 1.72 (q, J = 7.9 Hz, 2H), 1.39 (s, 9H), 1.24 – 1.19 (m, 
5H), 0.85 (t, J = 7.2 Hz, 3H). 13C NMR (100MHz, CDCl3); Major: 171.8, 155.2, 139.9, 
128.4, 128.3, 127.0, 79.8, 60.9, 58.4, 49.1, 33.3, 28.3, 20.5, 13.9, 13.8. HRMS Calcd. for 
C19H30N1O4 (M+1): 336.2175, Found: 336.2175. FTIR (mixture, neat):  3442, 3558, 
2960, 2932, 2871, 1718, 1496, 1454, 1391, 1367, 1340, 1253, 1171, 1048, 1026, 863, 





2-(9H-Fluoren-9-ylmethoxycarbonylamino)-3-phenyl -hexanoic acid ethyl ester 
(3.22). Rf = 0.2, 10% EtOAc/hexane; colorless oil; 1H NMR (400MHz, CDCl3); Major: 
7.78 (d, J = 7.6 Hz,2H), 7.61 (d, J = 7.2 Hz, 2H), 7.42(t, J = 7.6 Hz, 2H), 7.35 – 7.24 (m, 
5H), 7.14 (d, J = 7.6 Hz, 2H), 5.33 (d, J = 9.2 Hz, 1H), 4.55 (t, J = 8.2 Hz, 1H), 4.47 (dd, 
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J = 10.4, 7.2 Hz, 1H), 4.36 (dd, J = 10.4, 7.2 Hz, 1H), 4.23 (t, J = 6.8 Hz, 1H), 4.00 (q, J 
= 7.2 Hz, 2H), 2.96 (q, J = 7.3 Hz, 1H), 1.80 (q, J = 7.6 Hz, 2H), 1.24 – 1.15 (m, 2H), 
1.05 (t, J = 7.2 Hz, 3H), 0.88 (t, J = 7.4 Hz, 3H); Minor: 7.77 (d, J = 7.6 Hz,2H), 7.56 (t, 
J = 8.4 Hz, 2H), 7.41(td, J = 7.3, 1.9 Hz, 2H), 7.34 – 7.24 (m, 5H), 7.10 (d, J = 6.8 Hz, 
2H), 5.04 (d, J = 9.6 Hz, 1H), 4.66 (q J = 4.7 Hz, 1H), 4.45 (dd, J = 10.8, 7.2 Hz, 1H), 
4.34 (dd, J = 10.8, 6.8 Hz, 1H), 4.22 (t, J = 7.0 Hz, 1H), 4.15 (q, J = 7.2 Hz, 2H), 3.23 (q, 
J = 9.8 Hz, 1H), 1.73 (q, J = 11.4 Hz, 2H), 1.30 – 1.22 (m, 2H), 1.26 (t, J = 7.0 Hz, 3H), 
0.90 (t, J = 7.0 Hz, 3H); 13C NMR (100MHz, CDCl3); Major: 171.4, 155.7, 143.9, 143.7, 
141.3, 139.5, 128.4, 128.3, 127.7, 127.1, 127.0, 125.1, 125.0, 119.9, 66.9, 61.1, 58.8, 
49.1, 47.2, 33.2, 20.5, 13.9, 13.8. HRMS Calcd. for C29H32N1O4 (M+1): 458.2331, 
Found: 458.2336. FTIR (mixture, neat):  3442, 3558, 2960, 2932, 2871, 1718, 1496, 
1454, 1391, 1367, 1340, 1253, 1171, 1048, 1026, 863, 776, 757, 701 cm-1. 
 






(mixture of two diastereomers)
AcO
 
To a solution of Grubbs’ catalyst (17.6 mg, 0.021 mmol, 5 mol%) in DCM (2.2 
mL, 0.2 M) was added diene 3.19 (139.4 mg, 0.416 mmol, 100 mol%) and 1,4-diacetoxy-
cis-2-butene (215.0 mg, 1.248 mmol, 300 mol%), and the solution stirred for 12 hours at 
40 °C. The volatiles were removed by rotary evaporation, and the residue was purified by 
silica flash chromatography (Rf = 0.4, 20% EtOAc/hexane) to afford 57.8 mg as a 
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colorless oil (80% yield, E:Z = 10:1). 1H NMR (400 MHz, CDCl3): 7.35 – 7.30 (m, 3H), 
7.15 d, J = 6.8 Hz, 2H), 6.63 and 6.37 (minor: d, J = 11.6 Hz, major: d, J = 10.8 Hz, 1H), 
6.12 and 6.01 (major: t, J =  13.0 Hz, minor: t, J = 11.6 Hz, 1H), 5.85 and 5.53 – 5.47 
(major: dt, J =  15.2, 6.4 Hz, minor: m, 1H), 5.33 and 5.13 (major: d, J = 7.2 Hz, minor: 
m, 1H), 5.03 and 4.89 (major: d, J =7.6 Hz, minor: m, 1H), 4.77 and 4.48 (minor: d, J = 
6.8 Hz, major: d, J = 6.0 Hz, 2H), 4.12 (q, J = 7.1 Hz, 2H), 2.06 and 1.99 (minor: s, 
major: s, 3H), 1.41 (s, 9H), 1.16 (t, J = 7.4 Hz, 3H). 13C NMR (100 MHz, CDCl3): 13C 
NMR (100 MHz, CDCl3) Major: 190.6, 154.6, 139.4, 136.7, 130.4, 129.3, 129.2, 129.1, 
129.0, 128.2, 127.8, 79.9, 64.6, 61.7, 59.7, 28.2, 20.8, 13.9. HRMS Calcd. for 
C22H30N1O6 (M+1): 404.2073, Found: 404.2069. FTIR (neat):  3375, 3374, 2978, 2923, 
1741, 1715, 1493, 1368, 1325, 1230, 1161, 1056, 1025, 976, 865, 777, 704.  
 
3.6.3 Reducitve Coupling of 1,3-Diynes and Iminoacetates 
Representative Procedure for the Coupling of 1,3-Diyne 3.26 and N-(2,4,6-
triisopropyl) benzenesulfinyl iminoacetate 
To a solution of N-(2,4,6-triisopropyl)benzenesulfinyl iminoacetate (70.3 mg, 0.2 
mmol, 100 mol%) and 1,3-diyne 3.26 (56.1 mg, 0.4 mmol, 200 mol%) in DCM (2 mL, 
0.1M) at ambient temperature was added Rh(COD)2OTf (4.7 mg, 0.01 mmol, 5 mol%) 
and BIPHEP (5.3 mg, 0.01 mmol, 5 mol%). The system was purged with argon gas 
followed by hydrogen gas. The reaction was allowed to stir at ambient temperature under 
1 atm of hydrogen for 1 hour. The title compound was purified by flash silica 












3-Phenyl-2-(2,4,6-triisopropyl-benzenesulfinylamino) -hept-3-en-5-ynoic acid ethyl ester 
(3.27). Rf = 0.25, 15% EtOAc/hexane; colorless oil; 1H NMR (400 MHz, CDCl3): 7.44 – 
7.41 (m, 2H), 7.33 – 7.27 (m, 3H), 7.02 (s, 2H), 5.88 (qd, J = 2.4, 0.4 Hz, 1H), 4.94 (d, J 
= 8.0 Hz, 1H), 4.80 (d, J = 8.4 Hz, 1H), 4.19 – 4.08 (m, 2H), 3.92 (s,2H), 2.84 (qt, J = 6.9 
Hz, 1H), 1.82 (d, J = 2.4, 3H), 1.20 (d, J = 6.8, 6H), 1.18 (d, J = 6.8 Hz, 12H), 1.63 (t, J = 
7.2, 3H). 13C NMR (100 MHz, CDCl3): 170.8, 152.1, 148.0, 146.3, 137.4, 136.5, 128.6, 
128.1, 128.0, 122.9, 111.9, 91.9, 62.8, 61.8, 34.3, 28.1, 24.3, 24.1, 23.7, 23.7, 13.9, 4.5. 
HRMS Calcd. for C30H40N1O3S1 (M+1): 494. 2729, Found: 494.2736. FTIR (neat):  












ethyl ester (deuterio -3.27). Rf = 0.25, 15% EtOAc/hexane; colorless oil; 1H NMR (400 
MHz, CDCl3): 7.45 – 7.43 (m, 2H), 7.34 – 7.28 (m, 3H), 7.03 (s, 2H), 4.96 (d, J = 8.0 Hz, 
1H), 4.81 (d, J = 8.0 Hz, 1H), 4.19 – 4.09 (m, 2H), 3.92 (br, 2H), 2.89 – 2.82 (m, 1H),  
1.83 (s, 3H), 1.25 – 1.16 (m, 2H). 13C NMR (100 MHz, CDCl3): 170.8, 152.0, 148.0, 
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146.1, 137.3, 136.4, 128.5, 128.1, 128.0, 122.9, 91.8, 62.7, 61.8, 34.2, 28.1, 24.2, 24.1, 
23.7, 13.9, 4.5. HRMS Calcd. for C30H39D1N1O3S1 (M+1): 495. 2792, Found: 495.2785. 












3-Furan-2-yl-2-(2,4,6-triisopropyl-benzenesulfinyl amino)-hept-3-en-5-ynoic acid 
ethyl ester (3.28). Rf = 0.25, 15% EtOAc/hexane; colorless oil; 1H NMR (400 MHz, 
CDCl3): 7.29 (d, J = 2.0, 1H), 7.21 (d, J = 3.2, 1H), 7.05 (s, 2H), 6.44 (q, J = 1.7, 1H), 
5.68 (q, J = 2.7, 1H), 5.21 (d, J = 9.2 Hz, 1H), 4.93 (d, J = 9.2 Hz, 1H), 4.14 (q, J = 7.1 
Hz, 2H), 3.96 (s, 2H), 2.87 (qt, J = 6.9 Hz, 1H), 2.09 (d, J = 2.8, 3H), 1.24 – 1.19 (m, 
18H), 1.14 (t, J = 7.0, 3H). 13C NMR (100 MHz, CDCl3): 170.6, 151.9, 150.8, 147.9, 
141.4, 137.9, 135.4, 122.9, 111.7, 111.3, 107.9, 96.4, 78.1, 61.9, 61.8, 34.3, 28.2, 24.3, 
24.1, 23.8, 23.7, 13.9, 4.94. HRMS Calcd. for C28H38N1O4S1 (M+1): 484. 2522, Found: 
484.2504. FTIR (neat):  2960, 2868, 1741, 1597, 1565, 1463, 1384, 1364, 1261, 1194, 












amino)-hept-3-en-5-ynoic acid ethyl ester (3.29). Rf = 0.3, 15% EtOAc/hexane; 
colorless oil; 1H NMR (400 MHz, CDCl3): 7.40 – 7.37 (m, 2H), 7.32 – 7.26 (m, 3H), 7.02 
(s, 2H), 5.94 (t, J = 1.0 Hz, 1H), 4.95 (d, J = 8.8 Hz, 1H), 4.80 (d, J = 8.8 Hz, 1H), 4.28 
(d, J = 2.0 Hz, 2H), 4.16 – 4.10 (m, 2H), 3.91 (s,2H), 2.84 (qt, J = 7.0 Hz, 1H), 1.20 (d, J 
= 7.2, 6H), 1.17 (d, J = 6.8 Hz, 12H), 1.16 (t, J = 7.2, 3H), 0.83 (s, 9H), -0.017 (s, 6H). 
13C NMR (100 MHz, CDCl3): 170.6, 152.1, 148.1, 148.0, 137.3, 136.2, 128.6, 128.3, 
128.1, 123.0, 111.0, 93.2, 81.6, 62.8, 61.9, 52.1, 34.3, 28.1, 25.7, 24.3, 24.1, 23.7, 18.2, 
13.9, -5.31. HRMS Calcd. for C36H54N1O4Si1S1 (M+1): 624.3543, Found: 624.3534. 
FTIR (neat):  2958, 2928, 2857, 1739, 1597, 1566, 1495, 1462, 1444, 1364, 1301, 1256, 











hept-3-en-5-ynoic acid ethyl ester  (3.30). Rf = 0.3, 25% EtOAc/hexane; colorless oil; 
1H NMR (400 MHz, CDCl3): 7.40 – 7.37 (m, 2H), 7.38 – 7.27 (m, 3H), 7.02 (s, 2H), 5.90 
(d, J = 0.8 Hz, 1H), 4.94 (d, J = 8.4 Hz, 1H), 4.82 (d, J = 8.4 Hz, 1H), 4. 49 (s, 1H), 4.19 
– 4.07 (m, 2H), 3.90 – 3.88 (m, 4H), 2.84 (qt, J = 6.9 Hz, 1H), 1.40 (s, 9H), 1.21 (d, J = 
7.2, 6H), 1.17 (dd, J = 6.8, 2.0 Hz, 12H), 1.15 (t, J = 7.2, 3H). 13C NMR (100 MHz, 
CDCl3): 170.5, 155.1, 152.1, 148.4, 148.1, 137.3, 136.2, 128.5, 128.4, 128.1, 123.0, 
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110.8, 90.9, 80.2, 79.8, 62.9, 62.0, 34.3, 31.2, 28.3, 28.2, 24.3, 24.1, 23.7, 23.7, 13.9. 
HRMS Calcd. for C35H48N2O5S1 (M): 608.3284, Found: 608.3283. FTIR (neat):  2961, 
2869, 1738, 1598, 1566, 1463, 1443, 1425, 1384, 1364, 1260, 1191, 1094, 1027, 938, 













5-ynoic acid ethyl ester (3.32). Rf = 0.2, 30% EtOAc/hexane; colorless oil; 1H NMR 
(400 MHz, CDCl3): 7.06 (s, 2H), 5.72 (s, 1H), 5.32 (d, J = 8.4 Hz, 1H), 4.75 (d, J = 8.4 
Hz, 1H), 4.59 (d, J = 14.4 Hz, 1H), 4.45 (d, J = 14.0 Hz, 1H), 4.41 (d, J = 0.8 Hz, 2H),  
4.23  – 4.15 (m, 2H), 3.94 (s, 2H), 3.50 (S, 1H), 2.89 – 2.82 (m, 1H), 2.31 (s, 1H), 1.31 
(d, J = 6.8, 6H), 1.24 (t, J = 7.2, 3H), 1.22 (d, J = 6.8 Hz, 12H). 13C NMR (100 MHz, 
CDCl3): 170.3, 152.4, 149.1, 147.7, 137.1, 123.1, 111.5, 95.5, 80.6, 62.3, 61.8, 60.4, 
51.3, 34.3, 28.5, 24.3, 24.1, 23.7, 14.0. HRMS Calcd. for C25H38N1O5S1 (M+1): 464. 
2471, Found: 464.2472. FTIR (neat):  3353, 2962, 2928, 2870, 1738, 1597, 1567, 1463, 
1425, 1385, 1364, 1262, 1193, 1168, 1079, 1052, 1025, 911, 879, 733, 648 cm-1. 
Procedure for Desulfinylation and N-Protection of the Enyne 3.27 
The enyne 3.27 (188 mg, 0.38 mmol, 100 mol%) was dissolved in MeOH (38 mL, 
0.01M) and treated with HCl in dioxane (0.5 mL, 4.0 M in dioxane, 500 mol%). The 
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reaction was allowed to stir at ambient temperature for 1 hour. The reaction mixture was 
concentrated and coevaporated with MeOH. The residue was dissolved in DCM (38 mL, 
0.01M) followed by addition of DIPEA (0.2 mL, 300 mol%) and Boc2O (125 mg, 0.57 
mmol, 150 mol%). The reaction mixture was stirred for 12 hours before diluting with 
DCM and H2O. The organic phase was washed with an aqueous solution of citric acid (10 
wt%), a saturated aqueous solution of NaHCO3 and with H2O. After drying (Na2SO4), the 








2-tert-Butoxycarbonylamino-3-phenyl-hept-3-en-5-ynoic acid ethyl ester (3.33). Rf = 
0.5 15% EtOAc/hexane; colorless oil; 1H NMR (400 MHz, CDCl3): 7.47 – 7.36 (m, 2H), 
7.37 – 7.27 (m, 3H), 5.85 (d, J = 2.0 Hz, 1H), 5.36 (d, J = 7.2 Hz, 1H), 5.12 (d, J = 7.6 
Hz, 1H), 4.19 – 4.07 (m, 2H), 1.84 (d, J = 2.4, 3H), 1.42 (s, 9H), 1.15 (t, J = 6.8, 3H). 13C 
NMR (100 MHz, CDCl3): 170.4, 154.6, 146.1, 136.9, 128.3, 127.9, 110.9, 91.4, 80.0, 
61.7, 58.7, 28.2, 13.9, 4.5. HRMS Calcd. for C20H26N1O4 (M+1): 344.1862, Found: 
344.1861. FTIR (neat):  3375, 2978, 2932, 1740, 1717, 1495, 1367, 1325, 1247, 1164, 
1054, 1026, 913, 865, 744, 699 cm-1. 
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Exhaustive Hydrogenation of Enyne Product of the Enyne 3.33 
To a solution of enyne 3.33 (44 mg, 0.13 mmol, 100 mol%) in DCM (1.3 mL, 
0.1M) at ambient temperature was added Ir(COD)(Pyr)[P(c-Hex)3]PF6 (5.2 mg, 0.03 
mmol, 5 mol%). The system was purged with argon gas followed by hydrogen gas. The 
reaction was allowed to stir at ambient temperature under 1 atm of hydrogen for 24 hours. 






(mixture of two diastereomers)
H3C
 
2-tert-Butoxycarbonylamino-3-phenyl-heptanoic acid ethyl ester (3.34). Rf = 0.6, 
15% EtOAc/hexane; colorless oil; 1H NMR (400 MHz, CDCl3): 7.31 – 7.11 (m, 5H), 
5.04 and 4.78 (major: d, J = 9.2 Hz, minor: d, J = 8.8 Hz, 1H), 4.57 and 4.45 (minor: dd, 
J = 9.6, 5.2 Hz, major: t, J = 8.0 Hz, 1H), 4.12 and 3.97 (minor: q, J = 7.2 Hz, major: q, J 
= 7.2 Hz, 2H), 3.18 – 3.15 and 2.91 – 2.86 (minor: m, major: m, 1H), 1.82 – 1.74 (m, 
2H), 1.42 and 1.41 (major: s, minor: s, 9H), 1.38 – 1.01 (m, 7H), 0.85 – 0.80 (m, 3H). 13C 
NMR (100 MHz, CDCl3) Major: 171.7, 155.1, 139.9, 128.4, 128.2, 126.9, 79.7, 60.8, 
58.4, 49.3, 30.7, 29.5, 28.2, 22.5, 13.8. Minor:  171.7, 155.6, 139.4, 128.4, 128.2, 127.1, 
79.7, 61.0, 57.6, 47.8, 31.1, 29.4, 28.2, 22.5, 14.1. HRMS Calcd. for C20H32N1O4 (M+1): 
350.2331, Found: 350.2329. FTIR (neat):  3359, 2958, 2932, 2870, 1718, 1496, 1454, 
1367, 1250, 1171, 1055, 1027, 864, 700 cm-1. 
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3.6.4 Reductive Coupling of 1,3-Enynes and α-Ketoesters 
Representative Procedure for the Coupling of 1,3-Phenyl enyne and Ethyl pyruvate 
To a solution of Rh(COD)2OTf (1.9 mg, 0.004 mmol, 2 mol%), (R)-xylyl-
WALPHOS (3.2 mg, 0.004 mmol, 2 mol%) and triphenyl acetic acid (0.6 mg, 0.002 
mmol, 1 mol%) in DCE (0.5 mL) was added a solution of ethyl pyruvate (24 mg, 0.20 
mmol, 100 mol%) and enyne 6a (50.9 mg, 0.40 mmol, 200 mol%) in DCE (0.5 mL) at 45 
oC. The system was purged with argon gas followed by hydrogen gas. The reaction was 
allowed to stir at 45 oC under 1 atm of hydrogen for 3 hours. The title compound was 
purified by flash silical chromatography (Rf = 0.3, 15% EtOAc/hexane) to afford 45.5 







2-Hydroxy-2-methyl-3-phenyl-hexa-3,5-dienoic acid ethyl (3.35). Rf = 0.3, 15% 
EtOAc /hexane); colorless oil; 1H NMR (400 MHz, CDCl3): 7.33 – 7.25 (m, 3H), 7.11 – 
7.08 (m, 2H), 6.50 (d, J = 10.8 Hz, 1H), 5.95 (ddd, J = 18.7, 10.3, 10.1 Hz, 1H), 5.24 
(ddd, J = 18.8, 1.8, 0.6 Hz, 1H), 5.01 (ddd, J = 10.2, 2.0, 0.6 Hz, 1H), 4.18 – 4.04 (m, 
2H), 3.37 (s, br, 1H), 1.59 (s, 3H), 1.17 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3): 
175.3, 144.1, 137.6, 133.9, 129.8, 128.7, 127.9, 127.4, 119.2, 76.7, 62.0, 24.1, 13.9. 
HRMS Calcd. for C15H17O3 [M+1]: 246.1256, Found: 246.1259. FTIR (neat): 3509, 
2982, 2938, 2905, 2874, 1955, 1815, 1727, 1635, 1602, 1573, 1492, 1443, 1417, 1373, 
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1250, 1165, 1128, 1094, 1018, 996, 977, 913, 859, 778, 744, 707, 670, 587 cm-1. HPLC 
(Chiralcel OJ-H column, 2% i-PrOH/hexane, 0.5 mL/min, 254 nm), tminor = 18.4 min, 







4-deuterio-2-Hydroxy-2-methyl-3-phenyl-hexa-3,5-dienoic acid ethyl (deuterio-3.35). 
Rf = 0.3, 15% EtOAc/hexane; colorless oil; 1H NMR (400 MHz, CDCl3): 7.33 - 7.25 (m, 
3H), 7.11 - 7.08 (m, 2H), 5.99 (dd, J = 17.0, 10.28 Hz, 1H), 5.29 (dd, J = 17.2, 1.6 Hz, 
1H), 5.04 (dd, J = 10.0, 2.0 Hz, 1H), 4.18 – 4.04 (m, 2H), 3.39 (s, 1H), 1.59 (s, 3H), 1.17 
(t, J = 7.0 Hz, 3H). 13C NMR (100 MHz, CDCl3): 175.3, 144.0, 137.0, 133.9, 129.8, 
128.4 (t, J = 24.3 Hz), 127.9, 127.4, 119.2, 76.7, 62.1, 24.1, 14.0. HRMS Calcd. for 
C15H172H1O3 [M]: 247.1319, Found: 247.1317. FTIR (neat): 3501, 2982, 2937, 1727, 








methyl (3.37). Rf = 0.14, 20 %EtOAc/hexane; a white crystal; 1H NMR (400 MHz, 
CDCl3): 6.71 (dt, J = 16.8, 10.4 Hz, 1H), 6.32 (d, J = 11.2 Hz, 1H), 5.35 (dd, J = 16.8, 
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1.2 Hz, 1H), 5.30 (dd, J = 10.4, 1.2Hz, 1H), 4.80 (s, 1H), 4.12 (q, J = 7.2 Hz, 1H), 3.95 
(s, 1H), 3.77 (s, 3H), 3.73 (dd, J = 13.6, 3.2 Hz, 1H) 1.59 (s, 3H), 1.43 (s, 9H). 13C NMR 
(100 MHz, CDCl3): 176.5, 155.9, 138.6, 132.1, 130.7, 121.4, 79.7, 76.7, 53.5, 37.4, 28.6, 
25.1. HRMS Calcd. for C14H23NO5 (M+1): 286.1654, Found: 286.1654. FTIR(neat): 
3449, 3053, 2983, 2253, 1729, 1504, 1456, 1368, 1265, 1165, 976, 912, 741, 651. HPLC 
(Chiralcel OD column, 1% i-PrOH/hexanes, 1.0 mL/min, 254 nm), tminor = 19.3 min, tmajor 








3-Allylidene-2-hydroxy-2-methyl-octanoic acid ethyl ester (4.38). Rf = 0.3, 10% 
EtOAc /hexane); colorless oil; 1H NMR (400 MHz, CDCl3): 6.52 (ddd, J = 16.7, 10.5, 
10.5 Hz, 1H), 6.20 (d, J =  10.8 Hz, 1H), 5.23 (dd, J = 16.6, 2.2 Hz, 1H), 5.14 (dd, J = 
10.2, 1.8 Hz, 1H), 4.26 – 4.13 (m, 2H), 3.38 (d, br, 1H), 2.22 (ddd, J = 13.7, 10.3, 6.1 Hz, 
1H), 2.08 (ddd, J = 13.7, 10.3, 6.1,1H), 1.52 (s, 3H), 1.42 -1.22 (m, 6H), 1.26 (t, J = 7.2 
Hz, 3H), 0.86 (t, J = 7.0 Hz, 3H). 13C NMR (100 MHz, CDCl3): 175.9, 143.4, 132.8, 
126.3, 118.3, 77.0, 62.1, 32.3, 30.4, 27.9, 24.4, 22.4, 14.1, 14.0. HRMS Calcd. for 
C14H24O3 [M+1]: 241.1804, Found: 241.1802. FTIR (neat): 3508, 3081, 3055, 2980, 
2937, 2879, 1724, 1602, 1493, 1463, 1442, 1417, 1367, 1285, 1238, 1162, 1140, 1073, 
1025, 996, 913, 860, 777, 707, 670 cm-1. HPLC (Chiralpak AD column, 0.1 % i-









2-Hydroxy-3-(1H-indol-2-yl)-2-methyl-hexa-3,5-dienoic acid ethyl ester (3.39). Rf = 
0.25, 15% EtOAc/hexane; colorless oil; H NMR (400 MHz, CDCl3): 8.92 (s, 1H), 7.58 
(d, J = 8.0 Hz, 1H), 7.34 (d, J = 8.0 Hz, 1H), 7.67 (td, J = 7.5, 0.8 Hz, 1H), 7.08 (td, J = 
7.0, 0.8 Hz, 1H), 6.72 (dt, J = 16.8, 10.3 Hz, 1H), 6.44 (dd, J = 5.8, 4.6 Hz, 1H), 6.45 (s, 
1H), 5.43 (dt, J = 16.8, 0.9 Hz, 1H), 5.23 (dt, J = 10.2, 0.9 Hz, 1H), 5.23 (dt, J = 10.2, 0.9 
Hz, 1H), 4.25 – 4.14 (m, 2H), 3.78 (s, 1H), 1.61 (s, 3H), 1.18 (t, J = 7.2 Hz, 3H). 13C 
NMR (100 MHz, CDCl3): 175.4, 135.8, 134.0, 133.8, 133.0, 130.9, 127.7, 122.1, 121.0, 
120.3, 119.7, 111.0, 105.4, 77.4, 62.5, 24.4, 14.0. HRMS Calcd. for C17H19N1O3 [M+1]: 
286.1443, Found: 286.1439. FTIR (neat): 3407, 3055, 2981, 2936, 1727, 1617, 1454, 
1398, 1371, 1318, 1255, 1129, 1017, 916, 858, 796, 738, 702 cm-1. HPLC (Chiralcel OJ-








4-Allylidene-3-hydroxy-3-methyl-dihydro-furan-2-one (3.40). Rf = 0.1, 20 % EtOAc/ 
hexane; colorless oil; 1H NMR (400 MHz, CDCl3): 6.34 (dt, J = 11.2, 2.0 Hz, 1H), 6.29 
(m, 1H), 5.39 (d, J = 14.4 Hz, 1H), 5.32 (d, J = 9.2 Hz, 1H), 5.09 (dd, J = 14.0, 2.4 Hz, 
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1H), 4.93 (dd, J = 14.0, 2.4 Hz, 1H), 3.21 (s, 1H), 1.55 (s, 1H). 13C NMR (100 MHz, 
CDCl3): 178.4, 137.0, 130.3, 124.8, 121.3, 71.7, 67.7, 25.9. HRMS Calcd. for C8H10O3 
(M+1): 154.0630, Found: 154.0632. FTIR (neat): 3438, 2982, 2890, 2254, 1778, 1609, 
1466, 1440, 1374, 1361, 1265, 1203, 1165, 1117, 1017, 1001, 909, 732, 650, 588. HPLC 
(Chiralcel OJH column, 0.5% [0 – 30 min] – 3% [30 – 120 min] i-PrOH/hexanes, 1.0 









3-Acetoxymethyl-2-hydroxy-2-methyl-hexa-3,5-dienoic acid methyl ester (3.41). Rf = 
0.1, 20 % EtOAc/hexane; a colorless oil; 1H NMR(400 MHz, CDCl3): 6.67 (dt, J = 16.8, 
11.2 Hz, 1H), 6.47 (d, J = 11.2 Hz, 1H), 5.42 (dd, J = 16.4, 1.2 Hz, 1H), 5.34 (dd, J = 
10.0, 1.2 Hz, 1H), 4.84 (d, J = 12 Hz, 1H), 4.83 (d, J = 12 Hz, 1H), 3.78 (s, 3H), 3.74 (s, 
1H), 2.02 (s, 3H), 1.59 (s, 3H). 13C NMR (100 MHz, CDCl3): 175.8, 170.6, 135.8, 132.3, 
131.4, 121.9, 75.5, 58.8, 53.0, 24.7, 20.7. HRMS Calcd. for C11H16O5 (M + 1): 229.1076, 
Found: 229.1083. FTIR (neat): 3517, 3054, 2986, 2253, 1734, 1421, 1373, 1265, 1132, 
1024, 988, 911, 741, 651. HPLC (Chiralcel OD column, 1% i-PrOH/hexanes, 1.0 










3-(2-Acetoxy-ethyl)-2-hydroxy-2-methyl-hexa-3,5-dienoic acid methyl ester (3.42). 
Rf = 0.15, 20 % EtOAc/hexane; colorless oil; 1H NMR(400 MHz, CDCl3): 6.62 (dt, J = 
16.8, 10.4 Hz, 1H), 6.31 (d, J = 10.8 Hz, 1H), 5.33 (dd, J = 16.8, 1.2 Hz, 1H), 5.26 (dd, J 
= 10.4, 1.2 Hz, 1H), 4.10 (m, 2H), 3.79 (s, 3H), 3.58 (s, 1H), 2.66 (m, 1H), 2.44 (m, 1H), 
2.04 (s, 3H), 1.58 (s, 3H). 13C NMR (100 MHz, CDCl3): 176.0, 171.0, 137.4, 132.3, 
129.4, 120.0, 63.7, 53.1, 27.1, 24.6, 20.9. HRMS Calcd. for C12H18O5 (M+1): 243.1232, 
Found: 243.1236. FTIR (neat):3438, 3053, 2986, 2253, 1732, 1645, 1437, 1421, 1365, 
1265, 1131, 1095, 1034, 990, 911, 732, 651. HPLC (Chiralcel OD column, 1% i-








3-Acetoxymethyl-2-cyclopropyl-2-hydroxy-hexa-3,5-dienoic acid methyl ester (3.43). 
Rf = 0.4, 20% EtOAc/hexane; a colorless oil; 1H NMR (400 MHz, CDCl3): 6.72 – 6.62 
(m, 2H), 5.44 – 5.37 (m, 1H), 5.33 – 5.29 (m, 1H), 4.81 (q, J = 13.9 Hz, 4H), 3.78 (s, 
3H), 3.34 (s, 1H), 1.99 (s, 3H), 1.41 – 1.35 (m, 1H), 0.54 – 0.43 (m, 3H), 0.39 – 0.32 (m, 
1H). 13C NMR (100 MHz, CDCl3): 176.2, 170.6, 135.4, 133.3, 131.6, 121.9, 75.4, 59.3, 
53.2, 20.8, 15.9, 1.07, 0.04. HRMS Calcd. for C13H18N1O5 [M]: 254.1154, 
Found:.254.1155. FTIR (neat): 3490, 3088, 3010, 2954, 1736, 1598, 1436, 1380, 1364, 
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1233, 1162, 1026, 990, 960, 921, 833, 792 cm-1. HPLC (Chiralpak AD-H column, 1% i-








3-Acetoxymethyl-2-hydroxy-2-phenyl-hexa-3,5-dienoic acid methyl ester (3.44). Rf = 
0.21, 20 %EtOAc/hexane; colorless oil; 1H NMR(400 MHz, CDCl3): 7.49 (dd, J = 8.4, 
1.6 Hz, 2H), 7.34 (m, 3H), 6.65 (dt, J = 16.0, 10 Hz, 1H), 6.15 (d, J = 10.8 Hz, 1H), 5.30 
(dd, J = 5.2, 1.2 Hz, 1H), 5.28 (dd, J = 12.4, 1.2 Hz, 1H), 4.84 (d, J = 12.0 Hz, 1H), 4.79 
(d, J = 12.0 Hz, 1H), 4.15 (s, 1H), 3.84 (s, 3H), 1.97 (s, 3H). 13C NMR (100 MHz, 
CDCl3): 174.0, 170.7, 139.4, 135.8, 134.4, 131.4, 128.1, 126.9, 122.2, 81.4, 59.8, 53.3, 
20.6. HRMS Calcd. for C16H18O5 [M+1]: 291.1232, Found: 291.1235. FTIR (neat): 3500, 
3053, 2986, 2253, 1732, 1651, 1436, 1422, 1383, 1265, 1130, 1093, 1063, 1025, 989, 
912, 741, 651. HPLC (Chiralpak ADH column, 1% [0 min] – 5% [90 min] i-












3-Acetoxymethyl-2-(2-bromo-phenyl)-2-hydroxy-hexa-3,5-dienoic acid methyl ester 
(3.45). Rf = 0.14, 20 %EtOAc/hexane; colorless oil; 1H NMR(400 MHz, CDCl3): 7.70 (d, 
J = 2.0 Hz, 1H), 7.50 (dt, J = 6.0, 1.2 Hz 2H), 7.23 (t, J = 8.0 Hz, 1H), 6.64 (dt, J = 17.2, 
10.0 Hz, 1H), 6.12 (d, J = 11.2 Hz, 1H), 5.35 (dd, J = 3.2, 1.6 Hz, 1H), 5.32 (dd, J = 
10.4, 1.6 Hz, 1H), 4.80 (d, J = 12.8 Hz, 1H), 4.76 (d, J = 12.8 Hz, 1H), 4.19 (s, 1H), 3.86 
(s, 3H), 1.98 (s, 3H). 13C NMR (100 MHz, CDCl3): 173.5, 170.8, 141.6, 135.4, 134.6, 
131.3, 130.2, 129.6, 125.8, 122.8, 122.4, 81.0, 59.7, 53.6, 20.7. HRMS Calcd. for 
C16H17O5Br [M+1]: 369.0338, Found: 369.0340. FTIR (neat): 3500, 3053, 2986, 2253, 
1733, 1594, 1568, 1472, 1427, 1421, 1383, 1265, 1179, 1133, 1075, 1025, 988, 911, 748, 
651. HPLC (Chiralpak ADH column, 10% i-PrOH/hexanes, 1.0 mL/min, 254 nm), tminor 









3-Acetoxymethyl-2-ethyl-2-hydroxy-hexa-3,5-dienoic acid methyl ester (3.46). Rf = 
0.3, 20% EtOAc/hexane; colorless oil; 1H NMR (400 MHz, CDCl3): 6.64 (ddd, J = 16.6, 
11.0, 10.2 Hz, 1H), 6.62 (d, J = 11.2 Hz, 1H), 5.37 (dd, J = 16.4, 1.6 Hz, 1H), 5.29 (dd, J 
= 10.0, 1.6 Hz, 1H), 4.80 (s, 2H), 3.75 (s, 3H), 3.58 (s, br, 1H), 1.99 (dt, J = 21.2, 7.4, 
 126
1H), 1.99 (s, 3H), 1.81 (dt, J = 21.2, 7.4 Hz, 1H), 0.86 (t, J = 7.4 Hz, 3H). 13C NMR (100 
MHz, CDCl3): 175.4, 170.7, 135.2, 133.0, 131.6, 121.8, 78.5, 58.9, 53.1, 30.0, 20.8, 7.7. 
HRMS Calcd. for C12H18O5 [M]: 242.1154, Found: 242.1156. FTIR (neat): 3502, 3087, 
2956, 2881, 1736, 1597, 1437, 1382, 1364, 1320, 1236, 1149, 1065, 1023, 990, 960, 925, 
808, 756 cm-1. HPLC (Chiralpak AD-H column, 1% i-PrOH/hexane, 1.0 mL/min, 254 
nm), tminor = 20.0 min, tmajor = 30.1; ee = 86 %.  
 
Procedure for Site-Selective Hydrogenation of the Diene 3.35 
To a solution of diene 3.35. (100 mg, 0.406 mmol, 100 mol%) in toluene (2.7 mL, 
0.15M) was added RhCl(PPh3)3 (38 mg, 0.0406 mmol, 10 mol%). The system was 
purged with argon gas followed by hydrogen gas. The reaction was allowed to stir at 
ambient temperature under 1 atm of hydrogen for 4 hours. The title compound was 
purified by flash silica chromatography (Rf = 0.3, 15% EtOAc/hexane) to afford 97.8 mg 






2-Hydroxy-2-methyl-3-phenyl-hex-3-enoic acid ethyl ester (3.47). 1H NMR (400 
MHz, CDCl3): 7.31 – 7.22 (m, 3H), 7.07 – 7.04 (m, 2H), 5.89 (t, J = 7.4 Hz, 1H), 4.17 – 
4.04 (m, 2H), 3.26 (s, br, 1H), 1.77 (qt, J = 7.4, 2H), 1.55 (s, 3H), 1.18 (t, J = 7.2 Hz, 
3H). 13C NMR (100 MHz, CDCl3): 175.7, 141.7, 137.6, 131.0, 129.6, 127.8, 127.0, 76.7, 
61.8, 24.0, 22.3, 14.0. HRMS Calcd. for C15H20O3 [M]: 248.1412, Found: 248.1415. 
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FTIR (neat): 3507, 3054, 2964, 2935, 2872, 1726, 1599, 1573, 1492, 1442, 1373, 1300, 
1248, 1159, 1137, 1122, 1093, 1020, 969, 859, 764, 704, 678 cm-1. 
 
Procedure for Ozonolysis of Compound 3.47. 
Compound 3.47 (46.6 mg, 0.186 mmol, 100 mol%) was dissolved in DCM (9.3 
mL, 0.02M), and the solution was cooled to -78 °C. The solution was sparged with ozone 
for 5 min, and sparged with argon for 5 min. Triphenylphosphine (245 mg, 0.934 mmol, 
500 mol%) was added, and the reaction was allowed to stir for 10 hours while warming 
gradually to room temperature. The solvent was removed in vacuo. The title compound 
was purified by flash silical chromatography (Rf = 0.25, 15% EtOAc/hexane) to afford 








2-Hydroxy-2-methyl-3-oxo-3-phenyl-propionic acid ethyl ester (6d). 1H NMR (400 
MHz, CDCl3): 7.97 – 7.94 (m, 2H), 7.56 (tt, J = 7.4, 1.5 Hz, 1H), 7.46 – 7.41 (m, 2H), 
4.43 (s, 1H), 4.20 (q, J = 7.1 Hz, 2H), 1.72 (s, 3H), 1.14 (t, J = 7.0 Hz, 3H). 13C NMR 
(100 MHz, CDCl3): 195.9, 172.3, 133.7, 133.1, 129.4, 128.6, 79.4, 62.5, 23.5, 13.8. 
HRMS Calcd. for C12H14O4 [M+1]: 223.0970, Found: 223.0973. FTIR (neat): 3472, 
2975, 2940, 2848, 1732, 1679, 1618, 1443, 1391, 1374, 1251, 1159,1122, 1017, 972, 858, 
784, 750, 707 cm-1.  
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Procedure for the Exhaustive Hydrogenation of the Diene 3.35. 
To a solution of diene product 3.35 (103mg, 0.418 mmol, 100 mol%) in DCM (5 
mL, 0.1M) at ambient temperature was added Ir(COD)(Pyr)[P(c-Hex)3]PF6 (17mg, 
0.0209 mmol, 5 mol%). The system was purged with argon gas followed by hydrogen 
gas. The reaction was allowed to stir at ambient temperature under 1 atm of hydrogen for 
3 hours. The title compound was purified by flash silical chromatography (Rf = 0.3, 15% 





(mixture of two diastereomers)
OHH3C
 
2-Hydroxy-2-methyl-3-phenyl-hexanoic acid ethyl (3.49). 1H NMR (400 MHz, 
CDCl3): 7.32 - 7.29 (m, 3H), 7.28 - 7.22 (m, 2H), 4.34 – 4.21 and 4.05 -3.89 (major: m, 
2H, minor: m, 2H), 3.13 (s, 1H), 2.89 and 2.88 (major: dd, J = 11.6, 3.2 Hz, 1H), minor: 
dd, J = 11.6, 4.4 Hz, 1H), 1.95 – 1.81 (m, 1H), 1.32 (t, J = 7.0 Hz, 3H), 1.17 – 0.35 (m, 
4H), 1.14 (s, 3H), 0.85 and 0.80 (minor: t, J = 7.4 Hz, 3H, major: t, J = 7.4 Hz, 3H). 13C 
NMR (100 MHz, CDCl3): Major: 177.5, 139.7, 129.8, 127.9, 126.7, 62.0, 52.7, 32.6, 
25.0, 20.5, 14.2, 13.8. Minor:176.5, 140.3, 128.9, 127.9, 126.8, 61.6, 52.7, 30.2, 24.4, 
20.6, 14.0, 13.9. HRMS Calcd. for C15H22O3 [M+1]: 251.1647, Found: 251.1651. FTIR 
(neat): 3517, 3028, 2957, 2934, 2871, 1725, 1602, 1492, 1453, 1373, 1241, 1161, 1108, 
1019, 949, 912, 866, 771, 707 cm-1.  
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Procedure for Epoxidation of the Diene 3.35 
To a solution of VO(acac)2 (1.1 mg, 0.0041 mmol, 2.5 mol%) and compound 3.35 
(40.5 mg, 0.16 mmol, 100 mol%) in DCM (1.6 mL, 0.1 M) was added t-BuOOH (5 – 6 
M in Decane, 0.04 mL, 0.20 mmol, 125 mol%). The reaction mixture was allowed to stir 
at room temperature for 4 hours under argon atmosphere.  After removing of the solvent 
by evaporation, the title compound was purified by flash column chromatography (Rf = 









2-Hydroxy-2-(2-phenyl-3-vinyl-oxiranyl)-propionic acid ethyl ester (3.50). 1H NMR 
(400 MHz, CDCl3): 7.36 – 7.24 (m, 5H), 5.50 (dd, J = 17.2, 1.2 Hz, 1H), 5.24 (dd, J = 
10.4, 1.2 Hz, 1H), 5.06 – 4.99 (m, 1H), 4.14 – 4.02 (m, 2H), 3.88 (d, J = 8.8 Hz, 1H), 
3.49 and 3.36 (minor: s, 1H, major: s, 1H), 1.54 and 1.41 (major: s, 3H, minor: s, 3H), 
1.18 and 1.13 (minor: t, J = 7.2 Hz, 3H, major: t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, 
CDCl3): Major: 173.2, 133.9, 133.2, 128.5, 128.2, 127.8, 121.5, 75.7, 69.6, 61.7, 59.7, 
20.7, 13.8. Minor: 134.5, 68.0, 62.2, 40.0, 20.9. HRMS Calcd. for C15H18O4 [M+1]: 
263.1283, Found: 263.1280. FTIR (neat): 3445, 2983, 2253, 1733, 1710, 1509, 1455, 
1393, 1368, 1265, 1165, 1069, 981, 912, 732, 650.  
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Procedure for Cross-Metathesis of the Diene 3.35 
To a solution of Grubbs’ catalyst (6.2 mg, 0.0073 mmol, 5 mol%) in DCM (0.7 
mL, 0.2 M) were added compound 3.35 (36.1 mg, 0.147 mmol, 100 mol%) and 1,4-
diacetoxy-cis-2-butene (77.2 mg, 0.45 mmol, 300 mol%). The reaction mixture was 
allowed to stir at 40 oC under argon atmosphere for 14 hours. The title compound was 
purified by flash column chromatography (Rf = 0.18, 20 %EtOAc/hexane) to afford 33.6 









7-Acetoxy-2-hydroxy-2-methyl-3-phenyl-hepta-3,5-dienoic acid ethyl ester (3.54). 1H 
NMR(400 MHz, CDCl3): 7.38 – 7.29 (m, 3H), 7.13 – 7.08 (m, 2H), 6.82 and 6.52 (minor: 
d, J = 10.8 Hz, 1H, major: d, J = 10.0 Hz, 1H), 6.00 -5.81 (m, 2H), 5.48 (minor: dt, J = 
10.8, 7.2 Hz, 1H), 4.80 (minor: d, J = 7.2 Hz, 1H), 4.47 (d, J = 5.2 Hz, 2H), 4.20 – 4.03 
(m, 2H), 3.46 and 3.42 (minor: s, 1H, major: s, 1H), 2.08 and 2.00 (minor: s, 3H, major: 
s, 3H), 1.62 and 1.60 (minor: s, 3H, major: s, 3H), 1.19 and 1.15 (major: t, J = 7.2 Hz, 
3H, minor: t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3): Major: 175.2, 170.6, 145.2, 
136.7, 131.0, 129.7, 128.6, 127.9, 127.6, 126.9, 64.6, 62.1, 24.1, 20.8, 13.9. Minor: 
144.5, 137.0, 131.8, 129.8, 128.1. HRMS Calcd. for C18H22O5 [M+1]: 319.1545, Found: 
319.1544. FTIR (neat): 3521, 3154, 2984, 2253, 1791, 1726, 1651, 1557, 1471, 1376, 
1249, 1165, 1130, 1094, 1021, 976, 912, 732, 651. 
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Procedure for Oxidative Cleavage of the Diene 3.35. 
To a mixture of 0.8 mL of water and 1.9 mL of THF, OsO4 (5.0 mg, 0.0197 
mmol, 5 mol%) and compound 3.35 (97.2 mg, 0.395 mmol, 100 mol%) was added and 
then stirred for 5 minutes. While the temperature of the stirred mixture was maintained at 
24 – 26 °C, NaIO4 (186 mg, 0.868 mmol, 220 mol%) was added in portions over a period 
of 40 minutes. The solution was stirred for an additional 2 hours. The mixture was 
extracted thoroughly with ether and the combined organic layers were dried with Na2SO4. 
The solvent was removed in vacuo, and then the title compound was purified by flash 
silical chromatography (Rf = 0.25, 20% EtOAc/hexane) to afford 81.4 mg as a colorless 







2-Hydroxy-2-methyl-5-oxo-3-phenyl-pent-3-enoic acid ethyl ester (3.53). 1H NMR 
(300 MHz, CDCl3): 9.26 (d, J = 7.5 Hz, 1H), 7.38 - 7.31 (m, 3H), 7.20 – 7.16 (m, 2H), 
6.41 (d, J = 8.1 Hz, 1H), 4.22 – 4.05 (m, 2H), 3.59 (s, 1H), 1.62 (s, 3H), 1.17 (t, J = 7.2 
Hz, 3H). 13C NMR (75 MHz, CDCl3): 193.7, 173.8, 163.9, 133.8, 129.3, 128.9, 128.6, 
128.0, 76.9, 62.7, 23.8, 13.9. HRMS Calcd. for C14H16O4 [M]: 248.1049, Found: 
248.1061. FTIR (neat): 3472, 3024, 2975, 2940, 2848, 1732, 1679, 1618, 1443, 1391, 
1374, 1251, 1159, 1122, 1017, 972, 858, 784, 750, 707 cm-1.  
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Determination of Absolute and Relative Stereochemistry 
The exhaustive hydrogenation product 3.49 and epoxidation produet 3.50 were 
converted to amide compound 3.51 and 3.52, respectively. Then the abosoute and relative 
stereochemistry of two compounds 3.51 and 3.52 were determined by X-ray analysis. 
Synthesis of 3.51 
To a solution of 3.49 (121.6 mg, 0.468 mmol) in THF:MeOH:H2O (3:1:1, 0.8 
mL), LiOH·H2O (61.2 mg, 1.485 mmol) was added. The reaction mixture was stirred at 
30 oC for 12 h. After removal of THF and MeOH using N2 gas flow, the residue was 
acidified with 2N HCl (5 mL) and extracted with ethyl acetate (5 x 5 mL). The combined 
extracts were dried over MgSO4. After filteration and evaporation of the solvent in vacuo, 
108.4 mg of the acid compound was obtained. 
 
To the stirred solution of the crude acid compound (108.4 mg, 0.486 mmol) in 
CH2Cl2 (5 mL, 0.1M), 1-ethyl-3-(3-dimethylaminopropyl)-carbondiimide hydrochloride 
(EDCI, 93.2 mg, 0.486 mmol), 1-hydroxybenzotriazole hydrate (65.7 mg, 0.486 mmol), 
and triethylamine (0.23 mL, 0.535 mmol) at 0 oC. The solution was stirred for 10 min. at 
oC. (R)-naphthylethylamine (91.5 mg, 0.535 mmol) was added to the reaction mixture a 0 
oC, and the mixture was stirred for 12 h at room temperature. The solution was washed 
with 10% aqueous solution of citric acid, saturated aqueous NaHCO3 solution, and the 
organic layer was dried over MgSO4. After filteration, the dried solution was 
concentrated under reduced pressure, and the major diastereomer was isolated by flash 
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column chromatography (Rf = 0.3, 20 % EtOAc/hexane) to afford 102.7 mg as a white 








amide (3.51). 1H NMR (400 MHz, CDCl3): 7.82 – 7.75 (m, 4H), 7.48 – 7.41 (m, 3H), 
7.33 – 7.22 (m, 5H), 7.15 (d, J = 8.0 Hz, 1H), 5.31 (qt, J = 7.2 Hz, 1H), 3.08 (dd, J = 
12.0, 3.2 Hz, 1H), 2.04 (s, br, 1H), 1.95 – 1.85 (m, 1H), 1.61 (d, J = 6.8 Hz, 3H), 1.57 – 
1.49 (m, 1H), 1.11 (s, 3H), 1.08 – 1.01 (m, 2H), 0.80 (t, J = 7.4 Hz, 3H). 13C NMR (100 
MHz, CDCl3): 174.4, 140.5, 139.8, 133.3, 132.7, 129.6, 128.4, 128.2, 127.8, 127.6, 
126.8, 126.2, 125.8, 124.6, 124.5, 77.9, 52.6, 48.5, 31.7, 26.4, 21.7, 20.8, 14.0. HRMS 
Calcd. for C15H17O3 [M+1]: 246.1256, Found: 246.1259. FTIR (neat): 3394, 3057, 2969, 
2934, 2870, 1650, 1601, 1511, 1451, 1376, 1273, 1127, 945, 904, 859, 818, 775, 730 cm-
1. MP  158 – 159 oC.  
Synthesis of 3.52 
To a solution of 3.50 (121.6 mg, 0.468 mmol) in THF:MeOH:H2O (3:1:1, 0.8 
mL), LiOH·H2O (61.2 mg, 1.485 mmol) was added. The reaction mixture was stirred at 
30 oC for 12 h. After removal of THF and MeOH using N2 gas flow, the residue was 
acidified with 2 N HCl (5 mL) and extracted with ethyl acetate (5x 5 mL). The combined 
extracts were dried over MgSO4. After filtration and evaporation of the solvent in vacuo,  
108.4 mg of acid compound was obtained. 
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To the stirred solution of the crude acid compound (70.3 mg, 0.30 mmol) in 
CH2Cl2 (3 mL, 0.1M), 1-ethyl-3-(3-dimethylaminopropyl)-carbondiimide hydrochloride 
(EDCI, 59.0 mg, 0.30 mmol), 1-hydroxybenzotriazole hydrate (40.5 mg, 0.30 mmol), and 
triethylamine (0.05 mL, 0.33 mmol) at 0 oC. The solution was stirred for 10 min. at oC. 
(R)-naphthylethylamine (57.0 mg, 0.33 mmol) was added to the reaction mixture a 0 oC, 
and the mixture was stirred for 12 h at room temperature. The solution was washed with 
10% aqueous solution of citric acid, saturated aqueous NaHCO3 solution, and the organic 
layer was dried over MgSO4. After filtration, the dried solution was concentrated under 
reduced pressure, and the major diastereomer was isolated by flash column 










propionamide (3.52). 1H NMR (400 MHz, CDCl3): 7.81 – 7.78 (m, 3H), 7.73 (s, 1H), 
7.48 – 7.42 (m, 2H), 7.40 – 7.37 (m, 3H), 7.32 – 7.29 (m, 3H), 6.84 (d, J = 8.0 Hz, 1H), 
5.23 – 5.19 (m, 2H), 5.10 (dd, J = 10.4, 1.2 Hz, 1H), 4.96 – 4.87 (m, 1H), 3.52 (d, J = 8.0 
Hz, 1H), 3.47 (d, J = 1.6 Hz, 1H), 1.46 (d, J = 6.8 Hz, 3H), 1.39 (s, 3H). 13C NMR (100 
MHz, CDCl3): HRMS Calcd. for C25H25NO3 [M]: 387.1834, Found: 387.1843. FTIR 
(neat): 3379, 3086, 3056, 2976, 2931, 1651, 1601, 1524, 1445, 1365, 1226, 1174, 1113, 
985, 929, 819, 749, 712 cm-1. MP  136.5 – 137.5 oC.  
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X-Ray Cystallographic Data for 3.51 
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Chapter 4 Multicomponent Reductive Coupling of Acetylene with 
Carbonyls and Imines 
4.1 INTRODUCTION 
Multicomponent reactions are generally defined as reactions in which more than 
two starting materials react, and essentially all atoms of the starting materials are 
incorporated into the product.1 The goal of multicomponent processes is to achieve high 
levels of stuructural diversity by combining more than two simple and flexible building 
blocks in efficient one-pot protocols. Due to their inherent simple and concise 
experimental procedures, considerable attention has been devoted to the development of 
mutlicomponent reactions. In addition, hydrogen-mediated C-C bond formations2 have 
attracted increasing attention owing to their atom economical3 and environmentally 
friendly “green” benefits. Thus, multicomponent reductive coupling under hydrogenation 
conditions can be a powerful synthetic technology combining the advantages of 
multicomponent reactions and reductive coupling methods. In this section, we report 
three different types of hydrogen-mediated multicomponet reductive couplings: 1) 
multicomponent reductive coupling of acetylene and carbonyls, 2) multicomponent 
reductive coupling of acetylene and imines, and 3) multicomponent reductive coupling of 
acetylene and chiral aldehydes. 
 
4.2 MULTICOMPONENT REDUCTIVE COUPLING OF ACETYLENE TO CARBONYLS 
4.2.1 Optimization 
To investigate the possibility of the multicomponent reductive coupling under 
hydrogenation conditions, we chose the reductive coupling of acetylene4 and carbonyls as 
our model system. In this reductive coupling, four molecules are combined: two 
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molecules of acetylene, one molecule of a carbonyl compound, and elemental hydrogen 
to produce products of Z-dienylation.5 Initial studies involved exposure of glyoxalate 4.1 
to equal volumes of hydrogen and acetylene gas in the presence of Rh(COD)2OTf(5 
mol%) using triphenylacetic acid (TPAA, 5 mol%) as co-catalyst.2d Remarkably, the 
product of carbonyl Z-butadienylation 4.2 was formed in 32% yield (Table 4.1, entry 1). 
In the absence of the TPAA co-catalyst, compound 4.2 was formed in 17% yield (Table 
4.1, entry 2). Though often overlooked, it is well documented that many catalytic 
processes involving charged organometallic complexes are dependent on the nature of the 
counterion.6 We anticipated that the counterion would influence the Lewis acidity of our 
catalytic system. To test this hypothesis, we prepared rhodium complexes with varying 
couterion (OTf, BF4, SbF6, and “BARF” (BARF = B(3,5-(CF3)2C6H3)4)). Indeed, with all 
other variables held constant, the counterion dramatically affected the reactivity. 
Precatalysts possessing chloride counter-ions provide none of the reductive coupling 
product. However, in the series Rh(COD)2X, where the counter-ion X is OTf, BF4, SbF6 
and BARF, counter-ions that coordinate less strongly than OTf uniformly provide 4.2 in 
higher yield (Table 4.1, entries 1, 4-6). This trend appears to reflect the increasing Lewis 
acidity of the metal center with weaker coordinating anions. Using Rh(COD)2SbF6 as 
precatalyst, some standard phosphine ligands were screened (Table 4.1, entries 5, 7-9). 
Best results were obtained using BIPHEP. Employing Na2SO4 as an additive, the yield of 
coupling product was increased to 59% (Table 4.1, entry 10). Presumably, Na2SO4 
removes water, thus preventing the formation of catalytically inactive hydroxy-bridged 
rhodium dimers.7 Finally, increasing the loading of TPAA (7.5 mol%) increased the yield 
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4.2.2 Importance of Apparatus  
The mode of delivery of the two gases into the reaction mixture is crucial to the 
reaction’s success. Though there is no kinetic data, we observed that stir-rate and reaction 
vessel surface area appear to affect the reaction rate. According to these observations, the 
reactions seem to be mass-transfer-limited with respect to introduction of hydrogen 
and/or acetylene gas.8 Among the methods assayed, using an apparatus in which mixtures 
of hydrogen and acetylene are slowly delivered from a gas bag via cannula gave the best 




      1) Reaction Vessel: 2.0cm (Diameter) * 13.0cm (Length)     
 
      2) Gas bag : Tedlar® gas sampling bag (Aldrich) 
      3) Cannula (Double-tipped needle): 24 in.(Length) – 20 (gauge) 
Figure 4.1 Apparatus for multicomponent coupling of acetylene and carbonyls. 
4.2.3 Substrate Scope 
The optimized reaction conditions were successfully applied to a diverse set of 
carbonyl partners. In addition to glyoxate 4.1, α-ketoesters were examined to expand the 
substrate scope. Phenethyl pyruvate also participated in this transformation to provide the 
desired product 4.3 in 73% yield. Sterically demanding cyclopropyl-oxo-acetic acid 
methyl ester underwent multicomponent reductive coupling to produce the corresponding 
product 4.4 in 55% yield. However, isopropyl-oxo-acetic acid ethyl ester did not afford 
the desired product. Additionally, a protected isatin underwent reductive coupling to 
furnish the desired product 4.5 in 81% yield. Finally, aryl-oxo-acetic acid ethyl esters 
were also exposed to the standard conditions to produce the corresponding products 4.6-
4.8 in good yields (Table 4.2).  
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Notably, this multicomponent reductive coupling is applicable to simple 
(unactivated) aldehydes which have not yet been utilized in other hydrogenative 
reductive coupling methods reported by our group.2 Gratifyingly, a variety of aldehydes 
participated in this reaction to afford the corresponding products 4.9-4.13a in good yields 
(Table 4.3).  
 































However, this reductive coupling is still restricted to electron deficient aldehydes. 
Based on isolated yields and relative reaction rates, the reactivity of this reaction appears 
to be very sensitive to the electrophilicity of carbonyl coupling partners. Indeed, electron 
deficient carbonyls consistently gave better chemical yields than electron rich carbonyls. 
We speculate that the competitive reaction pathway, β-hydride elimination of a rhodium 
alkoxide intermediate, is favorable with electron rich carbonyl partners.7,10 Interestingly, 
when the reaction was performed without Brønsted acid cocatalyst, this side reaction 
became a major pathway to produce the conjugated ketone 4.13b along with terminally 



























4.13b 4.13c  
Scheme 4.1 Critical role of acid cocatalyst. 
 
To further demonstrate the reaction scope, enantioselective Z-butadienylation was 
attempted on aldehydes. Gratifyingly, using a rhodium catalyst ligated by (R)-MeO-
BIPHEP, the corresponding dienes 4.12b and 4.13a were produced in 88% and 89% ee, 
respectively (Scheme 4.2). Given the preliminary results of enantioselective reductive 
coupling of acetylene with aldehydes, the enantioselective reductive coupling of 
acetylene with α-ketoesters was tested. However, only moderate levels of enantio-




























Scheme 4.2 Enantioselective multicomponent coupling of acetylene and aldehydes. 
 
4.2.4 Mechanistic Studies 
To gain insight into the catalytic mechanism, the reductive coupling of acetylene 
gas and phenethyl pyruvate was conducted under a deuterium atmosphere. The product 
deuterio-4.3 incorporated a single deuterium atom at the diene terminus as the Z-
stereoisomer. We initially proposed two possible catalytic mechanisms (Scheme 4.3). In 
Cycle A, acetylene dimerization to form a rhodacyclopentadiene 4.1411,12 is followed by 
carbonyl insertion to furnish an oxarhodacycloheptadiene intermediate 4.15. In Cycle B, 
the same oxarhodacycloheptadiene intermediate 4.15 is generated by acetylene-carbonyl 
oxidative coupling through intermediate 4.18 followed by insertion of a second acetylene 
molecule. Protonolytic cleavage of the rhodium-oxygen bond in the oxarhodacyclo-
heptadiene 4.15, followed by σ-bond metathesis13 of intermediate 4.16 with elemental 
deuterium provides (alkenyldeuterido)-rhodium intermediate 4.17, which upon C-D 
































































Scheme 4.3 Plausible catalytic mechanisms. 
 
However, the deuterium labeling studies could not discriminate between Cycle A 
and Cycle B. In order to further probe the mechanisms, ESI studies were conducted. An 
aliquot of the crude reaction mixture from the hydrogen-mediated reductive coupling of 
gaseous acetylene to α-ketoester 4.19 was diluted 5000-fold in methanol, and directly 
subjected to ESI-mass spectroscopic analysis in the positive ionization mode. A 
representative ESI-mass spectrum of the reaction mixture sampled at one hour is shown 
in Figure 4.2. The most abundant ions, as assigned on the basis of their m/z values, 
correspond to species postulated to arise in Cycle A, as illustrated in Scheme 1. Of 
particular interest is the ion of m/z 677 which matches the molecular weight expected for 
the rhodacyclopentadiene 4.14 shown in Cycle A of Scheme 4.3. In addition, two other 
ions match the calculated molecular weights of the oxarhodacycloheptadiene (m/z 900) 
and the following product of protonolytic cleavage by triphenylacetic acid (m/z 1188). In 
contrast, ions corresponding to the oxarhodacyclopentadiene species 4.18 (calculated 
molecular weight 874 Da) of Cycle B are not observed. 
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Figure 4.2 ESI Mass full scan spectrum for the reductive coupling of acetylene to α-
ketoester. 
 
The structural assignment of the ion of m/z 1188 is corroborated by multi-stage 
collisional activated dissociation (CAD) (Figure 4.3). This ion dissociates by loss of 288 
Da, consistent with the elimination of triphenylacetic acid to regenerate the 
oxarhodacycloheptadiene intermediate 4.15 (m/z 900). When the latter intermediate is 
subjected to a second stage of CAD, it dissociates to an ion of m/z 677 which again 
matches the molecular weight of the rhodacyclopentadiene species shown in Cycle A, 
suggestive of a retro carbonyl insertion process. This ESI-MS data offers support for 
catalytic Cycle A, as shown in Scheme 4.3, but does not offer any evidence in support of 
catalytic Cycle B.  
 





































Figure 4.4 MS/MS/MS Spectrum of m/z 900.  













































4.2.5 Extension to Intramolecular Multicomponent Reductive Coupling 
If catalytic cycle A is operative, one would expect related rhodacyclopentadiene 
species to exhibit similar reactivity and engage in carbonyl insertion processes. 1,6-
Diynes are known to react with rhodium(I) salts to afford crystalline rhodacyclo-
pentadienes,10 which have been fully characterized. Accordingly, 1,6-diyne 4.20 (100 
mol%) was hydrogenated in the presence of α-ketoester 4.19 (100 mol%). The product of 
tandem reductive cyclization14 carbonyl coupling 4.22 was obtained in 58% yield as a 
single alkene geometrical isomer. Thus, as anticipated, the rhodacyclopentadiene 
intermediate 4.24 presumed to arise through oxidative coupling of the 1,6-diyne exhibits 
reactivity akin to that observed for the parent rhodacyclopentadiene obtained in couplings 
of gaseous acetylene. For nonsymmetric 1,6-diyne 4.21, tandem reductive cyclization-
carbonyl insertion occurred such that α-ketoester 4.19 coupled at the substituted terminus 
of the rhodacyclopentadiene intermediate 4.24 to furnish 4.23 through intermediates 
4.45-4.27 as a single geometrical and constitutional isomer. The relatively modest yields 
of tandem reductive cyclization-carbonyl insertion products 4.22 and 4.23 are due to 

















4.19, (Ar = p-NO2Ph)
4.20, R = H





































Scheme 4.4 Reductive coupling of 1,6-diynes with α-ketoester 4.19. 
 
In order to further support the proposed catalytic mechanism, ESI studies were 
conducted for this reaction. As expected, the ion of m/z 909 matches the molecular 
weight expected for the rhodacyclopentadiene 4.24 shown in Scheme 4.3. In addition, the 
other ion matches the calculated molecular weights of the oxarhodacycloheptadiene 4.25 
(m/z 1132). However, in this ESI study, the ion corresponding molecular weight expected 
for the intermediate 4.26 was not detected (Figure 4.4).  
The structural assignment of the ion of m/z 1132 is corroborated by multi-stage 
collisional activated dissociation (CAD) (Figure 4.5). This ion dissociates by loss of 223 
Da, consistent with the elimination of α-ketoester 4.19 to regenerate the 
oxarhodacycloheptadiene intermediate 4.24 (m/z 909) and rhodium BIPHEP complex 
(m/z 625). The results of these ESI studies are consistent with our proposed catalytic 








Figure 4.6 MS/MS spectrum of m/z 1132.  











































4.3 MULTICOMPONENT REDUCTIVE COUPLING OF ACETYLENE TO IMINES 
4.3.1 Introduction 
Enantiomerically enriched allylic amines are frequently used as synthetic 
intermediates, auxiliaries, and resolving agents in the synthesis of both natural and 
unnatural products.16 Accordingly, there are many effective methods to access allylic 
amines.17,18 However, most methods for catalytic enantioselective coupling of 
nonstabilized carbanion equivalents to imines rely upon preformed organometallics. 
Further, many organometallics used in such transformations are prepared via 
transmetallation. Here, preparation of the “primary organometallic” may itself require 
preexisting functionality to direct regiocontrolled metallation. For example, in metal-
catalyzed imine arylations employing organoboron reagents,19 aryllithiums that are 
prepared via metal-halogen exchange using n-BuLi are then transmetallated to boron. 
Here, three metallic reagents are used stoichiometrically prior to C-C coupling! Direct 
methods for the catalytic asymmetric coupling of nonstabilized organic fragments to 
imines circumvent use of preformed organometallics. Given the success in the 
multicomponent reductive coupling of acetylene with carbonyls,9 the asymmetric 
muticomponent reductive coupling of acetylene with imines was explored as a means of 
accessing enantiomerically enriched allylic amines. 
 
4.3.2 Optimization 
Initial studies involved exposure of N-(p-toluenesulfonyl) aldimine 4.28 to 
ambient pressure of acetylene and hydrogen gas at ambient temperature using conditions 
developed for the related aldehyde couplings as the starting point for optimization. Under 
aforementioned conditions, the desired product 4.30 was obtained in 8% yield. Then the 
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use of [Rh(COD)2]BARF as precatalyst provided 4.30 in higher yield. By increasing 
reaction temperature to 40 oC, the yield of coupling product 4.30 was increased to 21% 
yield. At this point, we decided to screen reaction media. Among solvents assayed, 
toluene gave a higher yield at an elevated temperature. To further optimize the chemical 
yield, a systematic assay of Brønsted acids was performed. Among acids assayed, m-
nitrobenzoic acid was identified as the optimal cocatalytst to provide the desired product 
in 68% yield. During the process of optimization, we observed that the color of the 
reaction media turned to the black at 80 oC. This observation indicated that the catalyst 
might decompose at high temperature. To avoid catalyst decomposition, we conducted 
the reaction at a lower temperature. However, at lower temperatures, the substrate 
solubility in toluene became a serious problem. Gratifyingly, changing the imine 
protecting group to benzenesulfonyl from p-toluenesulfonyl successfully resolved the 
solubility issues, and catalyst decomposition. Indeed, the use of benzenesulfonyl imine 
4.29 as a coupling partner provided the desired product 4.31 in 94% yield (Table 4.4).  
 


















































































The optimized conditions were applied to asymmetric reductive coupling of 
acetylene and imines. Gratifyingly, the first chiral ligand screened, (S)-Cl,MeO-BIPHEP, 
was found to promote excellent levels of asymmetric induction to produce the desired 




m-Nitrobenzoic acid,  Na2SO4
+ H2
(1 atm)









Scheme 4.5 Asymmetric reductive coupling of acetylene with compound 4.29. 
 
4.3.3 Substrate Scope 
Under the optimized conditions, aromatic N-arylsulfonyl aldimines were found to 
engage in highly enantioselective couplings with gaseous acetylene to furnish (Z)-
dienylallylic amines 4.32-4.43 in good yields as single geometrical isomers. However, 
benzaldimines possessing ortho substitution do not react efficiently. Heteroaryl N-
arylsulfonyl aldimine also underwent the reductive coupling to produce the 
corresponding product 4.40 in 73% yield with excellent enantioselectivity. In this class of 
reductive coupling, the arylsulfonyl protecting group was chosen in response to issues of 
solubility and reactivity. Generally, increased yields were observed upon introduction of 
Na2SO4, which presumably prevents imine hydrolysis and the production of catalytically 
inactive hydroxyl-bridged dimmers of rhodium.7 Indeed, in case of alkyl aldimines, the 
use of excess Na2SO4 (600 mol%) reproducibly provided the corresponding products 
4.41-4.43 in good yields (Table 4.5). 
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Table 4.5 Enantioselective reductive coupling of acetylene with imines.20  
Rh(COD)2X (5 mol%)
(S)-Cl, OMe-BIPHEP (5 mol%)













































































4.3.4 Elaboration of Reductive Coupling Products 
To illustrate the unique features of the (Z)-dienyl side chain, a variety of selective 
transformations were conducted. First of all, exhaustive hydrogenation of compound 4.32 
using Crabtree’s catalyst followed by deprotection of 4.44 provided saturated compound 
4.45 in 65% overall yield (Scheme 4.6). The reduced amine 4.45 was used for 
determining absolute stereochemical assignment by comparing to optical rotation value 
of an authentic sample ([α]D of compound 4.45 = -17.2 (c = 0.67, DCM, 94% ee and [α]D 
of an authentic sample of optically enriched material in literature = -17.4 (c = 1.19, DCM, 











4.45, 66% yield  
Scheme 4.6 Determination of absolute configuration. 
 
N-allylation of the diene product 4.41 followed by ring-closing metathesis of 4.46 
using the second generation Grubbs’ catalyst provided compound 4.47 in 94% yield.22 
Furthermore, functionalization of the diene terminus via cross-metathesis was explored. 
Exposure of the reductive coupling product 4.41 to cis-1,4-diacetoxy-2-butene in the 
presence of 5 mol% of the second generation Grubbs’ catalyst provided the allylic acetate 






























Scheme 4.7 Elaboration of coupling product via metathesis. 
 
In order to utilize the diene functionality of the coupling products, rhodium-
catalyzed intramolecular [4+2] cycloaddition was explored. N-homoallylation of the 
compound 4.41 provided compound 4.49 in 84% yield. Exposure of compound 4.49 to 
Rh(COD)2SbF6 in the presence of PPh3 produced cycloaddition product 4.50 in 87% 
yield as a 9:1 mixture of diastereomers. The relative stereochemistry is assigned based on 
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Livinghouse’s studies.23 Finally, site selective oxidative cleavage of compound 4.51 
under Johnson-Lemieux conditions provided aldehyde 4.52 in 83% yield. Further 
oxidation of aldehyde 4.52 in the presence of MnO2, NaCN, CH3COOH, and MeOH 
































Scheme 4.8 Elaboration of coupling product 4.51. 
 
4.3.5 Mechanistic Studies 
Based on mechanistic studies of the multicomponent reductive coupling of 
acetylene and carbonyls,9 a plausible catalytic mechanism is proposed. In the catalytic 
cycle, acetylene dimerization to form rhodacyclopentadiene 4.14 is followed by imine 
insertion25 to furnish an intermediate 4.54. Protonolytic cleavage of the rhodium-nitrogen 
bond in the intermediate 4.54 followed by σ-bond metathesis of the intermediate 4.55 
with elemental hydrogen provides (alkenylhydrido)rhodium intermediate 4.56, which 
upon C-H reductive elimination delivers the coupling product and the starting rhodium(I) 




































Scheme 4.9 Plausible catalytic cycle. 
 
To further confirm our proposed catalytic mechanism, we performed ESI-MS 
studies. Initially, we prepared a sample for ESI-MS studies from the reductive coupling 
reaction of gaseous acetylene to imine 4.29 in the presence of m-nitrobenzoic acid and 
BIPHEP. Of particular interest is the ion of m/z 677 which matches the molecular weight 
expected for the rhodacyclopentadiene shown in the catalytic cycle. In addition, the other 
ion matches the calculated molecular weight of the rhodacycloheptadiene (m/z 967). 
However, the ion of m/z 1134 which matches the molecular weight expected for the 
intermediate 4.55 shown in the catalytic cycle was not observed. This result indicates that 
the life time of intermediate 4.55 in the catalytic cycle is not long enough to be detected 
by ESI-MS methods. These results are consistent with a highly increased reaction rate 






Figure 4.7 ESI Mass full scan spectrum for reductive coupling of acetylene to imine 
using m-nitrobenzoic acid cocatalyst. 
 
Then we prepared a sample for ESI-MS studies from the reductive coupling 
reaction of gaseous acetylene to imine 4.29 in the presence of triphenylacetic acid and 
BIPHEP. Of particular interest is the ion of m/z 677 which matches the molecular weight 
expected for the rhodacyclopentadiene 4.53 shown in the catalytic cycle. In addition, two 
other ions match the calculated molecular weights of the rhodacycloheptadiene 4.54 (m/z 
967) and the intermediate 4.55 (m/z 1255) obtained via protonolytic cleavage by 
triphenylacetic acid (Figure 4.7). In both cases, the ion corresponding to the coupling 
product of mono acetylene and mono imine (calculated molecular weight 941 Da) was 
not observed.  
























Figure 4.8 ESI Mass full scan spectrum for reductive coupling of acetylene to imine 
using triphenylacetic acid cocatalyst.  
 
 
The structural assignment of the ion of m/z 1255 is corroborated by multi-stage 
collisional activated dissociation (CAD) (Figure 4.9). This ion dissociates by loss of 288 
Da, consistent with the elimination of triphenylacetic acid to regenerate the 
oxarhodacycloheptadiene intermediate 4.54 (m/z 967). The structural assignment of the 
ion of m/z 967 is corroborated by multi-stage collisional activated dissociation (CAD) 
(Figure 4.10). This ion dissociates by loss of 260 Da, consistent with the elimination of 
one phenyl and diphenylphosphine to produce a decomposed rhodium complex (m/z 
707).  



































Figure 4.9 MS/MS spectrum of m/z 1255. 
 
 
Figure 4.10 MS/MS spectrum m/z 967. 


























































4.4 REDUCTIVE COUPLING OF ACETYLENE WITH CHIRAL ALDEHYDES:            
THE FORMAL SYNTHESIS OF D-HEXOSES 
4.4.1 Introduction 
Enantiomerically pure 1,2-diols are important and commonly occurring functional 
group moeties in natural products26 including carbohydrates, polyketides, and chiral 
ligands used in asymmetric catalysis.27 Diastereoselective addition of alkenyl groups to 
chiral aldehydes is one of most powerful methods towards generating chiral allylic 
alcohols. The goal of the present study is to establish the viability of chiral catalyst-
controlled doubly diastereoselective reductive coupling between acetylene and optically 
active chiral aldehydes.28 If successful, such a strategy would provide selective access to 
1,2-syn-products and 1,2-anti-products which are not readily obtainable using substrate-
controlled diastereoselective reactions. Here, we report diastereoselective coupling of 
acetylene with chiral aldehydes, and application in the formal synthesis of natural D-
hexoses. 
4.4.2 Optimization 
The reductive coupling between acetylene and (R)-glyceraldehyde 4.57 was 
investigated as a model reaction. The reductive coupling between acetylene and (R)-
glyceraldehyde using achiral ligand BIPHEP provided the coupling products syn-4.58 
and anti-4.58 in a 1:1 diasteromeric ratio. Next, a chiral catalyst system was employed in 
the reaction. Chiral ligand (S)-MeO-BIPHEP provided the desired product in 46% yield 
and a 1:4 diasteromeric ratio. To increase chemical yields, we applied the optimized 
conditions for the reductive coupling of acetylene and imines to this catalytic system. The 
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coupling product was obtained in 57% yield with a 1:5.7 diasteromeric ratio. By 
employing pentafluorobenzoic acid as cocatalyst, the yield of coupling product was 
increased to 79%. The diastereoselectivity and chemical yield were further improved by 
careful examination of reaction temperature. At 4 oC, the yield of 4.58 was increased to 
83% with good anti-selectivity. We tested the reductive coupling using (R)-MeO-
BIPHEP to obtain syn-selectivity. Gratifyingly, the use of (R)-MeO-BIPHEP provided 
the coupling product as predominantly the syn diastereomer (Table 4.6). 
 










acid additive yield (%) dr (syn:anti)
(1 atm)
entry ligand X solvent
Triphenylacetic acid 70 1:11 BIPHEP SbF6 DCE
Triphenylacetic acid 46 1:42 (S)-MeO-BIPHEP SbF6 DCE
m-Nitrobenzoic acid 57 1:5.73 BARF Toluene
pentafluorobenzoic acid 79 1:5.44 (S)-MeO-BIPHEP BARF Toluene
(S)-MeO-BIPHEP
pentafluorobenzoic acid 83 1:6.75a (S)-MeO-BIPHEP BARF Toluene
a: the reaction was performed at 4 oC.






To determine the relative stereochemistry, compound syn-4.58 was further 
transformed. Benzylation of syn-4.58 followed by exhaustive hydrogenation of 4.59 
using Crabtree’s catalyst provided compound 4.60 in 98% and 99% yield, respectively. 
By 1H-NMR comparison with an authentic sample in the literature,29 we confirmed the 
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98% yield >99% yield
syn-4.58 4.59 4.60
 
Scheme 4.10 Determination of relative stereochemistry of syn-4.58. 
 
Under the optimized conditions, another chiral aldehyde was tested. Exposure of 
aldehyde (S)-4.61 to reaction with acetylene in the presence of (R)-MeO-BIPHEP led to 
formation of the corresponding diastereomerically enriched diol 4.62 in 95% yield with 
good syn-diastereoselectivity. The reductive coupling of aldehyde (S)-4.61 with acetylene 
in the presence of (S)-MeO-BIPHEP provided diol 4.62 in 92% yield and a moderate 












































4.4.3 A Versatile Route to Hexoses: Synthesis of the Key Intermediates 
Hexose carbohydrates play vital roles in a diverse set of biological processes such 
as signal transduction, cognition, and immunal response. Given the importance of 
hexoses, the development of efficient methods for their synthesis has continuously 
received significant attention.30 In this regard, we decided to explore the development of 
a practical method to access all eight L-hexoses as well as D-hexoses. We envisioned that 
the reductive coupling product 4.58 could be applied to the synthesis of D-hexoses. A 
versatile route for the synthesis of D-hexoses is presented in Scheme 4.12. Essential to 
this strategy is the rapid access of chiral key intermediates 4.63 and the utilization of 




















4.63 4.58 (R)-4.57D-Hexoses  
Scheme 4.12 General strategy for the synthesis of D-hexoses. 
 
In 2006, the Sasaki group reported diastereoselective synthesis of all eight L-
hexoses from L-Ascorbic acid.31 The strategy to synthesize all eight diastereopure L-
hexoses comprises the following major steps: (1) preparation of chiral aldehydes 4.65, 
one of which involving Mitsunobu inversion, from α-hydroxy ester 4.64 that is in turn 
readily available from L-ascorbic acid; (2) transformation of aldehyde 4.65 into four α,β-
unsaturated esters 4.63 with the specified (E) or (Z) configuration via Wittig olefination 
reactions; (3) stereoselective dihydroxylation of each of the α,β-unsaturated esters 4.63, 
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followed by partial reduction of resulting eight polyol esters 4.67, and (4) cyclization of 








































4.63, Key IntermediatesL-Ascorbic acid 4.64 4.65
4.66 4.67 4.68, L-Hexopyranoses  
Scheme 4.13 Sasaki’s strategy for the synthesis of L-hexoses. 
Our formal synthesis of D-hexoses started with benzylation of newly generated 
secondary alcohols. Exposure of syn-4.48 to benzylation conditions provided the 
compound 4.69 in 89% yield. The site selective oxidative cleavage of compound 4.69 
under Johnson-Lemieux conditions provided aldehyde 4.70 in 85% yield without cis-
trans isomerization. Further oxidation of aldehyde in presence of MnO2, NaCN, 
CH3COOH, and MeOH provided methyl ester 4.71 in 93% yield without alkene 
isomerization. Additionally, oxidation of aldehyde in presence of MnO2, NaCN, 
CH3COOH, and EtOH provided ethyl ester 4.72 in 86% yield. To obtain (E)-isomer 4.73, 
we tried isomerization of (Z)-α,β-unsaturated ester 4.72 with LiI in ether.32 Unfortunately, 
only starting material was recovered. The trimethylphosphine catalyzed isomerization 
was explored. Upon exposure of (Z)-α,β-unsaturated ester 4.72 to trimethylphosphine 
catalyst, the (E)-ester 4.73 was obtained in 50% yield along with almost 50% of starting 
material. Finally, we successfully optimized the isomerization reaction using 
trimethylphosphine as a catalyst and tert-butanol as solvent at 35 oC. The cis-trans 
isomerization of α,β-unsaturated thioester has been well documented in the literature.33 
However, cis-trans isomerization of α,β-unsaturated esters is relatively rare.34 This result 
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displays the feasibility of phosphine-catalyzed cis-trans isomerization of α,β-unsaturated 
esters. Using optimized conditions for syn-4.48, the anti-4.48 was also successfully 
transformed to the corresponding α,β-unsaturated esters 4.76 and 4.78 with good to 
























(a) NaH, BnBr, 0 oC (b) OsO4 (cat.), NaIO4, THF/H2O, rt (c) MnO2, NaCN, CH3CO2H (cat.), MeOH, rt












































Scheme 4.14 Synthesis of key intermediates for D-hexoses. 
 
Four esters 4.71, 4.73, 4.76, and 4.78 are enantiomers of four key intermediates 
used in Sasaki’s synthesis of L-hexoses. As such, the syntheses of esters 4.71, 4.73, 4.76, 
















































































4.5 SUMMARY AND CONCLUDING REMARKS 
It was found that gaseous acetylene couples to conventional aldehydes under 
hydrogenation conditions to furnish products of Z-butadienylation. Moreover, this 
methodology is successfully extended to asymmetric reactions. ESI-MS studies strongly 
support our proposed catalytic mechanism; inferring an oxidative-coupling followed by 
hydrogenative termination pathway. Likewise, the highly enantioselective catalytic 
vinylation of aldimines is achieved. This protocol does not employ preformed 
organometallic reagents, nor does it generate stoichiometric byproducts. 
The multicomponent coupling of acetylene and chiral aldehydes affords 1,2-diols 
in good yields with good to excellent diastereoselecitivity. In particular, catalyst-
controlled diastereoselective coupling allows the selective preparation of both the syn-
adduct and anti-adduct. This methodology has been successfully applied to the formal 
synthesis of all eight D-hexoses. Finally, one can also gain access to all eight L-hexose 













4.6 EXPERIMENTAL SECTION 
4.6.1 GENERAL  
All reactions were run under an atmosphere of argon, unless otherwise indicated. 
Anhydrous solvents were transferred by an oven-dried syringe. Flasks were flame-dried 
and cooled under a stream of nitrogen. Dichloroethane (DCE) was distilled from calcium 
hydride. Toluene was distilled from sodium and benzophenone. Triphenylacetic acid, m-
nitro-benzoic acid, and pentafluorobenzoic acid were used as received from Aldrich. 
BIPHEP and (S)-Cl,MeO-BIPHEP were used as received from Strem Chemicals. (R)-
MeO-BIPHEP and (S)-MeO-BIPHEP were used as received from Aldrich. Acetylene 
Gas was used as received from PRAXAIR (Atomic Absorption Grade). [Rh(COD)2]BF4, 
[Rh(COD)2]SbF6, and [Rh(COD)2]BARF were prepared in analogy with the previously 
reported procedures. 2,3-O-isopropylidene-D-glyceraldehyde and (R)-O-benzyllacta- 
aldehyde were prepared in analogy with the previously reported procedures. Analytical 
thin-layer chromatography (TLC) was carried out using 0.2-mm commercial silica gel 
plates (DC-Fertigplatten Kieselgel 60 F254). Preparative column chromatography 
employing silica gel was performed according to the method of Still. Solvents for 
chromatography are listed as volume/volume ratios. Infrared spectra were recorded on a 
Perkin-Elmer 1600 spectrometer. High-resolution mass spectra (HRMS) were obtained 
on a Karatos MS9 and are reported as m/z (relative intensity). Accurate masses are 
reported for the molecular ion (M + 1) or a suitable fragment ion. Proton nuclear 
magnetic resonance (1H-NMR) spectra were recorded with a Varian Gemini (400 MHz or 
300MHz) spectrometer. Chemical shifts are reported in delta (δ) units, parts per million 
(pip) downfield from trimethylsilane. Coupling constants are reported in Hertz (Hz). 
Carbon-13 nuclear magnetic resonance (13C-NMR) spectra were recorded with a Varian 
Gemini 300 (75 MHz) or 400 (100 MHz) spectrometer. Chemical shifts are reported in 
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delta (δ) units, ppm relative to the center of the triplet at 77.0 ppm for 
deuteriochloroform. 13C NMR spectra were routinely run with broadband decoupling. 
All the ESI-MS/MS work was conducted with a Thermo LCQ Duo quadrupole 
ion trap mass spectrometer equipped with an electrospray ionization source (San Jose, 
CA). The flow rate of the reaction mixtures (estimated ~2 μM) was 5 μL/min. The ESI 
spray voltage was +4.5 kV. The heated capillary temperature was set at 80 oC to 
minimize polymerization. One microliter of the reaction mixture was removed from the 
reaction vessel at specific intervals, diluted 5,000 times with methanol, and immediately 
infused into the LCQ instrument. 
 
4.6.2 Experimental Apparatus 
For reactions at room temperature  
 




1) Reaction Vessel: 2.0cm (Diameter) * 13.0cm (Length)  
2) Gas bag : Tedlar® gas sampling bag (Aldrich) 
3) Cannula (Double-tipped needle): 24 in.(Length) – 20 (gauge) 
 
4.6.3 Multicomponent Reductive Coupling of Acetylene and Carbonyls 
Representative Procedure 1 for the Coupling Products 4.2, 4.3, 4.4, 4.5, 4.9, 4.10, 
4.11, 4.12a, and 4.13 ([Rh(COD)2]SbF6 as catalyst; with Na2SO4 )  
[Rh(COD)2]SbF6 (5.5 mg, 0.01 mmol, 5 mol%), BIPHEP (5.3 mg, 0.01 mmol, 5 
mol%), triphenylacetic acid (4.4 mg, 0.015 mmol, 7.5 mol%), and Na2SO4 (58 mg, 0.4 
mmol, 200 mol%) and DCE (1.2 mL) were added to a reaction vessel and then stirred for 
30 minutes at room temperature. The mixture of hydrogen and acetylene gas 
(approximately 1:1 mixture) was introduced into the solution via cannula and then a 
solution of carbonyl substrate 4.1 (36mg, 0.2 mmol, 100 mol%) in DCE (0.8 mL) was 
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added to a reaction vessel. The mixture was stirred at room temperature under the 1 atm 
of hydrogen and acetylene gas mixture for 72 hours. The title compound was purified by 
flash column chromatography (Rf = 0.3, Pentane/Ether = 4/1) to afford 31.4 mg of 
compound 4.2 as a colorless oil (68 % yield). 
 
Representative Procedure 2 for the Coupling Products 4.6, 4.7, and 4.8 
([Rh(BIPHEP) (NBD)]SbF6 as catalyst; without Na2SO4 )  
[Rh(BIPHEP)(NBD)]SbF6 (9.6mg, 0.01 mmol, 5 mol%), triphenylacetic acid (2.9 
mg, 0.01 mmol, 5 mol%), and DCE (1.2 mL) were added to a reaction vessel and then 
stirred for 30 minutes at room temperature. The mixture of hydrogen and acetylene gas 
(approximately 1:1 mixture) was introduced into the solution via cannula and then a 
solution of carbonyl substrate (41.6mg, 0.2 mmol, 100 mol%) in DCE (0.8 mL) was 
added to a reaction vessel. The mixture was stirred at 45 oC under the 1 atm of hydrogen 
and acetylene gas mixture for 42 hours. The title compound was purified by flash column 
chromatography (Rf = 0.15, Hexane/DCM = 1/1.5 and then DCM only) to afford 29.9 mg 







(Z)-2-Hydroxy-hexa-3,5-dienoic acid phenethyl ester (4.2). Representative procedure 
1; Rf = 0.3, Pentane/Ether = 4/1; colorless oil. 1H NMR (400 MHz, CDCl3): 7.32 – 7.18 
(m, 5H), 6.72 (dt, J = 16.4, 10.5 Hz, 1H), 6.21 (t, J = 10.9 Hz, 1H), 5.38 – 5.27 (m, 2H), 
5.04 (dd, J = 3.2, 1.0 Hz, 1H), 4.45 – 4.34 (m, 2H), 2.95 (t, J = 7.0 Hz, 2H). 13C NMR 
(100 MHz, CDCl3): 176.5, 155.9, 138.6, 132.1, 130.7, 121.4, 79.7, 76.7, 53.5, 37.4, 28.6, 
 223
25.1. HRMS Calcd. for C14H17O3 (M+1): 233.1178, Found: 233.1171. FTIR(neat): 3465, 







(Z)-2-Hydroxy-2-methyl-hexa-3,5-dienoic acid phenethyl ester (4.2). Representative 
procedure 1; Rf = 0.2, Hexane/DCM = 1/1; colorless oil. 1H NMR (400 MHz, CDCl3): 
7.33 – 7.20 (m, 5H), 7.06 (dtd, J = 15.6, 10.7, 1.1 Hz, 1H), 6.03 (t, J = 11.6 Hz, 1H), 5.48 
(dd, 11.6, 0.8 Hz, 1H), 5.21 (dd, J = 12.4, 2.0 Hz, 1H), 5.19 – 5.17 (m, 1H), 4.45 – 4.36 
(m, 2H), 3.29 (s, br, 1H), 2.97 (t, J = 7.0 Hz, 2H). 13C NMR (100 MHz, CDCl3): 175.9, 
137.2, 132.6, 132.1, 130.9, 128.9, 128.5, 126.7, 120.4, 74.9, 66.6, 34.9, 27.8. HRMS 
Calcd. for C15H18O3 (M): 246.1256, Found: 246.1257. FTIR(neat): 3497, 3026, 2983, 








 (Z)-2-Hydroxy-2-methyl-hexa-3,5-dienoic acid phenethyl ester (deuterio-4.3). 
Represenatative procedure 1; Rf = 0.2, Hexane/DCM = 1/1; colorless oil. 1H NMR (400 
MHz, CDCl3): 7.32 – 7.20 (m, 5H), 7.06 (t, J = 10.8, 1H), 6.03 (t, J = 11.4 Hz, 1H), 5.48 
(d, 11.6, 1H), 5.17 (d, J = 10.0 Hz, 1H), 4.45 – 4.36 (m, 2H), 3.36 (s, br, 1H), 2.97 (t, J = 
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7.2 Hz, 2H). 13C NMR (100 MHz, CDCl3): 175.9, 137.2, 132.5, 132.1, 130.9, 128.9, 
128.5, 126.7, 120.4, 1201.1, 120.0, 74.9, 66.6, 34.9, 27.8. HRMS Calcd. for C15H18DO3 
(M+1): 248.1397, Found: 248.1403. FTIR(neat): 3497, 3026, 2983, 2931, 1730, 1692, 







(Z)-2-Cyclopropyl-2-hydroxy-hexa-3,5-dienoic acid methyl ester (4.4). Representative 
procedure 1; . Rf = 0.3, Pentane/Ether = 8/1; colorless oil; 1H NMR (400 MHz, CDCl3): 
7.02 (dtd, J = 16.8, 10.7, 1.2 Hz, 1H), 6.10 (t, J = 11.4 Hz, 1H), 5.61 (dd, 11.6, 0.8 Hz, 
1H), 5.23 – 5.16 (m, 2H), 3.83 (s, 3H), 3.18 (s, br, 1H), 1.33 – 1.27 (m, 1H), 0.61 -0.54 
(m, 1H), 0.48 – 0.39 (m, 2H), 0.37 – 0.32 (m, 1H). 13C NMR (100 MHz, CDCl3): 176.5, 
132.9, 132.7, 129.8, 120.3, 75.4, 75.1, 53.3, 53.3, 19.7, 0.65, 0.15. HRMS Calcd. for 
C10H15O3 (M+1): 183.1021, Found: 184.1024. FTIR(neat): 3505, 3086, 3011, 2953, 








ative procedure 1; Rf = 0.2, Hexane/EA = 5/1; yellowish brown solid; 1H NMR (400 
MHz, CDCl3): 8.23 (d, J = 8.4 Hz, 2H), 7.41 (ddd, J = 7.5, 1.3, 0.7 Hz, 1H), 7.24 (td, J = 
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7.5, 1.1 Hz, 1H), 6.65 (dtd, J = 16.8, 11.4, 1.2 Hz, 1H), 6.21 (t, J = 11.6 Hz, 1H), 5.53 (s, 
1H), 5.50 (d, J = 0.8, 1H), 5.28 (dt, J = 16.4, 0.8 Hz, 1H), 5.22 (d, J = 9.6 Hz), 3.14 (s, br, 
1H), 2.64 (s, 3H). 13C NMR (100 MHz, CDCl3): 177.3, 170.7, 139.5, 134.3, 131.8, 130.5, 
130.1, 127.8, 126.1, 124.5, 122.4, 117.0, 76.9, 26.5. HRMS Calcd. for C14H14NO3 (M+1): 
244.0974, Found: 244.0975. FTIR(neat): 3421, 2997, 2945, 1771, 1713, 1605, 1464, 








(Z)-2-Hydroxy-2-(4-methoxy-phenyl)-hexa-3,5-dienoic acid ethyl ester (4.6). Repre-
sentative procedure 2; Rf = 0.15, Hexane/DCM = 1/1.5 and then DCM only; colorless oil; 
1H NMR (400 MHz, CDCl3): 7.44 (d, J = 8.8 Hz, 2H), 7.44 (d, J = 8.8 Hz, 2H), 6.89 (dtd, 
J = 16.8, 10.6, 1.2 Hz, 1H), 6.85 (d, J = 8.8 Hz, 2H), 6.21 (t, J = 11.4 Hz, 1H), 5.97 (dd, 
11.6, 0.8 Hz, 1H), 5.20 (dt, J = 16.8, 1.1 Hz, 1H), 5.13 (d, J = 10.0 Hz, 1H), 4.29 – 4.15 
(m, 2H), 4.03 (s, br, 1H), 3.78 (s, 3H), 1.23 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, 
CDCl3): 174.9, 159.2, 134.5, 133.4, 133.2, 130.4, 127.3, 120.5, 113.6, 78.1, 62.8, 55.2, 
13.9. HRMS Calcd. for C15H19O4 (M+1): 263.1283, Found: 263.1285. FTIR(neat): 93, 
3082, 2979, 2933, 2835, 1724, 1607, 1582, 1508, 1463, 1442, 1367, 1298, 1247, 1175, 








(Z)-2-Hydroxy-2-phenyl-hexa-3,5-dienoic acid ethyl ester (4.7). Representative 
procedure 2; Rf = 0.25, Hexane/DCM = 1/1.5;  colorless oil; 1H NMR (400 MHz, 
CDCl3): 7.53 (d, J = 7.6 Hz, 2H), 7.35 – 7.27 (m, 3H), 6.89 (dt, J = 16.8, 10.6 Hz, 2H), 
6.21 (t, J = 11.2 Hz, 1H), 5.99 (d, 11.6, 1H), 5.20 (d, J = 17.2, 1H), 5.13 (d, J = 10.4 Hz, 
1H), 4.30 – 4.16 (m, 2H), 4.07 (s, br, 1H), 3.78 (s, 3H), 1.23 (t, J = 7.0 Hz, 3H). 13C 
NMR (100 MHz, CDCl3): 174.9, 142.7, 133.8, 133.4, 130.5, 128.5, 128.1, 126.2, 120.8, 
78.7, 63.2, 14.2. HRMS Calcd. for C14H16O3 (M): 232.1099, Found: 232.1101. 
FTIR(neat): 3495, 2982, 1726, 1588, 1492, 1368, 1297, 1243, 1164, 1095, 11068, 1029, 







(Z)-2-Hydroxy-2-(4-nitro-phenyl)-hexa-3,5-dienoic acid ethyl ester (4.8). Repre-
senative procedure 2; Rf = 0.2, Hexane/DCM = 1/1; colorless oil; 1H NMR (400 MHz, 
CDCl3): 8.20 (d, J = 8.4 Hz, 2H), 7.78 (d, J = 8.8 Hz, 2H), 6.78 (dt, J = 16.8, 10.6 Hz, 
1H), 6.26 (t, J = 11.2 Hz, 1H), 6.00 (d, 11.2 Hz, 1H), 5.25 (d, J = 16.8, 1H), 5.19 (d, J = 
10.0 Hz, 1H), 4.34 – 4.19 (m, 2H + 1H), 4.03 (s, br, 1H), 3.78 (s, 3H), 1.26 (t, J = 7.2 Hz, 
3H). 13C NMR (100 MHz, CDCl3): 173.5, 147.5, 134.6, 132.5, 129.1, 127.2, 123.4, 
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121.7, 77.9, 63.6, 13.9. HRMS Calcd. for C14H16NO5 (M+1): 278.1028, Found: 
278.1028. FTIR(neat): 3484, 3083, 2978, 2923, 2852, 1730, 1605, 1594, 1521, 1489, 






(Z)-1-(4-Nitro-phenyl)-penta-2,4-dien-1-ol (4.9). Representative procedure 1; Rf = 0.3, 
Hexane/EA = 5/1; colorless oil; 1H NMR (400 MHz, CDCl3): 8.16 (d, J = 9.2 Hz, 2H), 
7.53 (d, J = 9.2 Hz, 1H), 6.68 (dtd, J = 16.8, 10.8, 1.2 Hz, 1H), 6.17 (t, J = 10.9, 1H), 
5.50 (tdd, J = 6.3, 2.0, 1.4 Hz, 1H) 5.34 (dt, J = 16.4, 0.8 Hz, 1H), 5.30 (d, J = 10.2 Hz, 
1H), 2.35 (s, br, 1H). 13C NMR (100 MHz, CDCl3): 150.1, 147.1, 131.7, 131.6, 130.8, 
126.5, 123.7, 121.4, 68.8. HRMS Calcd. for C11H12NO3 (M+1): 206.0817, Found: 
206.0820. FTIR(neat): 3386, 3083, 3012, 2918, 1854, 1598, 1518, 1345, 1187, 1108, 







(Z)-(6-Bromo-pyridin-2-yl)-penta-2,4-dien-1-ol (4.10). Representative procedure 1; Rf 
= 0.3, Hexane/EA = 6/1; colorless oil; 1H NMR (400 MHz, CDCl3): 7.51 (t, J = 7.6 Hz, 
1H), 7.40 (d, J = 7.6 Hz, 1H), 7.20 (d, J = 7.6 Hz, 1H), 6.81 (dt, J = 16.8, 10.8 Hz, 1H), 
6.21 (t, J = 11.0 Hz, 1H), 5.62 (d, J = 9.2 Hz, 1H), ), 5.48 (t, J = 9.8 Hz, 1H), 5.34 (dd, J 
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= 9.2 Hz, 16.8, 0.8, 1H), 5.26 (d, J = 10.0 Hz, 1H), 3.81 (s, br, 1H). 13C NMR (100 MHz, 
CDCl3): 162.1, 141.0, 139.2, 132.1, 131.4, 126.9, 120.6, 119.6, 68.7. HRMS Calcd. for 
C10H11NOBr (M): 240.0024, Found: 240.0023. FTIR(neat): 3381, 3084, 2986, 2924, 







(Z)-1-(5-Nitro-furan-2-yl)-penta-2,4-dien-1-ol (4.11). Representative procedure 1; Rf = 
0.2, DCM only and then Hexane/EA = 2/1; colorless oil; 1H NMR (400 MHz, CDCl3): 
7.21 (d, J = 3.6 Hz, 1H), 6.68 (dt, J = 16.8, 10.7 Hz, 1H), 6.45 (dd, J = 3.6, 0.8 Hz, 1H), 
6.21 (t, J = 11.0, 1H), 5.66 (d, J = 8.4 Hz, 1H), 5.59 (t, J = 9.6 Hz, 1H), 5.06 (d, J = 16.8 
Hz, 1H), 5.26 (d, J = 10.0 Hz, 1H), 2.67 (s, br, 1H). 13C NMR (75 MHz, CDCl3): 158.6, 
133.7, 130.6, 127.1, 121.9, 112.5, 109.8, 63.8. HRMS Calcd. for C9H10NO4 (M+1): 
196.0610, Found: 196.0614. FTIR(neat): 3382, 3121, 2918, 2850, 1584, 1526, 1495, 






(Z)-1-Benzyloxy-hexa-3,5-dien-2-ol (4.12a). Representative procedure 1; Rf = 0.3, 
Hexane/EA = 4/1; colorless oil; 1H NMR (300 MHz, CDCl3): 7.38 -7.26 (m, 5H), 6.62 
(dtd, J = 16.8, 10.5, 0.9 Hz, 1H), 6.10 (t, J = 11.1 Hz, 1H), 5.39 (dd, J = 10.2, 9.0 Hz, 
1H), 5.26 (d, J = 16.5 Hz, 1H), 5.18 (d, J = 10.2 Hz, 1H), 4.76 (td, J =8.2, 2.5 Hz, 1H), 
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4.56 (s, 2H), 3.49 (dd, J =9.6, 3.3 Hz, 1H), 3.39 (dd, J =9.8, 8.3 Hz, 1H), 2.26 (s, br, 1H). 
13C NMR (100 MHz, CDCl3): 137.7, 132.2, 131.7, 129.3, 128.5, 127.8,127.8, 119.8, 
73.8, 73.4, 67.2. HRMS Calcd. for C21H23NO9 (M): 433.1373, Found: 433.1374. 
FTIR(neat): 3418, 3085, 3029, 2914, 2859, 1593, 1495, 1453, 1363, 1315, 1208, 1104, 








(Z)-2-(2-Hydroxy-hexa-3,5-dienyl)-isoindole-1,3-dione (4.13). Representative pro-
cedure 1; Rf = 0.3, Hexane/EA = 3/1; white solid; 1H NMR (300 MHz, CDCl3): 7.85 – 
7.80 (m, 2H), 7.73 -7.67 (m, 2H), 6.63 (dt, J = 16.8, 10.7 Hz, 1H), 6.10 (t, J = 11.0 Hz, 
1H), 5.44 (t, J = 9.6 Hz, 1H), 5.22 (d, J = 8.4, 1H), 5.15 (d, J = 9.9 Hz, 1H), 4.97 – 4.90 
(m, 1HB), 3.84 (dd, J = 13.8, 7.8 Hz, 1H), 3.73 (dd, J = 14.1, 5.0 Hz, 1H), 2.25 (s, br, 
1H). 13C NMR (75 MHz, CDCl3): 168.7, 134.1, 132.6, 131.9, 131.3, 130.2, 123.4, 120.4, 
66.5, 43.7. HRMS Calcd. for C14H14NO3 (M+1): 244.0974, Found: 244.0970. 
FTIR(neat): 3466, 2927, 2853, 1772, 1713, 1613, 1467, 1429, 1395, 1332, 1190,1068, 
1035, 10202, 914, 794. MP  99 – 100 oC 
 
Representative Procedure for Asymmetric Reductive Coupling 
General procedure 1 was used. [Rh(COD)2]BARF (11.8 mg, 0.01 mmol, 5 
mol%), (R)-MeO-BIPHEP (5.9 mg, 0.01 mmol, 5 mol%), triphenylacetic acid (4.4 mg, 
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0.015 mmol, 7.5 mol%), and Na2SO4 (58 mg, 0.4 mmol, 200 mol%) and DCE (1.2 mL) 
were added to a reaction vessel and then stirred for 30 minutes at room temperature. The 
mixture of hydrogen and acetylene gas (approximately 1:1 mixture) was introduced into 
the solution via cannula and then a solution of carbonyl substrate (60.0mg, 0.2 mmol, 100 
mol%) in DCE (0.8 mL) was added to a reaction vessel. The mixture was stirred at room 
temperature under the 1 atm of hydrogen and acetylene gas mixture for 72 hours. The 






(Z)-1-(tert-Butyl-diphenyl-silanyloxy)-hexa-3,5-dien-2-ol (4.12b). Rf = 0.3, Hexane 
/DCM = 1/1; colorless oil; 1H NMR (400 MHz, CDCl3): 7.68 - 7.64 (m, 4H), 7.45 - 7.36 
(m, 6H), 6.39 (dtd, J = 16.8, 10.6, 1.1 Hz, 1H), 6.05 (t, J = 11.2 Hz, 1H), 5.35 (dd, J = 
10.2, 9.2 Hz, 1H), 5.19 (dt, J = 16.8, 0.8 Hz, 1H), 5.10 (d, J = 10.0 Hz, 1H), 4.66 – 4.61 
(m, 1H), 3.62 (dd, J =10.4, 3.6 Hz, 1H), 3.55 (dd, J =10.2, 8.2 Hz, 1H), 2.64 (d, J =2.8 
Hz, 1H), 1.07 (s, 9H). 13C NMR (70 MHz, CDCl3): 135.5, 135.5, 133.1, 132.9, 132.2, 
131.8, 129.9, 129.8, 129.3, 127.8, 127.8, 119.5, 68.8, 67.4, 26.8, 19.2. FTIR(neat): 3418, 
3070, 2929, 2857, 1960, 1896, 1825, 1589, 1471, 1427, 1390, 1361, 1313, 1221, 1188, 
1112, 1056, 998, 909, 823, 739, 701, 613. HPLC (Chiralcel OD-H column, 0.5% i-









(Z)-2-(2-Hydroxy-hexa-3,5-dienyl)-isoindole-1,3-dione (4.13). Rf = 0.3, Hexane /EA = 
3/1;  white solid ;HPLC (Chiralcel AD-H column, 11% i-PrOH/hexanes, 0.5 mL/min, 
220 nm), tmajor = 44.2 min, tminor = 47.6 min; ee = 88%. 
 
Representative Procedures for Reductive Coupling of 1,6-Diyne with Carbonyl 
[Rh(COD)2]SbF6 (5.5 mg, 0.01 mmol, 5 mol%), BIPHEP (5.3 mg, 0.01 mmol, 5 
mol%), triphenylacetic acid (2.9 mg, 0.01 mmol, 5 mol%), and Na2SO4 (58 mg, 0.4 
mmol, 200 mol%) and DCE (1.2 mL) were added to a reaction vessel and then stirred for 
30 minutes at room temperature. A solution of 1,6-diyne 4.20 (42mg, 0.2 mmol, 100 
mol%) and carbonyl substrate 4.19 (45.6 mg, 0.2 mmol, 100 mol%) in DCE (0.8 mL) 
was added to a reaction vessel under 1 atm of hydrogen. The mixture was stirred at 45 oC 
under the 1 atm of hydrogen. After 24 hours, a solution of 1,6-diyne 4.19 (42 mg, 
0.2mmol, 100 mol%) in DCE (1 mL) was added to a reaction vessel. The mixture was 
stirred at 45 oC under the 1 atm of hydrogen for additional 18 hours. The title compound 
was purified by flash column chromatography (Rf = 0.2, Hexane/EA = 4/1) to afford 49.8 












cyclopentane-1,1-dicarboxylic acid dimethyl ester1 (4.22). Rf = 0.2, Hexane/EA = 4/1; 
colorless oil; 1H NMR (400 MHz, CDCl3): 8.15 – 8.12 (m, 2H), 7.75 – 7.,71 (M, 2h), 6.0 
(S, 1h), 5.43 (t, J = 2.0 Hz, 1H), 5.04 (s, 1H), 4.26 (s, 1H), 4.22 – 4.10 (m, 2H), 3.17 – 
3.06 (m, 2H), 3.04 – 2.89 (m, 2H)1.19 (t, J = 7.0 Hz, 2H). 13C NMR (100 MHz, CDCl3): 
173.6, 171.4, 171.3, 148.5, 147.5, 143.5, 140.5, 127.5, 124.0, 123.1, 116.8, 16.5, 63.5, 
56.7, 52.9, 52.9, 43.7, 42.1, 13.8. HRMS Calcd. for C14H23NO5 (M+1): 286.1654, Found: 
286.1654. FTIR(neat):3447, 2953, 1732, 1669, 1604, 1522, 1435, 1349, 1259, 1200, 











methylene-cyclopentane-1,1-dicarboxylic acid dimethyl ester (4.23). Rf = 0.2, 
Hexane/DCM/EA = 12/6/1; colorless oil; 1H NMR (400 MHz, CDCl3 8.06 (d, J = 8.8 Hz, 
2H), 7.76 (d, J = 9.2 Hz, 2H), 7.32 – 7.19 (m, 5H), 5.43 (s, 1H), 4.86 (s, 1H), 4.84 (s, 
1H), 3.76 – 3.68 (m, 1H), 3.78 (s, 3H), 3.64 (s, 3H), 3.50 – 3.42 (m, 1H), 2.91 (d, J = 
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16.8 Hz, 1H), 2.87 (d, J = 14.0 Hz, 1H), 2.78 (d, J =  15.6 Hz, 1H), 2.66 (d, J = 16.8 Hz, 
1H), 0.85 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3): 173.3, 172.0, 171.3, 148.3, 
147.2, 141.5, 141.0, 140.5, 135.9, 128.8, 128.3, 127.2, 123.0, 122.5, 117.6, 81.1, 63.2, 
56.1, 52.9, 52.8, 41.7, 41.4, 13.3. HRMS Calcd. for C14H23NO5 (M+1): 286.1654, Found: 
286.1654. FTIR(neat):3467, 2991, 2948, 2949, 2844, 1730, 1596, 1519, 1488, 1437, 
1341, 1242, 1203, 1173, 1134, 1078.  
 
4.6.4 Multicomponent Reductive Coupling of Acetylene with Imines 
Representative Procedure for Preparation of Aryl Imines 
p-Toluenesulfonamide (590 mg, 3.44 mmol, 100 mol%), tetraethyl orthosilicate 
(717 mg, 3.44 mmol, 100 mol%), and 3-bromo-4-fluorobenzaldehyde (698 mg, 3.44 
mmol, 100mol%) were combined in a reaction vessel equipped with short still head and a 
receiving flask. The reaction mixture was stirred at 165oC for 5 hours, and ethanol, upon 
formation was collected in the receiving flask. After cooling, the reaction was diluted 
with ether, suction filtered and filtrates washed with cold ether (3 x 10 mL). The crude 






(3-bromo-4-fluorophenyl)-N-tosylmethanimine. 1H NMR (400 MHz, CDCl3): 8.94 (s, 
1H), 8.18 (d, J = 6.2 Hz, 1H), 7.88 -7.84 (m, 3H) 7.35 (d, J = 8 Hz, 2H), 7.23 (t, J = 8.2 
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Hz, 1H), 2.44 (s, 3H). 13C NMR (100 MHz, CDCl3): 167.2, 164.2 (d, JF-C = 258.8 Hz), 
144.9, 136.0, 134.6, 132.6 (d, JF-C = 8.9 Hz), 129.9 (d, JF-C = 3.7 Hz), 129.9, 128.1, 17.3 
(d, JF-C = 23.2 Hz), 110.6 (d, JF-C = 21.7 Hz), 21.6. HRMS Calcd. for 
C14H12NO2FSBr(M+1): 355.9756, Found: 355.9756. FTIR (neat): 3440, 3210, 1607, 





(3-nitro-4-bromophenyl)-N-benzensulfonylmethanimine. 1H NMR (400 MHz, CDCl3): 
9.03 (s, 1H), 8.35 (s, ), 7.99 (d, J = 7.8 Hz, ), 7.94 – 7.87 (m ), 7.67 (t, J = 7.6 Hz ), 7.57 
(t, J = 7.4 Hz ). 13C NMR (100 MHz, CDCl3): 166.7, 137.1, 136.2, 134.3, 134.2, 132.7, 
129.4, 128.3, 126.9, 121.3. HRMS Calcd. for C13H10N2O4S Br(M+1): 368.9545, Found: 





(5-nitrothiophen-2-yl)-N-tosylmethanimine. 1H NMR (400 MHz, CDCl3): 9.05 (s, 1H), 
7.90 (d, J = 4.3 Hz, 1H), 7.85 (d, J = 8.4 Hz, 2H), 7.65 (d, J = 4.3 Hz, 1H), 7.35 (d, J = 
8.2 Hz, 2H), 2.44 (s, 3H). 13C NMR (100 MHz, CDCl3): 161.6, 145.7, 142.7, 136.1, 
134.3, 130.2, 128.6, 128.4, 21.9. HRMS Calcd. for C12H10N2O4S2 (M+1): 310.0082, 
Found: 310.0082. FTIR (neat): 3108, 1596, 1582, 1508, 1344, 1235, 1162, 1087, 821, 
760(cm-1). M.P. 196 - 199oC 
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Representative Procedure for Eantioselective Reductive Coupling of Acetylene to N-
Arylsulfonyl Imine 4.29 for the Coupling Product 4.35 
To a reaction vessel charged with [Rh(COD)2]BARF (11.8 mg, 0.01 mmol, 5 
mol%), (S)-Cl,MeO-BIPHEP (6.5 mg, 0.01 mmol, 5 mol%), m-nitrobenzoic acid (1.7 
mg, 0.01 mmol, 5 mol%), Na2SO4 (58 mg, 0.4 mmol, 200 mol%), and imine 4.29 (58 mg, 
0.2 mmol, 100 mol%) was added toluene (2.0 mL, 0.1 M). An equimolar mixture of 
hydrogen and acetylene gas was introduced into the solution via cannula. The mixture 
was stirred at room temperature under the 1 atm of hydrogen and acetylene gas mixture 
for 16 hours. The title compound was purified by flash column chromatography (Rf = 
0.3, Petroleum Ether/CHCl3/EtOAc = 6/3/1) to afford 56.5 mg of the coupling product 
4.35 as a yellowish oil (83 % yield).  
 
4.32  
(Z)-N-(4-nitrobenzensulfonyl)-1-phenylpenta-2,4-dien-1-amine (4.32). Rf = 0.3, 
petroleum ether/CHCl3/EtOAc = 6/3/1; white solid; 1H NMR (400 MHz, CDCl3): 8.17 (d, 
J = 9 Hz, 2H), 7.84 (d, J = 9 Hz, 2H), 7.21 – 7.16 (m, 5H), 6.59 (dt, J = 16.6 Hz, 10.2 Hz, 
1H), 5.98 (t, J = 10.4 Hz, 1H), 5.49 (dd, J = 9.0 Hz, 6.8 Hz, 1H), 5.32 – 5.16 (m, 4H). 13C 
NMR (100 MHz, CDCl3): 149.7, 146.5, 138.9, 131.9, 130.5, 128.8, 128.5, 128.4, 128.1, 
126.7, 123.9, 121.6, 55.1. HRMS Calcd. for C17H17N2O4S (M+1): 345.0909, Found: 
345.0912. HPLC (Chiralcel OD-H column, 5% i-PrOH/hexanes, 0.5 mL/min, 220 nm), 
tminor = 71.4 min, tmajor = 76.6 min; ee = 93%. FTIR (neat): 3266, 3102, 2890, 1528, 1432, 




(Z)-N-(4-nitrobenzensulfonyl)-1-p-tolylpenta-2,4-dien-1-amine (4.33). Rf = 0.4, 
petroleum ether/CHCl3/EtOAc = 6/3/1; white solid; 1H NMR (400 MHz, CDCl3): 8.16 (d, 
J = 9 Hz, 2H), 7.84 (d, J = 9 Hz, 2H), 7.06 – 6.99 (m, 4H), 6.59 ( dt, J = 16.6 Hz, 10.2 
Hz, 1H), 5.96 (t, J = 10.4 Hz, 1H), 5.44 (dd, J = 9.4 Hz, 6.6 Hz, 1H), 5.32 – 5.22 (m, 3H), 
5.15 (d, J = 6.5 Hz, 1H), 2.25 (s, 3H). 13C NMR (100 MHz, CDCl3): 149.7, 146.6, 138.1, 
136.0, 131.7, 130.6, 129.5, 129.1, 129.0, 128.7, 128.5, 126.7, 123.9, 123.8, 121.4, 54.9, 
20.9. HRMS Calcd. for C18H19N2O4S (M+1): 359.1066, Found: 359.1071. HPLC 
(Chiralcel OD-H column, 15% i-PrOH/hexanes, 0.5 mL/min, 220 nm), tminor = 22.0 min, 
tmajor = 30.1min; ee = 98% FTIR (neat): 3267, 3098, 2982, 1530, 1312, 1164, 1091, 1014, 
922, 854, 737 (cm-1). M.P. 98 - 100oC 
 
4.34  
(Z)-N-(p-tolylsufonyl)-1-(4-chlorophenyl)penta-2,4-dien-1-amine (4.34). Rf = 0.3, 
petroleum ether/CHCl3/EtOAc = 6/3/1; clear oil; 1H NMR (400 MHz, CDCl3): 7.59 (d, J 
= 8.2 Hz, 2H), 7.19 – 7.12 (m, 6H), 6.41 (dt, J = 16.4, 10.2 Hz, 1H), 5.95 (t, J = 10.2 Hz, 
1H), 5.32 -5.13 (m, 4H), 4.95 (d, J = 5.8Hz, 1H), 2.38 (s, 3H). 13C NMR (100 MHz, 
CDCl3): 143.5, 138.4, 137.3, 133.5, 131.5, 130.6, 129.4, 128.9, 128.7, 128.1, 127.3, 
121.0, 54.2, 21.5. HRMS Calcd. for C18H19NO2SCl (M+1): 348.0825, Found: 348.0823. 
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HPLC (Chiralcel OD-H column, 10% i-PrOH/hexanes, 0.5 mL/min, 220 nm), tminor = 
17.4 min, tmajor = 23.4 min; ee = 95%. FTIR (neat): 3265, 3029, 2923, 1597, 1491, 1435, 
1329, 1160, 1092, 1013, 920, 813, 673 (cm-1). 
 
4.35  
(Z)-N-benzensulfonyl-1-(4-nitrophenyl)penta-2,4-dien-1-amine (4.35). Rf = 0.3, 
petroleum ether/CHCl3/EtOAc = 6/3/1; yellowish oil; 1H NMR (400 MHz, CDCl3): 8.06 
(d, J = 8.8 Hz, 2H), 7.74 (d, J = 8.8 Hz, 2H), 7.54 – 7.50 (m, 1H), 7.42 – 7.39 (m, 4H), 
6.37 (dt, J = 16.6 , 10.4 Hz, 1H), 6.02 (t, J = 10.6 HZ, 1H), 5.43 (dd, J = 9.6, 6.4 Hz, 
1H), 5.30 – 5.20 (m, 3H), 5.12 (d, J = 6.4Hz). 13C NMR (100 MHz, CDCl3): 147.3, 
147.2, 140.0, 132.9, 132.5, 130.1, 129.0, 127.6, 127.5, 127.2, 123.8, 122.1, 54.2. HRMS 
Calcd. for C17H17N2O4S (M+1): 345.0909, Found: 345.0905. HPLC (Chiralcel OD-H 
column, 20% i-PrOH/hexanes, 0.5 mL/min, 254 nm), tminor = 16.8 min, tmajor = 27.0 min; 




Methyl 4-((Z)-N-(p-tolylsulfonyl)-1-aminopenta-2,4-dienyl)benzoate (4.36). Rf = 0.2, 
petroleum ether/CHCl3/EtOAc = 6/3/1; clear oil; 1H NMR (400 MHz, CDCl3): 7.87 (d, J 
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= 8.2 Hz, 2H), 7.60 (d, J = 8.2Hz, 2H), 7.27 (d, J = 8.2 Hz, 2H), 7.17 (d, J = 8.2 Hz, 2H), 
6.43 (dt, J = 16.8, 10.2 Hz, 1H), 5.98 (t, J = 10.6 Hz, 1H), 5.38 (dd, J = 9.6, 6.2 Hz, 1H), 
5.30 – 5.17 (m, 3H), 4.97 (d, J = 6.2 Hz, 1H), 3.88 (s, 3H), 2.36 (s, 3H). 13C NMR (100 
MHz, CDCl3): 166.6, 144.9, 143.5, 137.3, 131.9, 130.6, 129.9, 129.5, 128.7, 127.3, 
126.7, 121.3, 54.6, 52.1, 21.5. HRMS Calcd. for C20H22NO4S (M+1): 372.1270, Found: 
372.1268. HPLC (Chiralcel OD-H column, 10% i-PrOH/hexanes, 0.5 mL/min, 220 nm), 
tminor = 26.8 min, tmajor = 35.3 min; ee = 95% FTIR (neat): 3270, 2994, 1770, 1720, 1610, 




Rf = 0.3, petroleum ether/CHCl3/EtOAc = 6/3/1; yellowish solid; 1H NMR (400 MHz, 
CDCl3): 8.16 (d, J = 9.0 Hz, 2H), 7.83 (d, J = 9.0 Hz, 2H), 7.13 (t, J = 8.0 Hz, 1H), 6.76 
– 6.53 (m, 4H), 5.98 (t, J = 10.6 Hz, 1H), 5.44 (dd, J = 9.4, 6.6 Hz, 1H), 5.30 – 5.19 (m, 
4H), 3.68 (s, 3H). 13C NMR (100 MHz, CDCl3): 159.84, 149.7, 146.5, 140.5, 131.9, 
130.5, 129.9, 128.4, 128.4, 123.8, 121.6, 118.9, 112.9, 112.7, 55.2, 55.0. HRMS Calcd. 
for C18H19N2O5S (M+1): 375.1015, Found: 375.1016. HPLC (Chiralcel AD-H column, 
15% i-PrOH/hexanes, 0.5 mL/min, 220 nm), tmajor = 47.1 min, tminor = 75.9 min; ee = 97%  
FTIR (neat): 3266.79, 2878.5, 2330.9, 1603.6, 1528.8, 1431.6, 1344.2, 1311.9, 1263.27, 




(Z)-N-(p-tolylsulfonyl)-1-(3-bromo-fluorophenyl)penta-2,4-dien-1-amine (4.38). Rf = 
0.2, petroleum ether/CHCl3/EtOAc = 6/3/1; clear oil; 1H NMR (400 MHz, CDCl3): 7.57 
(d, J = 8.2 Hz, 2H), 7.29 (d, J = 6.5 Hz, 1H), 7.18 (d, J = 8.2 Hz, 2H), 7.16 – 7.12 (m, 
1H), 6.95 (t, J = 8.2 Hz, 1H), 6.41 (dt, J = 16.6, 10.2 Hz, 1H), 5.98 (t, J = 10.2 Hz, 1H), 
5.31 – 5.18 (m, 4H), 4.98 (d, J = 6.2 Hz, 1H), 2.38 (s, 3H). 13C NMR (100 MHz, CDCl3): 
158.4 (d, JF-C = 247 Hz), 143.7, 137.3 (d, JF-C = 3.7 Hz), 137.1, 131.9 (d, JF-C = 6.7 Hz), 
130.5, 129.5, 128.4, 127.5 (d, JF-C = 7.5 Hz), 127.2, 121.5, 116.4 (d, JF-C = 22.4 Hz), 
109.1 (d, JF-C = 21.7 Hz), 53.7, 21.5. HRMS Calcd. for C18H18NO2FSBr (M+1): 
410.0026, Found: 410.0230. HPLC (Chiralcel OD-H column, 5% i-PrOH/hexanes, 0.5 
mL/min, 220 nm), tminor = 28.6 min, tmajor = 36.6 min; ee = 97% FTIR (neat): 3265, 2970, 
2923, 1597, 1494, 1436, 1329, 1246, 1160, 1093, 1047, 921, 813 (cm-1). 
 
4.39  
(Z)-N-(benzensulfonyl)-1-(4-bromo-3-nitrophenyl)penta-2,4-dien-amine (4.39). Rf = 
0.3, petroleum ether/CHCl3/EtOAc = 6/3/1; a yellow oil; 1H NMR (400 MHz, CDCl3): 
7.72 (d, J = 7.2 Hz, 2H), 7.62 – 7.51(m, 3H), 7.41 (t, J = 8 Hz, 2H), 7.34 (d, J = 8 Hz, 
1H), 6.34 (dt, J = 16.6, 10.8 Hz, 1H), 6.04 (t, J = 10.2 Hz, 1H), 5.39 – 5.19 (m, 4H), 5.04 
 240
(d, J = 6.4 Hz, 1H). 13C NMR (100 MHz, CDCl3): 149.9, 141.6, 140.1, 135.5, 133.2, 
133.2 131.9, 130.2, 129.3, 127.4, 127.1, 124.2, 122.8, 113.8, 53.9. HRMS Calcd. for 
C17H16N2O4SBr (M+1): 423.0014, Found: 423.0014. HPLC (Chiralcel OD-H column, 
20% i-PrOH/hexanes, 0.5 mL/min, 220 nm), tminor = 15.2 min, tmajor = 22.4 min; ee = 





(Z)-N-(p-tolylsulfonyl)-1-(5-nitrothiophen-2-yl)penta-2,4-dien-1-amine (4.40). Rf = 
0.2, petroleum ether/CHCl3/EtOAc = 6/3/1; a brown oil; 1H NMR (400 MHz, CDCl3): 
7.69 – 7.62 (m, 3H), 7.24 (d, J = 10.8 Hz, 2H), 6.83 (d, J = 4.1 Hz, 1H), 6.32 (dt, J = 
16.6, 9.8 Hz, 1H), 6.04 (t, J = 10.8Hz, 1H), 5.57 – 5.45 (m, 1H), 5.32 – 5.13(m, 4H), 2.39 
(s, 3H). 13C NMR (100 MHz, CDCl3): 153.3, 151.1, 144.2, 136.8, 133.2, 129.8, 129.7, 
128.5, 127.2, 126.3, 124.4, 122.5, 51.0, 21.5. HRMS Calcd. for C16H17N2O4S2 (M+1): 
365.0630, Found: 365.0629. HPLC (Chiralcel OD-H column, 15% i-PrOH/hexanes, 0.5 
mL/min, 220 nm), tminor = 21.2 min, tmajor = 37.1 min; ee = 95% FTIR (neat): 3260, 3106, 






(Z)-N-(1-Cyclohexyl-penta-2,4-dienyl)-4-methyl-benzenesulfonamide (4.41). Rf = 
0.3, hexane/CHCl3/EtOAc = 8/3/1); white solid; 1H NMR (300 MHz, CDCl3): 7.66 (d, J 
= 8.1 Hz, 2H), 7.19 (d, J = 8.1 Hz, 2H), 6.33 (dt, J = 16.5 Hz, 10.7 Hz, 1H), 5.80 (t, J = 
10.9 Hz, 1H), 5.10 (d, J = 16.5 Hz, 1H), 5.05 (d, J = 11.1 Hz, 1H), 4.96 (t, J = 10.4 Hz, 
1H), 4.73 (d, J = 8.1 Hz, 1H), 3.97 (dd, J = 17.1, 7.5 Hz, 1H), 2.36 (s, 3H), 1.79 – 1.59 
(m, 5H), 1.42 – 1.30 (m, 1H), 1.23 – 1.03 (m, 3H), 0.96 – 0.84 (m, 2H). 13C NMR (75 
MHz, CDCl3): 142.9, 138.0, 131.4, 131.0, 129.4, 129.3, 127.2, 119.1, 55.9, 43.0, 29.1, 
28.5, 26.2, 25,9, 25.8, 21.4. HRMS Calcd. for C18H26NO2S (M+1): 320.1684, Found: 
320.1687. FTIR(neat): 3273, 2925, 2852, 1652, 1598, 1558, 1540, 1506, 1448, 1327, 
1158, 1093, 1042, 905, 812, 674 (cm-1). HPLC (Chiralcel OD-H column, 5% i-
PrOH/hexanes, 0.5 mL/min, 220 nm), tminor = 16.7 min, tmajor = 21.8 min; ee = 97% MP : 
113 - 114 oC 
NHTs
4.42  
(Z)- N-(1-Isopropyl-penta-2,4-dienyl)-4-methyl-benzenesulfonamide (4.42). Rf = 0.3, 
hexane/CHCl3/EtOAc = 8/3/1; white solid; 1H NMR (400 MHz, CDCl3): 7.68 (d, J = 8.4 
Hz, 2H), 7.22 (d, J = 8.0 Hz, 2H), 6.35 (dtd, J = 16.8 Hz, 10.6, 0.4 Hz, 1H), 5.85 (t, J = 
10.8 Hz, 1H), 5.14 (d, J = 16.8 Hz, 1H), 5.09 (d, J = 10.0 Hz, 1H), 4.99 (t, J = 10.4 Hz, 
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1H), 4.60 (d, J = 8.0 Hz, 1H), 4.02 – 3.96 (m, 1H), 2.39 (s, 3H), 1.79 – 1.70 (m, 1H), 0.89 
(d, J = 6.8 Hz, 3H), 0.85 (d, J = 6.4, 3H). 13C NMR (75 MHz, CDCl3): 142.9, 137.9, 
131.3, 131.3, 129.3, 128.9, 127.2, 119.2, 56.5, 33.4, 21.4, 18.5, 17.9. HRMS Calcd. for 
C15H22NO2S (M+1): 280.1371, Found: 280.1374. FTIR(neat): 3273, 2962,2927, 2874, 
1916, 1802, 1647, 1598, 1495, 1434, 1328, 1304, 1158, 1093, 1047, 915, 813, 788, 706, 
676 (cm-1). HPLC (Chiralcel OD-H column, 5% i-PrOH/hexanes, 0.5 mL/min, 220 nm), 
tminor = 18.1 min, tmajor = 20.6 min; ee = 98% MP : 71 - 72 oC 
NHTs
4.43  
(Z)- N-(1-Cyclopropyl-penta-2,4-dienyl)-4-methyl-benzenesulfonamide (4.43). Rf = 
0.3, hexane/CHCl3/EtOAc = 8/3/1); clear oil; 1H NMR (300 MHz, CDCl3): 7.72 (dd, J = 
6.5, 1.7 Hz, 2H), 7.27 (d, J = 8.7 Hz, 2H), 6.41 (dtd, J = 17.1 Hz, 10.2, 0.9 Hz, 1H), 5.91 
(td, J = 11.1, 0.9 Hz, 1H), 5.22 (d, J = 16.5 Hz, 1H), 5.15 (d, J = 9.9 Hz, 1H), 5.08 (t, J = 
10.5 Hz, 1H), 4.61 (s, br, 1H), 3.82 – 3.74 (m, 1H), 2.43 (s, 3H), 1.00 – 0.89 (m, 1H), 
0.50 – 0.43 (m, 2H), 0.27 – 0.21 (m, 2H). 13C NMR (75 MHz, CDCl3): 143.2, 137.9, 
131.2, 130.9, 129.4, 129.2, 127.3, 119.7, 55.0, 21.5, 16.6, 3.5, 2.5. HRMS Calcd. for 
C15H20NO2S (M+1): 278.1215, Found: 278.1215. FTIR(neat): 3265, 3078, 3008, 2918, 
2848, 1598, 1431, 1325, 1157, 1093, 1028, 911, 813 (cm-1). HPLC (Chiralcel OD-H 




Determination of Absolute Stereochemistyry 
Procedure for the Exhaustive Hydrogenation of 4.32 
To the solution of diene 4.32(40 mg, 0.174 mmol, 100 mol%) in DCM (1.2 mL, 
0.1 M) at ambient temperature was added Crabtree’s catalyst (7.0 mg, 0.0087 mmol, 5 
mmol). The reaction was purged with argon followed by hydrogen. The reaction was 
allowed to stir at ambient temperature under 1 atm of hydrogen for 30h. The volatiles 
were removed under reduced pressure. The title compound was purified by silica gel 
flash chromatography (Rf = 0.4: 60/30/10 Petroleum Ether/CHCl3/EtOAc) to afford to 




(S)-N-(4-nitrobezylsufonyl)-1-phenylpentan-1-amine (4.44). 1H NMR (400 MHz, 
CDCl3): 8.04 (d, J = 8.9 Hz, 2H), 7.66 (d, J = 8.9 Hz, 2H), 7.11 – 7.05 (m, 3H), 6.92 (d, J 
=7.5 Hz, 2H), 5.02 (d, J = 7.2 Hz, 1H), 4.37 (q, J = 7.2 Hz, 1H), 1.82 – 1.61 (m, 2H), 
1.30 – 1.09 (m, 4H), 0.82 (t, J = 6.8 Hz, 3H). 13C NMR (100 MHz, CDCl3): 149.5, 146.6, 
140.0, 128.5, 128.1, 127.8, 126.5, 123.7, 58.8, 37.3, 27.9, 22.1, 13.8. FTIR (neat): 3280, 
2932, 2874, 1529, 1456, 1349, 1164, 1092, 913, 744 (cm-1). HRMS Calcd. For 
C17H21N2O4S (M+1): 349.1222, Found: 349.1223.  
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Procedure for the Deprotecton of p-Nitrobenzenesulforyl Group 
A mixture of compound 4.44 (74 mg, 0.212 mmol, 100 mol%), PhSH (0.087 mL, 
0.848 mmol, 400 mol%), and K2CO3 (176 mg, 1.272 mmol, 600 mol%) were dissolved in 
MeCN (2.12 mL, 0.1M). The reaction mixture was stirred at 50oC for 24 h under argon 
pressure. The title compound was purified by silica gel flash chromatography (Rf = 0.05: 
50/50/1 Petroleum Ether/EtOAc/TEA) to afford to afford 22.6 mg of 4.45 as a clear oil 




(S)-1-phenylpentan-1-amine (4.45). 1H NMR (400 MHz, CDCl3): 7.33 – 7.20 (m, 5H), 
3.85 (t, J = 6.8 Hz, 1H), 1.67 – 1.30 (m, 4H), 1.29 – 1.17 (m, 4H), 0.85 (t, J = 7.2 Hz, 
3H). [α]D = -17.2 (c = 0.67, DCM, 94% ee) compared to [α]D = -17.4 (1.19, DCM, 94 % 
ee). 
 
Elaboration of the Redcutive Coupling Product 
Procedure for N-Homoallylation of 4.41. 
Amine 4.41 (34.2 mg, 0.108 mmol, 100 mol%), Cs2CO3 (176.2 mg, 1.08 mmol, 
10 eq.), and homoallyl bromide (73.0 mg, 1.08 mmol, 10 eq.) were suspended in 0.35 mL 
of DMF and the mixture stirred overnight at 70 oC. Water and ether were added to the 
suspension, and the aqueous layer was extracted three times with ether. The combined 
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organic layers were dried with Na2SO4. After filtration and concentration under low 
pressure. The residue was purified by flash column chromatography (Rf = 0.4, Hexane 






(4.46). 1H NMR (300 MHz, CDCl3): 7.60 (d, J = 8.1 Hz, 2H), 7.17 (d, J = 7.8 Hz, 2H), 
6.64 (dt, J = 16.8 Hz, 10.2 Hz, 1H), 6.00 (t, J = 11.1 Hz, 1H), 5.73 – 5.60 (m, 1H), 5.25 – 
5.17 9m, 3H), 5.04 – 4.97 (m, 2H), 4.52 (t, J = 10.5 Hz, 1H), 3.16 – 2.95 (m, 2H), 2.49 – 
2.39 (m, 1H), 2.35 (s, 3H), 2.30 – 2.18 (m, 1H), 2.01 (d, J = 12.6 Hz, 1H), 1.76 – 1.62 (m, 
4H), 1.44 – 1.33 (m, 1H), 1.23 – 0.99 (m, 4H), 0.90 – 0.77 (m, 1H). 13C NMR (75 MHz, 
CDCl3): 142.7, 137.7, 135.0, 132.5, 132.0, 129.2, 127.5, 127.2, 119.7, 116.7, 60.5, 43.8, 
40.3, 35.1, 30.5, 30.2, 26.3, 26.1, 25.9, 21.5. HRMS Calcd. for C22H32NO2S (M+1): 
374.2154, Found: 374.2151. FTIR(neat): 2924, 2851, 1641, 1598, 1450, 1337, 1154, 
1090, 917, 812, 750, 663 (cm-1).  
 
Procedure for Ring-Closing Metathesis of 4.46. 
The triene 4.46 (17.6 mg, 0.047 mmol, 100 m0l%) was dissolved in dry degassed 
DCM (0.5 mL, 0.1M) in a round-bottom flask under argon. The Grubbs catalyst (2.0 mg, 
0.0024 mmol, 5 mol%) was added, and the solution was stirred at reflux until the starting 
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material was totally consumed. The solvent was evaporated, and the crude was purified 
by flash column chromatography (Rf = 0.4, Hexane /EtOAc = 10/1) to afford 14.3 mg of 




6-Cyclohexyl-1-(toluene-4-sulfonyl)-1,2,3,6-tetrahydro-pyridine (4.47). 1H NMR (400 
MHz, CDCl3): 7.67 (d, J = 8.4 Hz, 2H), 7.20 (d, J = 8.4 Hz, 2H), 5.73 -5.69 (m, 1H), 5.53 
(d, J = 10.8 Hz, 1H), 3.98 (s, br, 1H), 3.84 – 3.79 (m, 1H), 3.17 – 3.09 (m, 1H), 1.92 (d, J 
= 12.8 Hz, 1H), 1.75 – 1.47 (m, 6H), 1.23 – 1.01 (m, 6H). 13C NMR (75 MHz, CDCl3): 
142.8, 138.8, 129.4, 127.1, 126.2, 125.1, 58.3, 43.1, 39.1, 30.2, 29.8, 26.3, 26.2, 26.1, 
22.4, 21.5. HRMS Calcd. for C18H26NO2S (M+1): 320.1684, Found: 320.1688. 
FTIR(neat): 3036, 2924, 2851, 1598, 1494, 1449, 1342, 1283, 1212, 1159, 1059, 1041, 
963, 925, 814, 717, 649 (cm-1). 
 
Procedure for Cross Metathesis of 4.41. 
Amine 4.41 (25 mg, 0.078 mmol) was dissolved in anhydrous DCM (0.4 mL) and 
1,4-acetate-2-butene (40 mg, 0.234 mmol) was added, following Grubb’s II (3.3 mg, 
0.0039 mmol). The reaction mixture was stirred for 14 hours. The title compound was 
purified by flash column chromatography (Rf = 0.2, Petroleum Ether/CHCl3/EtOAc = 





(2E,4Z)-6-N-p-tolylsulfonyl-amino-6-cyclohexylhexa-2,4-dienyl acetate (4.48). 1H 
NMR (400 MHz, CDCl3): 7.64 (d, J = 8.2 Hz, 2H), 7.24 (d, J = 8.2 Hz, 2H), 6.24 (dd. J = 
15.0, 11.2 Hz, 1H) 5.82 (t, J = 10.9 Hz, 1H), 5.64 (dt, J = 15.0, 6.5 Hz, 1H), 5.02 (t, J = 
10.6 Hz, 1H), 4.53 (d, J = 6.5 Hz, 1H), 4.65 (d, J = 7.8 Hz, 2H), 3.94 (dt, J = 10.2, 7.2 
Hz, 1H), 2.37 (s, 3H), 2.08 (s, 3H), 1.77 – 1.59 (m, 5H), 1.39 – 1.32 (m, 1H), 1.17 – 1.04 
(m, 3H), 0.95 – 0.85 (m, 2H). 13C NMR (100 MHz, CDCl3): 170.7, 143.1, 137.9, 130.1, 
129.6, 129.4, 128.8, 128.2, 127.2, 64.5, 55.9, 42.9, 29.1, 28.5, 26.2, 25.9, 25.8, 21.5, 20.9. 
HRMS Calcd. for C21H30NO4S (M+1): 392.1896, Found: 392.1891. FTIR (neat): 3270, 
2926, 2852, 1740, 1598, 1448, 1330, 1240, 1160, 1093, 1027, 956, 814 (cm-1). 
 
Procedure for N-Allylation of 4.41. 
Amine 4.41 (104.3 mg, 0.33 mmol, 100 mol%), K2CO3 (68.4 mg, 0.49 mmol, 150 
mol%.), and allyl bromide (60.0 mg, 0.49 mmol, 150 mol%).) were suspended in 1.1 mL 
of DMF and the mixture stirred overnight at room temperature. Water and ether were 
added to the suspension, and the aqueous layer was extracted three times with ether. The 
combined organic layers were dried with Na2SO4, and the solvent was removed under 
low pressure. The residue was purified by flash column chromatography (Rf = 0.4, 






1H NMR (400 MHz, CDCl3): 7.60 (d, J = 8.0 Hz, 2H), 7.16 (d, J = 8.0 Hz, 2H), 6.65 (dt, 
J = 16.8 Hz, 10.8 Hz, 1H), 6.00 (t, J = 11.2 Hz, 1H), 5.80 – 5.70 (m, 1H), 5.28 (t, J = 
11.0 Hz, 1H), 5.22 (dt, J = 16.4 Hz, 1H), 5.17 (d, J = 10.4 Hz, 1H), 5.10 (dd, J = 17.4, 1.4 
Hz, 1H), 5.01 (dd, J = 9.8, 1.4 Hz, 1H), 4.53 (t, J = 10.6 Hz, 1H), 3.75 (dd, J = 16.4, 7.4 
Hz, 1H), 3.66 (ddt, J = 16.2, 5.8, 1.4 Hz, 1H), 1.96 (d, J = 12.8 Hz, 1H), 1.74 – 1.56 (m, 
4H), 1.50 – 1.40 (m, 1H), 1.23 – 0.93 (m, 4H), 0.85 – 0.71 (m, 1H). 13C NMR (100 MHz, 
CDCl3): 142.7, 137.7, 135.8, 132.2, 131.9,, 129.1, 127.8, 127.5, 119.5, 117.0, 60.3, 47.0, 
39.6, 30.1, 26.2, 26.0, 25.7, 21.4. HRMS Calcd. for C21H30NO2S (M+1): 360.1997, 
Found: 360.1995. FTIR(neat): 2923, 2852, 1738, 1593, 1492, 1449, 1337, 1262, 1155, 
1090, 1037, 1007, 921, 812, 767, 662 (cm-1).  
 
Procedure for Rh-Catalyzed [4+2] Cycloaddition of 4.49 
A flame-dried 10 mL Schlenk tube was charged with [Rh(COD)2]SbF6 (3.1 mg, 
0.0057 mmol, 5 mol%) and PPh3 (4.5 mg, 0.017 mmol, 15 mol%), and fitted with a 
rubber septum. The flask was evacuated under high vacuum and back filled with argon. 
The precatalyst was dissolved in toluene (0.6 mL), allowed to stir for 5 min, then purged 
with H2 and rapidly stirred for an additional 30 min. The H2 was removed and followed 
by back filling with argon. The triene 4.49 (40.7 mg, 0.113 mmol, 100 mol%) in toluene 
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(0.6 mL) was then added by syringe and the reaction mixture was warmed to 80 oC with 
stirring 20 min. After the cycloaddition was complete (TLC), the solvent was evaporated, 
and the crude was purified by flash column chromatography (Rf = 0.4, Hexane /EtOAc = 






(Note: The ratio of two diastereomers was determined by HPLC using the reacemic 
product. In addition, the relative stereochemistry of the major diastereomer was assigned 
based on the report by Livinghouse). 1H NMR (400 MHz, CDCl3): 7.65 (d, J = 8.0 Hz, 
2H), 7.22 (d, J = 8.0 Hz, 2H), 5.10 -5.08 (m, 1H), 4.93 (d, J = 10.4 Hz, 1H), 3.36 (dd, J =  
9.6, 7.6 Hz, 1 H), 3.20 (d, J = 3.6 Hz, 1H), 3.01 (t, J = 9.0 Hz, 1H), 2.45 – 2.43 (m, 2H), 
1.81 – 1.56 (m, 7H), 1.51 – 1.34 (m, 2H), 1.31 -1 0.85 (m, 6H). 13C NMR (75 MHz, 
CDCl3): 142.8, 138.8, 129.1, 128.1, 127.7, 126.5, 71.3, 50.5, 43.0, 39.6, 34.8, 30.4, 28.0, 
26.6, 26.4, 26.2, 21.5, 20.9, 20.2. HRMS Calcd. for C21H30NO2S (M+1): 360.1997, 
Found: 360.1995. FTIR(neat): 3018, 2928, 2848, 1598, 1449, 1342, 1304, 1160, 1405, 





Procedure for Boc-Protection of 4.41 
A solution of amine (61.0 mg, 0.19 mmol, 100 mol%) and Boc2O (52.0 mg, 0.23 
mmol, 120 mol%) in MeCN (1 mL, 0.2M) was treated with DMAP (2.4 mg, 0.019 mmol, 
10 mol%) and left overnight under argon. Water and ether were added to the suspension, 
and the aqueous layer was extracted three times with ether. The combined organic layers 
were dried with Na2SO4, and the solvent was removed under low pressure. The residue 
was purified by flash column chromatography (Rf = 0.4, Hexane /EtOAc = 10/1) to 







amide (4.41a). 1H NMR (300 MHz, CDCl3): 7.67 (d, J = 8.4 Hz, 2H), 7.21 (d, J = 8.1 Hz, 
2H), 6.85 (dt, J = 16.8 Hz, 10.6 Hz, 1H), 6.23 (t, J = 10.9 Hz, 1H), 5.86 (t, J = 10.4 Hz, 
1H), 5.32 (d, J = 16.5 Hz, 1H), 5.23 (d, J = 10.2 Hz, 1H), 5.08 (t, J = 10.1 Hz, 1H), 2.38 
(s, 3H), 2.11 -2.00 (m, 1H), 1.90 – 1.78 (m, 2H), 1.72 – 1.63 (m, 3H), 1.28 (s, 9H), 1.37 – 
1.00 (m, 4H), 0.89 – 0.78 (m, 1H). 13C NMR (75 MHz, CDCl3): 150.6, 143.5, 137.8, 
133.2, 132.1, 129.2, 129.0, 127.7, 120.0, 84.0, 60.7, 39.5, 31.1, 29.8, 27.9, 26.2, 25.9, 
25.8, 21.5. HRMS Calcd. for C23H34NO4S (M+1): 420.2209, Found: 420.2206. 
FTIR(neat): 2929, 1724, 1597, 1495, 1450, 1393, 1355, 1278, 1256, 1162, 1087, 991, 
813, 706, 665 (cm-1).   
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Procedure for Site-Selective Oxidative Cleavage of 4.41a 
To a mixture of 1.2 mL of water and 2.9 mL of THF, OsO4 (2.5 mg, 0.01 mmol, 5 
mol%) and diene 4.41a (85.2 mg, 0.20 mmol, 100 mol%) was added and then stirred for 
5 minutes. While the temperature of the stirred mixture was maintained at 24 – 26 °C, 
NaIO4 (95.5 mg, 0.45 mmol, 220 mol%) was added in portions over a period of 40 
minutes. The solution was stirred for an additional 2 hours. The mixture was extracted 
thoroughly with ether and the combined organic layers were dried with Na2SO4. The 
solvent was removed in vacuo, and then the title compound was purified by flash silical 








amide (4.51). 1H NMR (300 MHz, CDCl3): 10.2 (d, J = 8.1 Hz), 7.69 (d, J = 8.4 Hz, 2H), 
7.30 (d, J = 7.5 Hz, 2H), 7.04 (t, J = 10.9 Hz, 1H), 6.18 (dd, J = 10.8, 8.1 Hz, 1H), 5.54 (t, 
J = 10.5 Hz, 1H), 2.25 (m, 1H)- 2.06 (s, 3H), 1.89 – 1.65 (m, 5H), 1.34 (s, 9H), 1.30 – 
0.88 9m, 5H). 13C NMR (75 MHz, CDCl3): 191.3, 150.3, 147.2, 144.3, 137.0, 132.4, 
129.3, 127.9, 85.0, 59.3, 38.5, 31.3, 29.6, 27.8, 26.0, 25.7, 25.6, 21.6. HRMS Calcd. for 
C22H32NO5S (M+1): 422.2001, Found: 422.2004. FTIR(neat):2930, 2853, 1725, 1683, 
1597, 1450, 1348, 1281, 1150, 1087, 1022, 943, 812, 768, 665 (cm-1).  
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Procedure for Oxidation of 4.51 
To a solution of aldehyde 4.51 (31.8 mg, 0.075 mmol, 100 mol%) in MeOH (1.4 
mL, 0.05M) was added manganese dioxide (154 mg, 1.5 mmol, 20 eq.) and sodium 
cyanide (15.5 mg, 0.30 mmol, 400 mol%). The resulting suspension was stirred at room 
temperature for 3 hrs, filtered and the filtrate evaporated. The residue was redissolved in 
water and extracted with ether, the combined organic extracts were dried with Na2SO4 
and evaporated. The residue was purified by flash silical chromatography (Rf = 0.4, 








methyl ester (5.52). 1H NMR (300 MHz, CDCl3): 7.75 (d, J = 8.4 Hz, 2H), 7.27 (d, J = 
7.8 Hz, 2H), 6.63 (dd, J = 11.9, 10.0 Hz, 1H), 6.00 (dd, J = 11.7, 0.6 Hz, 1H), 5.92 (t, J = 
10.2 Hz, 1H), 3.78 (s, 3H), 2.43 (s, 3H), 2.14 – 2.03 (m, 1H), 1.84 – 1.64 (m, 5H), 1.37 (s, 
9H), 1.34 – 1.04 (m, 5H). 13C NMR (75 MHz, CDCl3): 166.0, 150.8, 144.1, 143.7, 137.3, 
129.0, 127.9, 122.5, 84.3, 60.0, 51.5, 39.4, 30.3, 29.7, 27.9, 26.1, 26.0, 26.0, 21.5. HRMS 
Calcd. for C23H34NO6S (M+1): 452.2107, Found: 452.2110. FTIR(neat): 2930, 2852, 








4.6.5 Reductive Coupling of Acetylene with Chiral Aldehydes: The Formal Synthesis 
of D-Hexoses 
Representative Procedure for Diastereoselective Reducitve Coupling 
[Rh(COD)2]BARF (11.8mg, 0.01 mmol, 5 mol%), (R)-MeO-BIPHEP (5.9mg, 
0.01 mmol, 5 mol%), petafluorobenzoic acid (2.1mg, 0.01 mmol, 5 mol%), and Na2SO4 
(58mg, 0.4 mmol, 200 mol%) and Toluene (1.2 mL) were added to a reaction vessel and 
then stirred for 15 minutes at room temperature. The mixture of hydrogen and acetylene 
gas (approximately 1:1 mixture) was introduced into the solution via cannula and then a 
solution of carbonyl substrate 4.57 (26mg, 0.2 mmol, 100 mol%) in Toluene (0.8 mL) 
was added to a reaction vessel. The mixture was stirred at room temperature under the 1 
atm of hydrogen and acetylene gas mixture for 12 hours. The title compound was purified 
by flash column chromatography (Rf = 0.3, pentane/ether = 2/1) to afford 28.7 mg of syn-










(Z,1R)-1-((4R)-2,2-Dimethyl-[1,3]dioxolan-4-yl)-penta-2,4-dien-1-ol (syn-4.58). Rf = 
0.3, Pentane/Ether = 2/1; colorless oil; 1H NMR (400 MHz, CDCl3): 6.70 – 6.63 (m, 1H), 
6.16 (td, J = 11.2, 0.8 Hz, 1H), 5.37 – 5.21 (m, 3H), 4.47 (t, J = 8.0 Hz, 1H), 4.04 – 4.00 
(m, 1H), 3.95 (d, J = 6.4 Hz, 1H), 3.93 (d, J = 6.4 Hz, 1H), 3.68 (dd, J = 5.6, 5.4 Hz, 1H), 
2.39 (s, br, 1H), 1.45 (s, 3H), 1.35 (s, 3H). 13C NMR (100 MHz, CDCl3): 133.4, 131.5, 
128.4, 120.6, 109.9, 79.1, 69.2, 65.7, 26.9, 25.2. HRMS Calcd. for C10H17O3 (M+1): 










Z,1S)-1-((4R)-2,2-Dimethyl-[1,3]dioxolan-4-yl)-penta-Z-2,4-dien-1-ol (anti-4.58). Rf = 
0.3, Pentane/Ether = 2/1; a colorless oil; 1H NMR (400 MHz, CDCl3): 6.62 (dtd, J = 16.4, 
10.6, 1.2 Hz, 1H), 6.16 (td, J = 11.2, 0.7 Hz, 1H), 5.34 (t, J = 9.8 Hz, 1H), 5.28 (dd, J = 
16.8, 0.2 Hz, 1H), 5.21 (d, J = 10.0 Hz, 1H), 4.73 – 4.71 (m, 1H), 4.10 (td, J = 6.6, 4.4 
Hz, 2H), 3.98(dd, J = 8.2, 6.8 Hz, 1H), 3.92 (dd, J = 8.4, 6.8 Hz, 1H), 2.08 (d, J = 2.8 Hz, 
1H), 1.43 (s, 3H), 1.34 (s, 3H). 13C NMR (100 MHz, CDCl3): 133.0, 131.5, 128.5, 120.3, 










(Z,2S,3R)-2-Benzyloxy-hepta-4,6-dien-3-ol (anti-4.62). Rf = 0.3, Hexane/EA = 8/1; o 
afford 41.6 mg as a colorless oil (95 % yield, 11:1 dr). 1H NMR (400 MHz, CDCl3): 7.36 
– 7.24 (m, 5H), 6.61 – 6.51 (m, 1H), 6.12 (t, J = 11.0 Hz, 1H), 5.46 (t, J = 9.4 Hz, 1H), 
5.25 (dt, J = 16.8, 0.8 Hz, 1H), 5.16 (d, J = 10.4 Hz, 1H), 4.68 – 4.64 (m, 1H), 4.64 (dt, J 
= 12.0 Hz, 1H), 4.53 (d, J = 11.6 Hz, 1H), 3.64 – 3.59 (m, 1H), 2.31 (d, J = 4.4 Hz, 1H), 
1.14 (d, J = 6.4 Hz, 3H). 13C NMR (100 MHz, CDCl3): 138.4, 131.8, 131.7, 129.8, 128.4, 










(Z,2S,3S)-2-Benzyloxy-hepta-4,6-dien-3-ol (syn-4.62). Rf = 0.3, Hexane/EA = 8/1; 
colorless oil; 1H NMR (300 MHz, CDCl3): 7.38 – 7.26 (m, 5H), 6.65 (dtd, J = 16.5,10.7, 
1.2 Hz, 1H), 6.17 (t, J = 11.2 Hz, 1H), 5.38 (t, J = 10.0 Hz, 1H), 5.27 (dd, J = 16.5, 1.7 
Hz, 1H), 5.19 (d, J = 11.4 Hz, 1H), 4.46 (d, J = 11.4 Hz, 1H), 4.40 (t, J = 8.2 Hz, 1H), 
3.47 – 3.39 (m, 1H), 2.38 (d, J = 2.1 Hz, 1H), 1.14 (d, J = 6.3 Hz, 3H). 13C NMR (75 
MHz, CDCl3): 138.1, 133.2, 132.0, 129.6, 128.54, 127.8, 119.7, 78.6, 71.5, 71.2, 15.4. 
HRMS Calcd. for C14H19O2 (M+1): 219.1385, Found: 219.1384. 
 
Representative Procedure for Benzylation of the Coupling Product. 
NaH (17.2mg, 130 mol%) was added to a solution of diene product syn-4.58 
(61mg, 100 mol% ) in anhydrous DMF (2.0mL, 0.12M) at 0 oC under argon atmosphere. 
After 10 min benzyl bromide (78.9mg, 137 mol% in DMF (0.75mL)) was added in one 
portion. The reaction mixture was stirred for 2h, and then carefully quenched with 
saturated NH4Cl. The mixture was extracted with ether. The combined organic phase 
washed with water and brine, and dried with MgSO4. After filtration and evaporation 
under reduced pressure. The title compound was purified by flash column 













(Z,4R)-4-((1R)-1-Benzyloxy-penta-2,4-dienyl)-2,2-dimethyl-[1,3]dioxolane (4.69). Rf 
= 0.3, Hexane/EA = 10/1; colorless oil; 1H NMR (400 MHz, CDCl3): 7.36 – 7.24 (m, 
5H), 6.50 (dtd, J = 16.8, 10.0, 0.8 Hz, 1H), 6.31 (td, J = 11.2, 0.4 Hz, 1H), 5.36 – 5.28 
(m, 2H), 5.21 (d, J = 10.4 Hz, 1H), 4.67 (d, J = 12.4, 1H), 4.44 (d, J = 12.4 Hz, 1H), 4.32 
(ddd, J = 9.6, 6.8, 0.8 Hz, 1H), 4.22 (q, J = 6.4 Hz, 1H), 3.94 (dd, J = 8.8, 6.8 Hz, 1H), 
3.69 (dd, J = 10.0, 6.0 Hz, 1H), 1.39 (s, 3H), 1.36 (s, 3H). 13C NMR (75 MHz, CDCl3): 
138.1, 135.0, 131.7, 128.2, 127.9, 127.5, 127.2, 120.4, 109.8, 77.9, 74.9,69.9, 65.7, 26.5, 










(Z,4R)-4-((1S)-1-Benzyloxy-penta-2,4-dienyl)-2,2-dimethyl-[1,3]dioxolane (4.74). Rf = 
0.3, Hexane/EA = 10/1; a colorless oil; 1H NMR (400 MHz, CDCl3): 7.35 – 7.24 (m, 
5H), 6.54 (dt, J = 16.8, 11.0 Hz, 1H), 6.31 (t, J = 11.0 Hz, 1H), 5.43 (t, J = 10.2, 1H), 
5.31 (d, J = 16.4 Hz, 1H), 5.20 (d, J = 10.0 Hz, 1H), 4.61 (d, J = 12.0, 1H), 4.35 (d, J = 
12.0 Hz, 1H), 4.23 (dd, J = 9.2, 6.4 Hz, 1H), 4.12 (dd, J = 11.6, 6.4 Hz, 1H), 4.06 (dd, J = 
8.2, 6.2 Hz, 1H), 3.89 (dd, J = 8.4, 5.6 Hz, 1H), 1.39 (s, 3H), 1.33 (s, 3H). 13C NMR (75 
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MHz, CDCl3): 138.0, 134.8, 131.5, 128.4, 128.3, 127.9, 127.6, 120.1, 109.4, 77.5, 74.7, 
70.1, 66.7, 26.4, 25.1. HRMS Calcd. for C17H23O3 (M+1): 275.1647, Found: 275.1646. 
 
Representative Procedure for Site-Selective Oxidative Cleavage 
To a mixture of THF and water (11.7mL, 0.05M,THF:wate = 2.5:1), OsO4 (3.0 
mg, 5 mol%) and diene 4.69 (64.0 mg, 100 mol%) was added and then stirred for 5 
minutes. While the temperature of the stirred mixture was maintained at 24 – 26 °C, 
NaIO4 (110.0 mg, 220 mol%) was added in portions over a period of 40 minutes. The 
solution was stirred for an additional 2 hours. The mixture was extracted thoroughly with 
ether and the combined organic layers were dried with Na2SO4. The solvent was removed 
in vacuo, and then the title compound was purified by flash silical chromatography (Rf = 










(Z,4R)-4-Benzyloxy-4-((4R)-2,2-dimethyl-[1,3]dioxolan-4-yl)-but-2-enal (4.70). Rf = 
0.3, Hexane/EA = 4/1; colorless oil; 1H NMR (400 MHz, CDCl3): 9.89 (d, J = 8.0 Hz, 
1H), 7.34 – 7.24 (m, 5H), 6.47 (dd, J = 16.0, 8.8 Hz, 1H), 6.17 (dd, J = 11.6, 7.6 Hz, 1H), 
4.78 (dd, J = 9.2, 5.2 1H), 4.68 (d, J = 12.6 Hz, 1H), 4.48 (d, J = 12.0 Hz, 1H), 4.31 (q, J 
= 6.0, 1H), 3.99 (dd, J = 8.6, 7.0 Hz, 1H), 3.87 (dd, J = 9.0, 5.8 Hz, 1H), 1.33 (3, 3H), 
1.31 (m, 3H). 13C NMR (75 MHz, CDCl3): 191.0, 146.6, 137.1, 133.6, 128.5, 128.1, 
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(Z,4S)-4-Benzyloxy-4-((4R)-2,2-dimethyl-[1,3]dioxolan-4-yl)-but-2-enal (4.75). Rf = 
0.3, Hexane/EA = 4/1; colorless oil; 1H NMR (400 MHz, CDCl3): 9.93 (d, J = 8.0 Hz, 
1H), 7.36 – 7.26 (m, 5H), 6.48 (dd, J = 11.6, 8.8 Hz, 1H), 6.19 (ddd, J = 11.5, 7.5, 0.9 
Hz, 1H), 4.64 (d, J = 11.6, 1H), 4.61 (d, J = 8.8 Hz, 1H), 4.61 (q, J = 8.8, 1H), 4.43 (d, J 
= 11.6, 7.0 Hz, 1H), 4.15 – 4.07 (m, 1H), 3.94 – 3.89 (m, 1H), 1.36 (s, 3H), 1.31 (s, 3H). 
13C NMR (75 MHz, CDCl3): 190.7, 148.0, 136.9, 133.5, 128.6, 128.2, 127.9, 109.9, 76.5, 
75.0, 71.4, 67.1, 26.4, 24.8. HRMS Calcd. for C16H20O4 (M+1): 277.1440, Found: 
277.1437. 
 
Representative Procedure for the Oxidation of Enal to α,β-Unsaturated Ester 
To a solution of aldehyde 4.70 (37.9 mg, 0.137 mmol, 100 mol%) in MeOH (2.74 
mL, 0.05M) was added manganese dioxide (280 mg, 2.74 mmol, 20 eq.) and sodium 
cyanide (28.3 mg, 0.55 mmol, 400 mol%). The resulting suspension was stirred at room 
temperature for 3 hrs, filtered (Celite) and the filtrate was evaporated under reduced 
pressure. The residue was redissolved in water and extracted with ether. The combined 
organic extracts were dried with Na2SO4 and evaporated. The residue was purified by 
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flash silical chromatography (Rf = 0.3, Hexane/EA=6/1) to afford 39.1 mg of 4.71 as a 












(Z,4R)-4-Benzyloxy-4-((4R)-2,2-dimethyl-[1,3]dioxolan-4-yl)-but-2-enoic acid methyl 
ester (4.71). Rf = 0.3, Hexane/EA=6/1; colorless oil; 1H NMR (400 MHz, CDCl3): 7.31 – 
7.23 (m, 5H), 6.17 (dd, J = 12.0, 9.0 Hz, 1H), 5.99 (dd, J = 11.7, 0.9 Hz, 1H), 5.14 (ddd, 
J = 9.2, 5.2, 1.1 1H), 4.60 (d, J = 12.0 Hz, 1H), 4.58 (d, J = 12.1 Hz, 1H), 4.26 – 4.20 (m, 
1H), 3.97 – 3.87 (m, 2H), 3.68 (s, 3H), 1.40 (s, 3H), 1.34 (s, 3H). 13C NMR (75 MHz, 
CDCl3): 166.1, 146.2, 138.1, 128.2, 127.7, 127.6, 123.1, 109.8, 77.6, 74.4, 71.5, 65.3, 












(Z,4R)-4-Benzyloxy-4-((4R)-2,2-dimethyl-[1,3]dioxolan-4-yl)-but-2-enoic acid ethyl 
ester (4.72). Rf = 0.3, Hexane/EA=6/1; colorless oil; 1H NMR (400 MHz, CDCl3): 7.32 – 
7.22 (m, 5H), 6.15 (dd, J = 11.6, 9.2 Hz, 1H), 5.97 (d, J = 12.2 Hz, 1H), 5.13 (dd, J = 9.0, 
2.4 1H), 4.61 (d, J = 12.0 Hz, 1H), 4.47 (d, J = 12.0 Hz, 1H), 4.25 – 4.19 (m, 1H), 4.13 
(q, J = 7.2 Hz, 2H), 3.96 – 3.86 (m, 2H), 1.40 (s, 3H), 1.34 (s, 3H), 1.23 (t, J = 7.1Hz, 
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3H). 13C NMR (75 MHz, CDCl3): 166.5, 145.7, 138.1, 128.2, 127.8, 127.6, 123.6, 109.8, 













methyl ester (4.76). Rf = 0.3, Hexane/EA=6/1; colorless oil; 1H NMR (400 MHz, 
CDCl3): 7.33 – 7.25 (m, 5H), 6.16 (dd, J = 12.2, 9.0 Hz, 1H), 6.06 (dd, J = 11.6, 0.8 Hz, 
1H), 5.14 (ddd, J = 9.2, 5.6, 0.8, 1H), 4.57 (d, J = 12.4 Hz, 1H), 4.47 (d, J = 11.6 Hz, 
1H), 4.19 (q, J = 6.0 Hz, 1H), 4.03 (dd, J = 8.4, 5.6 Hz, 1H), 4.03 (dd, J = 8.4, 5.6 Hz, 
1H), 3.84 (dd, J = 8.6, 6.2 Hz, 1H), 3.68 (s, 3H), 1.37 (s, 3H), 1.32 (s, 3H). 13C NMR (75 
MHz, CDCl3): 166.0, 145.5, 137.9, 128.3, 127.9, 127.7, 123.8, 109.5, 74.4, 71.5, 66.3, 












(Z,4S)-4-Benzyloxy-4-((4R)-2,2-dimethyl-[1,3]dioxolan-4-yl)-but-2-enoic acid ethyl 
ester (4.77). Rf = 0.3, Hexane/EA=6/1; colorless oil;  1H NMR (400 MHz, CDCl3): 7.31 
– 7.25 (m, 5H), 6.15 (dd, J = 11.7, 8.7 Hz, 1H), 6.05 (d, J = 11.7 Hz, 1H), 5.15 (dd, J = 
9.0, 5.4 1H), 4.58 (d, J = 11.7 Hz, 1H), 4.46 (d, J = 12.0 Hz, 1H), 4.22 – 4.10 (m, 2H), 
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4.02 (dd, J = 8.4, 6.6 Hz, 1H), 3.85 (dd, J = 11.6, 5.9, 1H), 1.37 (s, 3H), 1.32 (s, 3H), 
1.24 (t, J = 7.2Hz, 3H). 13C NMR (75 MHz, CDCl3): 165.7, 145.2, 137.9, 128.3, 127.9, 
127.7, 125.3, 109.5, 77.4, 74.3, 71.4, 66.2, 60.4, 26.1, 25.2, 14.1. HRMS Calcd. for 
C16H20O4 (M): 321.1702, Found: 321.1698. 
 
Representative Procedure for cis-trans Isomerization of α,β-Unsaturated Ester 
To a solution of Z-ester 4.72 (31.5 mg, 0.098 mmol, 100 mol%) in t-BuOH (4.9 
mL, 0.05M) was added trimethylphosphine in toluene (39.2μL, 0.039, 40 mol%). The 
resulting solution was stirred at 35 oC for 12 hrs. t-BuOH was evaporated. The residue 
was purified by flash silical chromatography (Rf = 0.3, Hexane/EA=6/1) to afford 28.9 












(Z,4R)-4-Benzyloxy-4-((4R)-2,2-dimethyl-[1,3]dioxolan-4-yl)-but-2-enoic acid ethyl 
ester (4.73). Rf = 0.3, Hexane/EA=6/1; colorless oil; 1H NMR (400 MHz, CDCl3): 7.35 – 
7.25 (m, 5H), 6.82 (dd, J = 15.8, 6.2 Hz, 1H), 6.09 (d, J = 15.6 Hz, 1H), 4.67 (d, J = 12.0, 
1H), 4.46 (d, J = 12.0 Hz, 1H), 4.25 – 4.17 (m, 3H), 4.77 (t J = 6.4 Hz, 1H), 3.96 (dd, J = 
8.6, 6.6 Hz, 1H), 3.77 (dd, J = 8.6, 6.2 Hz, 1H), 1.37 (s, 3H), 1.32 (s, 3H), 1.28 (t, J = 7.0 
Hz, 3H). 13C NMR (75 MHz, CDCl3): 165.7, 143.3, 128.4, 127.8, 127.7, 124.4, 109.8, 
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(E,4S)-4-Benzyloxy-4-((4R)-2,2-dimethyl-[1,3]dioxolan-4-yl)-but-2-enoic acid ethyl 
ester (4.78). Rf = 0.3, Hexane/EA=6/1; a colorless oil; 1H NMR (400 MHz, CDCl3): 7.36 
– 7.25 (m, 5H), 6.89 (dd, J = 15.9, 6.0 Hz, 1H), 6.08 (dd, J = 15.9, 1.5 Hz, 1H), 4.63 (d, J 
= 11.4, 1H), 4.41 (d, J = 12.0 Hz, 1H), 4.20 (q, J = 7.1, 2H), 4.12 – 4.00 (m, 2H), 3.94 
(td, J = 6.3, 1.1 Hz, 1H), 3.87 (dd, J = 8.1, 5.1 Hz, 1H), 1.39 (s, 3H), 1.32 (s, 3H), 1.29 (t, 
J = 6.9 Hz, 3H). 13C NMR (75 MHz, CDCl3): 165.7, 143.3, 128.4, 127.8, 127.7, 124.4, 
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Chapter 5 Nucleophilic Catalysis via Phosphine Conjugate Addition 
5.1 BACKGROUND 
Organophosphorous compounds have been increasingly important in organic 
synthesis. Generally, phosphines serve as precursors to phosphonium ylides in the Wittig 
reaction,1 and as nucleophilic triggers in the Misunobu reaction.2 In these processes, the 
phosphine is stoichometrically consumed and converted into a phosphine oxide. 
Phosphines are also commonly used as ligands in transition metal catalysis to control 
reactivity and selectivity.3 Despite the long history of organophosphorous compounds as 
stoichiomeric reagents and ligands, the use of phosphines as nucleophilic catalysts was 
first introduced in 1963 by Rauhut and Currier.4 Recently, nucleophilic phosphine 
catalysis has received extensive attention in organic synthesis. For example, the 
phosphine-catalyzed Baylis-Hillman reaction is one of the most powerful methods for C-
C bond formation.5 As nucleophilic catalysts, phosphines should have the balance of 
nucleophilicity, leaving group ability, and the ability to stabilize an adjacent carbanion. It 
is well documented that triaryl phosphines are better nucleophiles than the corresponding 
amines. For example, the rate of the SN2 reaction of EtI with Et2PhP is over 500 times 
faster than with Et2PhN.6 Indeed, triakylphosphines have even better nucleophilicity than 
triaryl phosphines. In general, increasing leaving group ability is correlated with 
decreasing basicity. The pKa values of triethylphosphosphonium (HPEt3+) and 
triethylammonium (HNEt3+) are 8.7 and 10.7, respectively. These pKa values indicate 
that triethylphosphine is a better leaving group than triethylamine. Finally, phosphines 
have a special ability to stabilize the carbanion generated from nucleophilic addition to 
conjugated carbonyl compounds via an electrostatic interaction between the positive 
charge on phosphonium and the negative charge on the enolate oxygen. The combination 
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of these unique properties allow phosphines to act as both strong nucleophiles and good 
leaving groups, fulfilling the critical requirements for nucleophilic catalysts. 
The Krische group has been very interested in the development of catalytic 
systems for the nucleophilic activation of enones utilizing phosphine catalysts. Recently, 
an intramolecular variant of the Rauhut-Currier reaction was developed in our lab.7 To 
further extend nucleophilic phosphine catalysis, we have attempted to develop new 
catalytic transformations employing phosphines as catalysts. Here we report two new 
methodologies related to nucleophilic phosphine catalysis: (1) catalytic cycloallylation 
via nucleophilic phosphine catalysis and (2) allylic amination of Morita-Baylis-Hillman 
acetates.  
 
5.2 CATALYTIC CYCLOALLYLATION VIA NUCLEOPHILIC PHOSPHINE CATALYSIS 
5.2.1 Introduction 
Regioselective enolate generation via nucleophilic catalysis has been broadly 
utilized in organic chemistry. Additionally, the enolates generated via nucleophilic 
catalysis have been coupled to a diverse set of electrophilic partners, including carbonyl 
compounds and enones (Scheme 5.1).5 The classic example of such a transformation is 
the organocatalytic condensation of aldehydes with α,β-unsaturated carbonyl compounds. 
This reaction was first described by Morita in 1968;8 the methodology was later 























Scheme 5.1 Classic examples of nucleophilic phosphine catalysis. 
 
In addition, it has been well documented that preformed enolates can be coupled 
to allylic halides10 and “nonclassical” eletrophilic partners, such as metallo-π-allyl 
species.11 Indeed, metal-catalyzed allylation of enolates has been well studied by Trost 








90% yield  
Scheme 5.2 Coupling of a preformed enolate and nonclassical electrophile. 
 
In this regard, the compatibility of palladium-based and tertiary phosphine 
catalytic systems suggest the feasibility of catalytic enone allylation processes, whereby 
activation of latent nucleophilic (enone) and electrophilic (allyl carbonate) partners is 
achieved through phosphine catalysis and palladium-π-allyl formation, respectively. 
Herein, we report catalytic enone cycloallylation via concomitant activation of the latent 








R = CO2OMe or COMe
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Scheme 5.3 General strategy for catalytic cycloallylation. 
 
5.2.2 Optimization 
In order to access the proposed transformation, catalytic intramolecular 
cycloallylation of mono-enone mono-allylic acetate 5.1 was attempted using 
tributylphosphine and Pd(PPh3)4 as nucleophilic and electrophilic activators, respectively. 
Initial experiments performed in an aprotic medium using 10 mol% Pd(PPh3)4 and 50 
mol% PBu3 resulted in a poor yield of cycloallylation product 5.3 (Table 5.1, entry 1). It 
was postulated that capture of the metallo π-allyl intermediate would be facilitated if the 
transiently generated enolate were stabilized in a polar solvent.7 Accordingly, the use of 
tert-butyl alcohol as solvent increased the yield of 5.3 to 21 % at a reduced loading of 
Pd(PPh3)4 (Table 5.1, entry 2). When the loading of PBu3 was increased to 100 mol%, the 
yield increased to 67 % (Table 5.1, entry 3). Gratifyingly, when mono-enone mono-
allylic carbonate 5.2 was used as substrate instead of mono-enone mono-allylic acetate, 
the yield increased dramatically to 92 % (Table 5.1, entry 4). It was rationalized that 
either methoxy ion or methyl carbonate ion, generated in the palladium-π-allyl formation 
step, facilitated the β-elimination reaction to regenerate the phosphine catalyst, thus 
improving the yield. This enhanced yield was found to persist even at 1 mol% loading of 
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5.1, R = COCH3 5.3
5.2, R = CO2CH3
 
 
5.2.3 Preparation of substrates 
After optimization, a set of structurally diverse substrates was synthesized via 
concise synthetic pathways: (1) cross-metathesis using Grubbs-II,13 (2) Swern 














    DCM, -78oC, Et3N.
2. RCOCH=PPh3,






Overall Yield (step1 and 2)
5.5,   R = phenyl, 75%
5.6,   R = 2-naphthyl, 51%
5.7,   R = 2-furyl, 52%
5.8,   R = Methyl, 73%
5.9,   R = benzoyloxymethyl, 82%
5.10, R = cyclopropyl, 79%
5.11, R = ethoxy, 96%
5.12, R = thoethyl, 71%
5.5-5.12
 
Scheme 5.4 Preparation of substrates. 
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5.2.4 Substrate Scope 
With these substrates in hand, the scope of the catalytic cycloallylation was 
examined. Aromatic and heteroaromatic enone substrates 5.6 and 5.7 successfully 
participated in the reaction to provide the corresponding products 5.13 and 5.14 in 82% 
and 83% yield, respectively. Aliphatic enone substrates 5.8 and 5.9 (i.e. methyl and 
benzoyloxymethyl substituted enone) underwent cycloallylation to produce the 
cycloallylation products 5.15 and 5.16 in good yields. The cycloallylation of cyclopropyl 
substituted enone 5.10 is noteworthy, as cyclopropanes possessing adjacent π-
unsaturation are known to react readily with low-valent transition-metal complexes. 
However, cyclopropyl functionality was tolerated under the reaction conditions to 
provide the desired product 5.17 in 76% yield. Whereas enoate 5.11 provided only trace 
amounts of cycloallylation product 5.18, the corresponding thioenoate 5.12 was readily 
cyclized to produce the desired product 5.19 in 73 % yield. This result is consistent with 
enhanced performance of thioenoates in Morita-Baylis-Hillman-type cyclizations15 and is 
remarkable in view of the well-established susceptibility of thioesters to oxidative 
addition by low-valent palladium.16 Finally, the cycloallylation reaction extends to the 
formation of six-membered rings. Aromatic and aliphatic substituted enones provided 
six-membered cycloallyation products 5.20-5.22 in good yields. On the basis of the 
Thorpe-Ingold effect,17 it was assumed that conformationally predisposed substrates 
possessing geminal substitution would provide better yields. However, it turned out the 
Thorpe-Ingold effect was not applicable to this catalytic system since cycloallytion 




Table 5.2 Catalytic cycloallylation of mono-enone mono-allylic carbonate. 
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5.18, X = O  <5













5.2.5 Mechanistic Studies 
Based on our experimental data, a plausible catalytic mechanism was proposed. 
Our proposed mechanism arises from the combination of the nucleophilic features of the 
Morita-Baylis-Hillman reaction with the electrophilic features of the Trost-Tsuji reaction. 
The proposed catalytic cycle begins with the nucleophilic 1,4-addition of tributyl-
phosphine to mono-enone mono allylic acetate 5.1 to reversibly generate a zwitterionic 
enolate. This addition is accompanied by palladium-π-allyl formation to generate 
complex 5.23, which undergoes enolate alkylation to yield intermediate 5.24. Finally, β-
elimination assisted by acetate ion provides cycloallylation product 5.3 and regenerates 



























Scheme 5.5 Plausible catalytic cycle. 
 
 
5.3 REGIOSELECTIVE ALLIC AMINATION OF MORITA-BAYLIS-HILLMAN ACETATES  
5.3.1 Introduction 
The synthesis of β-amino acids18 has been of considerable interest, not only 
because they are useful precursors of β-peptides19 and β-lactams,19b,20 but also many β-
amino acids show antibiotic, antifungal, cytotoxic or other important biological properties 
in their free form or as part of peptidic products.21 The Morita-Baylis-Hillman (MBH) 
reaction with imine electrophiles has been utilized in the synthesis of β-amino acids. 
Recently, an alternative method exploring a two-step protocol for the amination of 
Morita-Baylis-Hillman acetates using stoichiometric DABCO was reported by Kim.22 In 
2002, Kim also reported the catalytic asymmetric allylic amination of Morita-Baylis-














entry Chiral amine (mol%) yield (%) % ee
1 (DHQD)2PHAL (10 mol%) 9 44
2 12 70(DHQD)2PHAL (50 mol%)  
Scheme 5.6 Kim’s asymmetric allylic amination using chiral amine. 
 
However, Kim’s protocol suffers from unsatisfactory chemical yields, and limited 
scope since only aryl substituted substrates participate. In order to overcome the 
limitations with tertiary amine-based regioselective allylic amination of Morita-Baylis-
Hillman acetates, we have attempted to apply nucleophilic phosphine catalysis to allylic 
amination reaction. Herein, we report the phosphine catalyzed regioselective allylic 
amination of Morita-Baylis-Hillman acetates.24 
 
5.3.2 Optimization 
In order to investigate the leaving group effect, compounds 5.25-5.28 were 
prepared and subjected to regioselective allylic amination. From this investigation, we 
found that the ΔpKa between the conjugate acid of the leaving group and the 
pronucleophile played a very important role in the allylic amination reaction. If the pKa 
of the conjugate acid of the leaving group is too low, the deprotonation of the 
pronucleophile is inefficient (Table 5.3, entries 1 and 2). Finally, slightly lower pKa of 
the conjugate acid of the leaving group and 4,5-dichlorophthalimide pronucleophile gave 
the optimum yield (Table 5.3, entry 6). 
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5.3.3 Substrate Scope 
Under the optimized reaction conditions, the scope of the catalytic allylic 
amination was examined with a set of structurally diverse substrates. In the case of enoate 
substrates 29-31, 4,5-dichlorophthalimide gave better yields than phthalimide due to the 
difference of pKa values between the conjugate acids of the leaving group and 
pronucleophile. However, in case of the enone substrates, the aryl substituted substrates 
32 and 33 were less sensitive to the pronucleophile due to the enhanced substrate 
electrophilicity. Interestingly, the alkyl substituted substrate 34 was sensitive to the 
pronucleophile, presumably resulting from the lower electrophilicity of alkyl substituted 
enone substrate compared to aryl substituted enones (Table 5.4).  
One of the great advantages of phosphine catalyzed allylic amination of Morita-
Baylis-Hillman acetates is the extension to β-substituted substrates. These substrates are 
not compatible with DABCO catalyst.22 For β-substituted α,β-unsaturated  carbonyl 
compounds, a more nucleophilic phosphine than triphenylphosphine is required, and 
trialkylphosphines were investigated.15 Upon exposure of the β-substituted substrates 
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5.35 and 5.36 to tributylphosphine catalyzed allylic amination reaction, we observed 
efficient conversion to give amination products 5.35b and 5.36b in good yield (Scheme 
5.7). 
 














5.29a, X=H    8%









5.31a, X=H  15 %a





5.30a, X=H  76%a







5.32a, X=H  91%





5.34a, X=H  20 %





5.33a, X=H  92%
5.33b, X=Cl  95%
4,5-Dichlorophthalimide 
or Phthalimide











5.35, X = O 60 oC 5.35b, 86 %
5.36, X = S 25 oC 5.36b, 71 %  
Scheme 5.7 Regioretentive allylic amination of cyclic MBH acetates. 
For substrates 5.35 and 5.36, the catalyzed and uncatalyzed imide addition would 
afford identical products. In order to identify the operative reaction manifold, deuterio-
5.35 was prepared and subjected to the optimized reaction conditions. Substitution was 
found to occur with 95:5 retention of regiochemistry, strongly supporting a reaction 




















Scheme 5.8 Deuterium labeling study. 
 
5.3.4 Mechanistic Studies 
Based on deuterium labeling studies and experimental data, a plausible catalytic 
mechanism was proposed. It is suggested that the allylic amination of Morita-Baylis-
Hillman acetates occurs through a successive SN2’-SN2’ mechanism. A nucleophilic 
tertiary phosphine undergoes 1,4-addition to the allylic substrate 5.36 followed by 
elimination of acetate anion via SN2’ type reaction to generate a quaternary phosphonium 
salt, which is stabilized by acetate anion to give an electrophile-leaving group ion-paired 
species 5.37. Acetate anion then activates the pronucleophile via acid-base reaction to 
generate an anionic nucleophile, followed by the formation of electrophile-nucleophile 
ion-pair to give intermediate 5.38. Finally, the anionic nucleophile undergoes a second 
SN2’ reaction to provide the allylic amination product 5.39 and regenerate the phosphine 
catalyst (Scheme 5.9).  
 
5.3.5 Deracemization of Morita-Baylis-Hillman Acetates 
To investigate the feasibility of Morita-Baylis-Hillman acetates deracemization, 
commercially available chiral phosphines were screened. As a result, (R)-Cl-MeO-
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BIPHEP under optimized conditions provided amination product 5.32a in 80 % yield as a 





























Scheme 5.9 Proposed catalytic cycle. 
 



















































5.4 SUMMARY AND CONCLUDING REMARKS 
We have shown that catalytic enone cycloallylation occurs via concomitant 
activation of latent nucleophilic and electrophilic partners. This cycloallylation is 
achieved through the use of a two-component catalyst system uniting the nucleophilic 
features of the Moria-Baylis-Hillman reaction with the electrophilic features of the Trost-
Tsuji reaction. In addition, we have demonstrated the first phosphine-catalyzed 
intermolecular allylic amination of Morita-Baylis-Hillman acetates. Furthermore, this 
methodology was extended to β-substituted systems which N-nucleophilic system (e.g. 
DABCO) cannot catalyze. Additionally, a deuterium labeling study strongly supports our 
proposed mechanism. Though a deracemization reaction did not provide a high ee, it 
suggests that deracemization is feasible with further optimization. Finally, the 
regioselective allylic amination of MBH acetates provides strong support for the 












5.5 EXPERIMENTAL SECTION 
5.5.1 General  
All reactions were run under an atmosphere of argon, unless otherwise indicated. 
Anhydrous solvents were transferred by an oven-dried syringe. Flasks were flame-dried 
and cooled under a stream of nitrogen. Dichloromethane (DCM) was distilled from 
calcium hydride. Analytical thin-layer chromatography (TLC) was carried out using 0.2-
mm commercial silica gel plates (DC-Fertigplatten Kieselgel 60 F254). Preparative 
column chromatography employing silica gel was performed according to the method of 
Still. Solvents for chromatography are listed as volume/volume ratios. Infrared spectra 
were recorded on a Perkin-Elmer 1600 spectrometer. High-resolution mass spectra 
(HRMS) were obtained on a Karatos MS9 and are reported as m/z (relative intensity). 
Accurate masses are reported for the molecular ion (M + 1) or a suitable fragment ion. 
Proton nuclear magnetic resonance (1H-NMR) spectra were recorded with a Varian 
Gemini (400 MHz or 300MHz) spectrometer. Chemical shifts are reported in delta (δ) 
units, parts per million (pip) downfield from trimethylsilane. Coupling constants are 
reported in Hertz (Hz). Carbon-13 nuclear magnetic resonance (13C-NMR) spectra were 
recorded with a Varian Gemini 400 (100 MHz) spectrometer. Chemical shifts are 
reported in delta (δ) units, ppm relative to the center of the triplet at 77.0 ppm for 
deuteriochloroform. 13C NMR spectra were routinely run with broadband decoupling. 
Enantiomeric purity was determined using a Varian Pro Star HPLC equipped with 
Chiralcel OD column, eluting with 15% isopropanol in hexane. 
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5.5.2 Catalytic Enone Cycloallylation 











To a degassed solution of bis(tricyclohexylphosphine)benzylidine ruthenium (IV) 
dichloride (Grubbs second-generation catalyst) (250 mg, 0.29 mmol, 0.27 mol%) in 
CH2Cl2 (460 mL) was added 4-penten-1-ol (10 g, 116 mmol, 110 mol%) and allyl methyl 
carbonate (12g, 106 mmol, 100 mol%). The reaction was allowed to stir at reflux for 12 
hours. The solvent was evaporated in vacuo and the reaction was purified via flash 
chromatography (7:3 Haxane:EtOAc) to provide the allylic carbonate (11.6 g, 64 %) as a 
yellow oil, with an alkene isomer ratio of 6:1. This ratio varied from 4:1-10:1. Spectral 





Carbonic acid 6-hydroxy-hex-2-enyl ester methyl ester. 1H NMR (400 MHz, CDCl3): 
5.75 (dt, J = 15.4, 6.7 Hz, 1H), 5.54 (dtt, J = 15.4, 6.5, 1.5 Hz, 1H), 4.49 (dd, J = 1.0, 6.5 
Hz, 2H), 3.69 (s, 3H), 3.52 (q, J = 5.9 Hz, 2H), 2.51 (t, J = 5.0 Hz, 1H), 2.07 (q, J = 7.2 
Hz, 2H), 1.57 (dt, J = 14.7, 6.7 Hz, 2H). 13C NMR (100 MHz, CDCl3): 155.5, 136.3, 
123.5, 68.3, 61.7, 54.5, 31.4, 28.3. HRMS Calcd. for C8H14O4 (M+1): 175.0970, Found: 
175.0974. FTIR (neat): 3375, 2941, 1747, 1445, 1259, 942, 793 cm-1. 
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A stirred solution of oxalyl chloride (1.4 mL, 13.8 mmol, 120 mol%) in CH2Cl2 
(50 mL, 0.28 M) was cooled to -78 oC in a dry ice-acetone bath. To this solution was 
added a solution of DMSO (2.0 mL, 27.6 mmol, 240 mol%) in CH2Cl2 (25 mL) at -78 oC. 
The reaction was allowed to stir for 15 minutes. To the reaction was added a solution of 
the allylic carbonate (2.0 g, 11.5 mmol, 100 mol%) in CH2Cl2 (25 mL) at -78 oC. The 
final reaction concentration was 0.11 M with respect to allylic carbonate. The reaction 
was allowed to stir for 45 minutes in -78 oC. Neat triethylamine (8 ml, 58 mmol, 500 
mol%) was added and the reaction was allowed to stir at -78 oC for 10 minutes, followed 
by warming to room temperature. The reaction mixture was washed with ammonium 
chloride, water, and brine successively and then dried over sodium sulfate and 
concentrated in vacuo. CHCl3 (100 mL, 0.1 M in 1a’) and 1-phenyl-2-(triphenyl)-λ5-
phosphanylidene)-ethanone (8.7g, 23.0 mmol, 200 mol%) was added. The reaction was 
heated to reflux and allowed to stir for 12 hours. The solvent was evaporated in vacuo 
and the residue was purified by flash chromatography (7:3 Hexane:EtOAc) to afford 2.4 
g (75 % over two steps) of 5.5 as colorless oil. This substrate was isolated as a 4:1 






This substrate was isolated as a 4:1 mixture of alkene isomers at the position of the allylic 
carbonate. Spectral data for the major isomer is reported. 
 
Carbonic acid methyl ester 8-oxo-8-phenyl-octa-2,6-dienyl ester (5.5). 1H NMR (400 
MHz, CDCl3): 7.91 (dd, J = 8.2, 1.0 Hz, 2H), 7.54 (td, J = 7.4, 1.4 Hz, 1H), 7.46 (t, J = 
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7.7 Hz, 2H), 7.01 (dt, J = 15.4, 6.8 Hz, 1H), 6.88 (d, J = 15.4 Hz, 1H), 5.83 (dt, J = 15.4, 
6.5 Hz, 1H), 5.66 (dt, J = 14.4, 6.3 Hz, 1H), 4.57 (d, J = 6.5 Hz, 2 H), 3.75 (s, 3H), 2.42 
(dt, J = 7.9, 6.7 Hz, 2H), 2.30 (dt, J = 7.2, 7.0 Hz, 2H). 13C NMR (100 MHz, CDCl3): 
190.9, 155.8, 148.5, 138.1, 135.4, 132.9, 128.8, 126.7, 124.8, 68.5, 63.6, 55.0, 32.6, 32.2, 
30.9, 26.4. HRMS Calcd. for C16H18O4 (M+1): 275.1283, Found: 275.1271. FTIR (neat): 






This substrate was isolated as a 4:1 mixture of alkene isomers at the position of the allylic 
carbonate. Spectral data for the major isomer is reported. 
Carbonic acid methyl ester 8-naphthalen-2-yl-8-oxo-octa-2,6-dienyl ester (5.6). 1H 
NMR (400 MHz, CDCl3): 8.43 (s, 1H), 8.04-7.96 (m, 2H), 7.93-7.86 (m, 2H), 7.58 (dtd, 
J = 19.3, 7.4, 1.4 Hz, 2H), 7.07 (d, J = 4.5 Hz, 2H), 5.85 (dtt, J = 15.4, 6.5, 1.0 Hz, 1H), 
5.70 (dtt, J = 15.4, 6.3, 1.4 Hz, 1H), 4.60 (dd, J = 6.2, 1.0 Hz, 2.0H), 3.76 (s, 3H), 2.47 
(dtd, J = 7.2, 5.6, 1.7, 2H), 2.34 (dtd, J = 7.2, 5.6, 1.7 Hz, 2H). 13C NMR (100 MHz, 
CDCl3): 190.3, 155.5, 148.4, 135.3, 135.1, 135.0, 132.4, 129.9, 129.4, 128.4, 128.2, 
127.7, 126.6, 126.3, 124.45, 124.38, 68.1, 54.6, 31.9, 30.7. HRMS Calcd. for C20H20O4 








This substrate was isolated as a 4:1 mixture of alkene isomers at the position of the allylic 
carbonate. Spectral data for the major isomer is reported.  
Carbonic acid 8-furan-2-yl-8-oxo-octa-2,6-dienyl ester methyl ester (5.7). 1H NMR 
(300 MHz, CDCl3): 7.62 (dd, J = 1.4, 0.6 Hz, 1H), 7.24 (dd, J = 3.5, 0.8 Hz, 1H), 7.12 
(dt, J = 15.4, 6.7 Hz, 1H), 6.81 (dt, J = 15.4, 1.5 Hz, 1H), 6.56 (dd, J = 3.5, 1.7 Hz, 1H), 
5.83 (dtt, J = 15.7, 6.2, 1.0 Hz, 1H), 5.66 (dtt, J = 15.6, 6.2, 1.1 Hz, 1H), 4.58 (dd, J = 
5.9, 1.1 Hz, 2H), 3.78 (s, 3H), 2.40 (dtd, J = 14.3, 7.2, 1.4 Hz, 2H), 2.31 (dtd, J = 13.7, 
7.0, 1.4 Hz, 2H). 13C NMR (100 MHz, CDCl3): 178.2, 155.8, 153.5, 147.7, 146.8, 135.4, 
125.6, 124.8, 117.8, 112.6, 68.5, 55.0, 32.1, 30.9. HRMS Calcd. for C14H16O5 (M+1): 





This substrate was isolated as a 61 mixture of alkene isomers at the position of the allylic 
carbonate. Spectral data for the major isomer is reported. 
Carbonic acid methyl ester 8-oxo-nona-2,6-dienyl ester (5.8). 1H NMR (300 MHz, 
CDCl3 ): 6.68-6.59 (m, 1H), 5.96-5.90 (td, J = 1.35, 16.2 Hz, 1H), 5.54-5.47 (m, 1H), 
4.43 (dd, J = 0.9, 6.3 Hz, 2H), 3.63 (s, 3H), 2.21-2.10 (m, 4H), 2.09 (s, 3H). 13C NMR 
(75 MHz, CDCl3): 198.5, 155.7, 147.0, 135.1, 131.9, 124.8, 68.3, 54.8, 31.7, 30.7, 27.0. 
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HRMS: Calcd. for C11H16O4(M+1): 213.1127, Found: 213.1125. FTIR (neat): 2957, 






This substrate was isolated in >95% alkene isomeric purity. 
Benzoic acid 9-methoxycarbonyloxy-2-oxo-nona-3,7-dienyl ester (5.9). 1H NMR (400 
MHz, CDCl3): 8.08 (dd, J = 7.9, 1.4 Hz, 2H), 7.56 (t, J = 7.5 Hz, 1H), 7.43  (t, J = 7.7 
Hz, 2H), 6.94 (td, J = 16.1, 6.8 Hz, 1H), 6.22 (d, J = 16.1 Hz, 1H), 5.76 (dt, J = 15.4, 6.5 
Hz, 1H), 5.61 (dt, J = 15.4, 6.3 Hz, 1H), 5.03 (s, 2H), 4.54 (dd, J = 6.5, 0.7 Hz, 2H), 3.74 
(s, 3H), 2.33 (dt, J = 7.9, 6.7 Hz, 2H), 2.22 (dt, J = 7.5, 6.8 Hz, 2H). 13C NMR (100 MHz, 
CDCl3): 192.1, 155.4, 147.7, 134.6, 133.2, 129.7, 129.2, 128.3, 126.2, 124.6, 68.0, 67.3, 
54.6, 31.7, 30.3. HRMS Calcd. for C18H20O6 (M+1): 333.1338, Found: 333.1340. FTIR 




This substrate was isolated as a 10:1 mixture of alkene isomers at the position of the 
allylic carbonate. Spectral data for the major isomer is reported. 
Carbonic acid 8-cyclopropyl-8-oxo-octa-2,6-dienyl ester methyl ester (5.10). 1H NMR 
(300 MHz, CDCl3 ): 6.85-6.77 (m, 1H), 6.18 (td, J = 1.43, 15.6 Hz, 1H), 5.81-5.74 (m, 
1H), 5.63-5.58 (m, 1H), 4.54 (dd, J = 0.75, 6.15 Hz, 2H), 3.74 (s, 3H), 2.32-2.21 (m, 4H), 
 339
2.10-2.05 (m, 1H), 1.10-1.01 (m, 2H), 0.89-0.83 (m, 2H). 13C NMR (75 MHz, CDCl3): 
200.0, 155.5, 145.2, 135.1, 130.8, 124.4, 68.2, 54.7, 31.5, 30.6, 18.7, 11.0. HRMS: Calcd. 
for C13H18O4 (M+1): 239.1283, Found: 239.1275. FTIR (neat): 3009, 2956, 1749, 1683, 






This substrate was isolated in >95% alkene isomeric purity. 
8-Methoxycarbonyloxy-octa-2,6-dienoic acid ethyl ester (5.11). 1H NMR (300 MHz, 
CDCl3): 6.88 (dt, J = 15.6, 6.5 Hz, 1H), 5.81-5.71 (m, 2H), 5.59 (dtt, J = 15.6, 6.2, 1.3 
Hz, 1H), 4.52 (dd, J = 6.3, 0.9 Hz, 2H), 4.13 (q, J = 7.2 Hz, 2H), 3.73 (s, 3H), 2.29-2.18 
(m, 4H), 1.23 (t, J = 7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3): 166.3, 155.5, 147.6, 
134.9, 124.4, 121.8, 68.1, 60.1, 54.6, 31.2, 30.4, 14.1. HRMS: Calcd. for 






This substrate was isolated as a 9:1 mixture of alkene isomers at the position of the allylic 
carbonate. Spectral data for the major isomer is reported. 
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8-Methoxycarbonyloxy-octa-2,6-dienethioic acid S-ethyl ester (5.12). 1H NMR (300 
MHz, CDCl3 ): 6.88-6.81 (m, 1H), 5.78-5.71 (m, 2H), 5.58-5.53 (m, 1H), 4.50 (dd, J = 
0.9, 6.3 Hz, 2H), 4.00 (q, J = 7.2 Hz, 2H), 3.70 (s, 3H), 2.25-2.15 (m, 4H), 1.21 (t, J = 7.1 
Hz, 3H). 13C NMR (75 MHz, CDCl3): 166.7, 155.8, 147.9, 135.3, 124.7, 122.1, 66.4, 
60.4, 54.9, 31.5, 30.7, 14.4. HRMS: Calcd. for C12H18O4S(M+1): 259.1004, Found: 





This substrate was isolated as a 6:1 mixture of alkene isomers at the position of the allylic 
carbonate. Spectral data for the major isomer is reported. 
Carbonic acid methyl ester 9-oxo-9-phenyl-nona-2,7-dienyl ester (5.5a). 1H NMR 
(300 MHz, CDCl3 ): 7.91-7.87 (m, 2H), 7.54-7.39 (m, 3H), 7.03-6.96 (m, 1H), 6.88-6.82 
(m, 1H), 5.82-5.72 (m, 1H), 5.62-5.52 (m, 1H), 4.54 (dd, J = 0.75, 6.45 Hz, 2H), 3.73 (s, 
3H), 2.32-2.25 (m, 2H), 2.19-2.04 (m, 2H), 1.64-1.54 (m, 2H). 13C NMR (75 MHz, 
CDCl3): 190.6, 155.5, 149.0, 136.0, 132.5, 128.4, 128.4, 126.1, 126.1, 124.0, 68.3, 54.6, 
40.0, 31.5, 27.1. HRMS: Calcd. for C17H20O4 (M+1): 289.1440, Found: 289.1431.FTIR 
(neat): 2935, 1748, 1670, 1621, 1447 cm-1. 
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Representative Procedure for Catalytic Enone Cycloallyliation 
A solution of mono-enone mono-allylic carboneate 5.2 (0.39 mmol, 100 mol%) in 
t-BuOH (4 mL, 0.1 M) was degassed under vacuum in a sonicator. To this solution was 
added Pd(PPh3)4 (18 mg, 0.016 mmol, 1 mol%) and tributylphosphine (0.97 mL, 0.39 
mmol, 100 mol%). The reaction was heated to 60 oC and allowed to stir for 5 hours at 60 
oC. The solvent was evaporated in vacuo and the reaction was purified by flash 




Phenyl-(5-vinyl-cyclopent-1-enyl)-methanone (5.3). 1H NMR (300 MHz, CDCl3): 
7.79-7.75 (m, 2H), 7.56-7.49 (m, 1H), 7.46-7.40 (m, 2H), 6.51 (dt, J = 2.6, 1.7 Hz, 1H), 
5.91 (ddd, J = 17.1, 10.1, 7.3 Hz, 1H), 5.10 (dd, J = 17.2, 1.4 Hz, 1H), 4.99 (ddd, J = 
10.3, 1.5, 0.9 Hz, 1H), 3.87 (q, J = 6.7 Hz, 1H), 2.75-2.62 (m, 1H), 2.58-2.45 (m, 1H), 
2.33-2.21 (m, 1H), 1.92-1.82 (m, 1H). 13C NMR (75 MHz, CDCl3): 193.9, 146.3, 140.0, 
139.1, 132.2, 129.2, 128.4, 114.4, 48.7, 32.9, 30.4. HRMS Calcd. for C14H14O (M+1): 







Naphthalen-2-yl-(5-vinyl-cyclopent-1-enyl)-methanone (5.13). 1H NMR (400 MHz, 
CDCl3): 8.28 (d, J = 0.7 Hz, 1H) 7.94 (dd, J = 8.2, 1.4 Hz, 1H), 7.91-7.86 (m, 3H), 7.56 
(dtd, J = 18.0, 6.8, 1.5 Hz, 2H), 6.58 (dt, J = 2.6, 1.7 Hz, 1H), 5.15 (dt, J = 17.1, 1.4 Hz, 
1H), 5.02 (dt, J = 10.3, 1.2 Hz, 1H), 3.94 (q, J = 7.2 Hz, 1H), 2.78-2.68 (m, 1H), 2.60-
2.51 (m, 1H), 2.37-2.27 (m, 1H), 1.97-1.88 (m, 1H). 13C NMR (100 MHz, CDCl3): 193.8, 
146.5, 146.3, 140.0, 136.3, 135.4, 132.6, 130.6, 129.5, 128.4, 128.2, 128.0, 126.9, 125.4, 
114.5, 48.9, 33.0, 30.4. HRMS Calcd. for C18H16O (M+1): 249.1279, Found: 249.1269. 





Furan-2-yl-(5-vinyl-cyclopent-1-enyl)-methanone (5.14). 1H NMR (400 MHz, CDCl3): 
7.58 (d, J = 0.7 Hz, 1H), 7.16 (dd, J = 4.1, 0.7 Hz, 1H), 7.00 (dd, J = 4.1, 2.4 Hz, 1H), 
6.51 (dt, J = 2.1, 1.7 Hz, 1H), 5.86 (ddd, J = 17.1, 10.1, 7.5 Hz, 1H), 5.06 (dd, J = 17.1, 
1.4 Hz, 1H), 4.95 (d, J = 10.3 Hz, 1H), 3.86 (q, J = 6.2 Hz, 1H), 2.72-2.62 (m, 1H), 2.59-
2.49 (m, 1H), 2.26-2.16 (m, 1H), 1.86-1.77 (m, 1H). 13C NMR (100 MHz, CDCl3): 179.5, 
153.4, 146.3, 145.4, 145.3, 139.9, 118.3, 114.3, 112.2, 48.5, 33.0, 30.1. HRMS Calcd. for 
C12H12O2 (M+1): 189.0916, Found: 189.0910. FTIR (neat): 3133, 2942, 1637, 1564, 





1-(5-Vinyl-cyclopent-1-enyl)-ethanone (5.15). 1H NMR (300 MHz, CDCl3 ): 6.77-6.75 
(m, 1H), 5.88-5.77 (m, 2H), 5.03-4.91 (m, 1H), 3.61-3.58 (m, 1H), 2.61-2.47 (m, 2H), 
2.28 (s, 3H), 2.19-2.07 (m, 1H), 1.85-1.76 (m, 1H). 13C NMR (75 MHz, CDCl3): 196.1, 
147.4, 144.8, 139.8, 113.4, 46.7, 32.0, 30.4, 27.1. HRMS: Calcd. for C9H12O (M+1): 






Benzoic acid 2-oxo-2-(5-vinyl-cyclopent-1-enyl)-ethyl ester (5.16). 1H NMR (400 
MHz, CDCl3): 8.10 (dd, J = 7.2, 0.7 Hz, 2H), 7.57 (dt, J = 7.4, 0.7 Hz, 1H), 7.45 (t, J = 
7.7 Hz, 1H), 6.92 (t, J = 2.4 Hz, 1H), 5.84 (ddd, J = 17.1, 10.1, 7.5 Hz, 1H), 5.21 (ddd, J 
= 59.2, 15.9, 0.7 Hz, 2H), 5.07 (d, J = 17.1 Hz, 1H), 5.00 (dt, J = 10.3, 0.7 Hz, 1H), 3.70 
(q, J = 1.4 Hz, 1H), 2.70-2.59 (m, 1H), 2.58-2.49 (m, 1H), 2.24-2.13 (m, 1H), 1.88-1.80 
(m, 1H). 13C NMR (100 MHz, CDCl3): 190.0, 166.0, 144.9, 144.0, 139.3, 133.2, 129.9, 
129.4, 128.4, 114.2, 66.4, 47.3, 32.4, 30.0. HRMS Calcd. for C16H16O3 (M+1): 257.1178, 





Cyclopropyl-(5-vinyl-cyclopent-1-enyl)-methanone (5.17). 1H NMR (300 MHz, CDCl3 
): 6.89-6.86 (m, 1H), 5.89-5.77 (m, 1H), 5.03-4.91 (m, 2H), 3.63-3.61 (m, 1H), 2.60-2.47 
(m, 2H), 2.33-2.26 (m, 1H), 2.22-2.11 (m, 1H), 1.85-1.62 (m, 1H), 1.05-1.00 (m, 2H), 
0.86-0.80 (m, 2H). 13C NMR (75 MHz, CDCl3): 198.2, 147.7, 143.6, 140.1, 113.4, 47.3, 
32.1, 30.4, 17.7, 10.9, 10.6. HRMS: Calcd. for C11H14O (M+1): 163.1123, Found: 





5-Vinyl-cyclopent-1-enecarbothioic acid S-ethyl ester (5.19). 1H NMR (300 MHz, 
CDCl3 ): 6.83-6.81 (m, 1H), 5.86-5.75 (m, 1H), 5.08-4.95 (m, 2H), 3.68-3.64 (m, 1H), 
2.94-2.83 (m, 2H), 2.53-2.42 (m, 2H), 2.24-2.11 (m, 1H), 1.84-1.75 (m, 1H), 1.24 (t, J = 
7.5 MHz, 3H). 13C NMR (75 MHz, CDCl3): 188.8, 146.0, 142.6, 139.4, 114.2, 47.9, 31.7, 
30.7, 22.9, 14.8. HRMS: Calcd. for C10H14OS (M+1): 183.0844, Found: 184.0839. FTIR 







Phenyl-(6-vinyl-cyclohex-1-enyl)-methanone (5.20). 1H NMR (300 MHz, CDCl3 ): 
7.69-7.66 (m, 2H), 7.51-7.36 (m, 3H), 6.5 (t, J = 4.05 Hz, 1H), 5.90-5.79 (m, 1H), 5.02-
4.94 (m, 2H), 3.6 (s, 1H), 2.35-2.11 (m, 2H), 1.80-1.61 (m, 4H). 13C NMR (75 MHz, 
CDCl3): 197.3, 143.51, 140.3, 140.1, 138.6, 131.6, 129.3, 128.0, 115.1, 36.3, 27.5, 26.1, 
17.6. HRMS: Calcd. for C15H16O (M+1): 213.1279, Found: 213.1276. FTIR (neat): 2934, 












5.5.3 Regioselective Allylic Amination of MBH Acetates 
Representative Procedure for Phosphine Catalyzed Allylic Amination of Morita-
Baylis-Hillman Acetate 
To a THF solution (1.6 mL, 0.3 M) of Morita-Baylis-Hillman acetate (0.5 mmol, 
100 mol%) and phthalimide (1.0 mmol, 200 mol%) was added PPh3 (0.1 mmol, 20 
mol%) under Ar. The reaction mixture was stirred at ambient temperature until complete 
consumption of starting material, at which point the reaction mixture was evaporated 









yl ester (5.29a). 1H NMR (400 MHz, CDCl3): 8.23-8.19 (m, 2H), 7.87-7.83 (m, 2H), 
7.78-7.74 (m, 2H), 7.63-7.60 (m, 2H), 6.64 (d, J = 1.5 Hz, 1H), 6.52 (s, 1H), 5.67 (d, J = 
1.5 Hz, 1H), 3.72(s, 3H). 13C NMR (100 MHz, CDCl3): 167.5, 165.5, 147.6, 144.0, 
136.3, 134.4, 131.5, 129.8, 129.6, 123.8, 123.6, 53.7, 52.4. HRMS Calcd. for 
C19H15N2O6(M+1) 367.093011, found 367.091940. FTIR (neat): 3081, 2953, 1722, 1608, 











acrylic acid methyl ester (5.29b). 1H NMR (400 MHz, CDCl3): 8.23-8.20 (m, 2H), 7.93 
(d, J = 0.6 Hz, 2H), 7.60-7.57 (m, 2H), 6.63 (d, J = 1.2 Hz, 1H), 6.46 (s, 1H), 5.62 (d, J = 
1.8 Hz, 1H), 3.73 (d, J = 0.6 Hz, 3H). 13C NMR (100 MHz, CDCl3): 165.7, 165.4, 147.7, 
143.5, 139.5, 135.9, 130.5, 130.2, 129.6, 125.7, 123.9, 54.2, 52.4. HRMS Calcd. for 
C19H13N2O6Cl2 (M+1): 435.015067, found 435.014595. FTIR (neat): 3095, 2925, 1723, 






2-[(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-phenyl-methyl]-acrylic acid methyl ester 
(5.30a). 1H NMR (400 MHz, CDCl3): 7.85-7.79 (m, 2H), 7.72-7.68 (m, 2H), 7.45-7.43 
(m, 2H), 7.37-7.26 (m, 3H), 6.56 (s, 1H), 6.40 (s, 1H), 5.63 (d, J = 1.8 Hz, 1H), 3.70 (d, J 
= 0.9 Hz, 3H). 13C NMR (100 MHz, CDCl3): 167.8, 166.0, 137.4, 136.9, 133.9, 131.7, 
129.5, 128.5, 128.0, 123.3, 54.5, 52.1. HRMS Calcd. for C19H16NO4 (M+1): 322.1079, 
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Found: 322.1086. FTIR (neat): 3064, 2952, 1770, 1727, 1632, 1386, 1356, 1331, 1265, 








methyl ester (3.30b). 1H NMR (400 MHz, CDCl3): 7.90 (d, J = 0.9 Hz, 2H), 7.43-7.28 
(m, 5H), 6.56 (d, J = 1.5 Hz, 1H), 6.32 (s, 1H), 5.59 (d, J = 2.1 Hz, 1H), 3.70 (s, 3H). 13C 
NMR (100 MHz, CDCl3): 165.9, 165.9, 138.9, 137.0, 136.5, 130.8, 130.0, 128.7, 128.5, 
128.3, 125.4, 55.1, 52.2. HRMS Calcd. for C19H14NO4Cl2 (M+1): 390.0300, Found: 
390.0300. FTIR (neat): 3032, 2953, 1779, 1722, 1438, 1382, 1354, 1265, 1191, 1143, 






3-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-2-methylene-hexanoic acid methyl ester 
(5.31a). 1H NMR (400 MHz, CDCl3): 7.85-7.79 (m, 2H), 7.74-7.67 (m, 2H), 6.53 (s, 1H), 
6.08 (d, J = 1.5 Hz, 1H), 5.29-5.23 (m, 1H), 3.71 (s, 3H), 2.37-2.29 (m, 1H), 1.98-1.84 
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(m, 1H), 1.40-1.25 (m, 2H), 0.94 (t, J = 7.5 Hz, 3H). 13C NMR (100 MHz, CDCl3): 
168.0, 166.3, 137.5, 133.8, 131.7, 128.0, 123.1, 52.0, 49.3, 31.9, 19.6, 13.5. HRMS 
Calcd. for C16H18NO4 (M+1): 288.1236, Found: 288.1249. FTIR (neat): 2959, 2931, 








methyl ester (5.31b). 1H NMR (400 MHz, CDCl3): 7.89 (s, 2H), 6.54 (s, 1H), 6.08 (d, J 
= 1.2 Hz, 1H), 5.24-5.19 (m, 1H), 3.70 (s, 3H), 2.37-2.21 (m, 1H), 1.95-1.84 (m, 1H), 
1.37-1.25 (m, 2H), 0.94(t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3): 166.1, 165.9, 
138.8, 136.9, 130.8, 128.5, 125.3, 52.0, 49.7, 31.7, 19.5, 13.5. HRMS Calcd. for 
C16H16NO4Cl2 (M+1): 356.0456, Found: 356.0456. FTIR (neat): 3096, 2960, 2874, 1778, 
1723, 1633, 1439, 1377, 1297, 1195, 1141, 1086, 961, 911, 815, 776, 745, 633, 602 cm-1. 










2-[2-Methylene-1-(4-nitro-phenyl)-3-oxo-butyl]-isoindole-1,3-dione (5.32a). 1H NMR 
(400 MHz, CDCl3): 8.19 (d, J = 11.6 Hz, 2H), 7.81 (dd, J = 7.2, 2.0 Hz, 2H), 7.71 (dd, J 
= 7.2, 2.0 Hz, 2H), 7.54 (d, J = 11.6 Hz, 2H), 6.50 (s, 1H), 6.41 (s, 1H), 5.74 (s, 1H), 2.40 
(s, 3H). 13C NMR (100 MHz, CDCl3): 197.7, 167.7, 147.5, 145.0, 144.6, 134.4, 131.5, 
129.5, 123.8, 123.6, 53.1, 26.0. HRMS Calcd. for C19H15N2O5 (M+1): 351.0981, Found: 
351.0981. FTIR (neat): 3081, 1772, 1716, 1680, 1606, 1521, 1384, 1348, 1107, 1086, 










(5. 32b). 1H NMR (400 MHz, CDCl3): 8.19 (d, J = 8.2 Hz, 2H), 7.88 (s, 2H), 7.52 (d, J = 
8.8 Hz, 2H),6.42 (dd, J = 5.0, 1.2 Hz, 2H), 5.68 (s, 1H), 2.39 (s, 3H). 13C NMR (100 
MHz, CDCl3): 197.7, 169.9, 147.7, 144.7, 144.1, 139.4, 130.6, 129.8, 129.5, 125.7, 
124.0, 53.6, 25.9. HRMS Calcd. for C19H13N2O5Cl2 (M+1): 419.0201, Found: 419.0190. 
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FTIR (neat): 3094, 1779, 1719, 1679, 1603, 1523, 1345, 1102, 909, 868, 736 cm-1. MP : 






3,4-Dimethyl-1-(2-methylene-3-oxo-1-phenyl-butyl)-pyrrole-2,5-dione (5.33a). 1H 
NMR (400 MHz, CDCl3): 7.77 (dd, J = 5.2, 3.2 Hz, 2H), 7.65 (dd, J = 5.6, 3.2 Hz, 2H), 
7.38 – 7.24 (m, 5H), 6.35 (d, J = 1.6 Hz, 1H), 6.32 (d, J = 1.6 Hz, 1H), 5.67 (d, J = 2.0 
Hz, 1H), 2.37 (s, 3H). 13C NMR (100 MHz, CDCl3): 198.3, 168.0, 146.3, 137.4, 133.9, 
131.7, 129.0, 128.6, 128.5, 128.0, 123.3, 53.9, 26.1. HRMS Calcd. for C19H16NO3 (M+1): 
306.1130, Found: 306.1129. FTIR (neat): 3062, 1769, 1714, 1679, 1387, 1360, 1330, 







5,6-Dichloro-2-(2-methylene-3-oxo-1-phenyl-butyl)-isoindole-1,3-dione (5.33b). 1H 
NMR (400 MHz, CDCl3): 7.85 (s, 2H), 7.34 – 7.29 (m, 5H), 6.33 (d, J = 1.6 Hz, 1H), 
6.28 (t, J = 1.8 Hz, 1H), 5.65 (d, J = 1.6 Hz, 1H), 2.37 (s, 3H). 13C NMR (100 MHz, 
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CDCl3): 198.3, 166.1, 145.9, 138.9, 137.0, 130.9, 129.6, 128.8, 128.5, 128.2, 125.4, 54.5, 
26.0. HRMS Calcd. for C19H14NO3Cl2 (M+1): 374.0351, Found: 374.0359. FTIR (neat): 






2-(2-Methylene-3-oxo-1-propyl-butyl)-isoindole-1,3-dione (5.34a). 1H NMR (400 
MHz, CDCl3): 7.82 – 7.68 (m, 2H), 7.71 – 7.68 (m, 2H), 6.34 (s, 1H), 6.26 (d, J = 0.8 Hz, 
1H), 5.34 (dd, J = 5.2, 4.8 Hz, 1H), 2.33 (s, 3H), 2.30 – 2.22 (m, 1H), 1.86 – 1.78 (m, 
1H), 1.36 -1.27 (m, 2H), 0.93 (t, J = 7.4 Hz, 3H). 13C NMR (100 MHz, CDCl3): 198.3, 
168.2, 146.1, 133.9, 131.8, 127.8, 123.9, 48.4, 32.3, 26.1, 19.7, 13.6. HRMS Calcd. for 
C16H18NO3 (M+1): 272.1287, Found: 272.1289. FTIR (neat): 2961, 2873, 1778, 1718, 







5,6-Dichloro-2-(2-methylene-3-oxo-1-propyl-butyl)-isoindole-1,3-dione (5.34b). 1H 
NMR (400 MHz, CDCl3): 7.87 (s, 2H), 6.36 (s, 1H), 6.26 (d, J = 1.2 Hz, 1H), 5.28 (dd, J 
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= 11.6, 4.8 Hz, 1H), 2.32 (s, 3H), 2.26 – 2.16 (m, 1H), 1.85 – 1.77 (m, 1H), 1.34 -1.23 
(m, 1H), 0.92 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3): 198.21, 166.11, 145.5, 
138.8, 130.9, 128.3, 125.3, 48.7, 32.0, 26.0, 19.6, 13.6. HRMS Calcd. for C16H16NO4Cl2 
(M+1): 340.0507, Found: 340.0518. FTIR (neat): 2961, 2873, 1778, 1718, 1680, 1610, 
1381, 1357, 1193, 744 cm-1. MP : 102 - 103 oC 
 
Representative Procedure for Phosphine Catalyzed Allylic Amination of of β-
substituted Morita-Baylis-Hillman acetate 
To a THF solution (1.6 mL, 0.3 M) of β-substituted Morita-Baylis-Hillman 
acetate 7 (0.5 mmol, 100 mol%) and 4,5-dichlorophthalimid (1.0 mmol, 200 mol%) was 
added PBu3 (0.1 mmol, 20 mol%) under Ar. The reaction mixture was stirred at 60 oC 
until complete consumption of starting material, at which point the reaction mixture was 









ethyl ester (5.35b). 1H NMR (400 MHz, CDCl3): 7.87 (s, 2H), 7.08 (t, J = 2.0 Hz, 1H), 
5.54 – 5.50 (m, 1H), 4.11 – 3.97 (m, 2H), 2.97 – 2.88 (m, 1H), 2.58 – 2.44 (m, 2H), 2.19 
 354
– 2.11 (m, 1H), 1.11 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3): 169.5, 163.5, 
148.6, 138.8, 132.3, 131.2, 125.3, 60.3, 54.4, 31.9, 28.9, 14.0. HRMS Calcd. for 
C16H14NO4Cl2 (M+1): 354.0300, Found: 354.0291. FTIR (neat): 2981, 1777, 1717, 1639, 









S-ethyl ester (5.36b). 1H NMR (400 MHz, CDCl3): 7.86 (s, 2H), 7.08 (d, J = 1.2 Hz, 
1H), 5.58 – 5.55 (m, 1H), 2.98 – 2.90 (m, 1H), 2.86 – 2.75 (m, 2H), 2.61 – 2.54 (m, 1H), 
2.51 – 2.41 (m, 1H), 2.16 – 2.08 (m, 1H), 1.16 (t, J = 7.4 Hz, 3H). 13C NMR (100 MHz, 
CDCl3): 187.8, 165.8, 146.6, 139.5, 138.7, 131.1, 125.4, 54.3, 32.1, 28.9, 22.9, 14.6. 
HRMS Calcd. for C16H14NO3SCl2 (M+1): 370.0071, Found: 370.0076. FTIR (neat): 












carboxylic acid ethyl ester (deuterio-5.35b). 1H NMR (400 MHz, CDCl3): 7.86 (s, 2H), 
7.08 (t, J = 2.6 1H), 5.95 – 5.55 (m, 0.16H), 4.10- 3.96 (m, 2H), 2.96 – 2.88 (m, 1H), 
2.59 – 2.47 (m, 2H), 2.18 – 2.11 (m, 1H), 1.10 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, 
CDCl3): 166.1, 163.7, 148.9, 139.0, 132.5, 131.4, 125.5, 60.6, 32.1, 29.0, 14.3. HRMS 
Calcd. for C16H13D1N1O4Cl2 (M+1): 355.0362, Found: 355.0372. FTIR (neat): 2980, 
1775, 1718, 1637, 1367, 1296, 1191, 1142, 1039, 740 cm-1.  
 
Representative Procedure for Asymmetric Allylic Amination  
To a THF solution (1.6 mL, 0.3 M) of Morita-Baylis-Hillman acetate (0.5 mmol, 
100 mol%) and phthalimid (1.0 mmol, 200 mol%) was added (R)-Cl-MeO-BIPHEP (0.1 
mmol, 20 mol%) under Ar, and then the reaction mixture was stirred at 60 oC until 
complete consumption of starting material, at which point the reaction mixture was 
evaporated onto silica gel and purified via silica gel chromatography (4:1 
Hexane:EtOAc). Yield: 80%. Then enantiomeric purity was determined using a Varian 
Pro Star HPLC equipped with Chiralcel OD column, eluting with 15% isopropyl alcohol 



























































































































































































































































1 Rein, T.; Pedersen, T. M. Synthesis 2002, 5, 579. 
2 Dembinkski, R. Eur. J. Org. Chem. 2004, 13, 3130. 
3 Miura, M. Angew. Chem., Int. Ed. 2004, 43, 2201.  
4 Rauhut, M.; Currier, H. (American Cyanamide Co.). U.S. Patent 3,074,999, 1963; 
Chem. Abstr. 1963, 58, 11224a. 
5 Basavaiah, D.; Rao, J. A.; Satyanarayana, T. Chem. Rev. 2003, 103, 811. 
6 White, D. A.; Baizer, M. M. Tetrahedron Lett. 1972, 13, 3130. 
7 (a) Wang, L.-C.; Luis, A. L.; Agapiou, K.; Jang, H.-Y.; Krische, M. J. J. Am. Chem. 
Soc. 2002, 124, 2402. (b) Luis, A. L.; Krische, M. J. Synthesis 2004, 2579. (c) Agapiou, 
K.; Krische, M. J. Org. Lett. 2003, 5, 1737. 
8 Morita, K.; Suzuki, Z; Hirose, H. Bull. Chem. Soc. Jpn. 1968, 41, 2815. 
9 Baylis, A. B.; Hillman, M. E. D. “Acrylic Compounds,” Patent, Celanese Co.,  
Germany 2155113 197220510, 1972. 
 
10 Kim, D.; Choi, W. J.; Hong, J. Y.; Park, I. Y.; Kim, Y. B Tetrahedron Lett. 1996, 37, 
1433. 
 
11 For reviews of the palladium-catalyzed allylic alkylation reaction, see: (a) Tsuji, J.; 
Minami, I. Acc. Chem. Res. 1987, 20, 140-145. (b) Trost, B. M. Chem. Rev. 1996, 96, 
395. (c) Heumann, A.; Reglier, M. Tetradedron 1995, 51, 975. (d) Consiglio, G.; 
Waymouth, R. M. Chem. Rev. 1989, 89, 257.  
 
12 Jellerichs, B. G.; Kong, J.-R.; Krische, M. J. J. Am. Chem. Soc. 2003, 125, 7758-7759. 
13 Chatterjee, A. K.; Morgan, J. P.; Scholl, M. Grubbs, R. H. J. Am. Chem. Soc. 2000, 
122, 3783-3784 
 
14 Ohsugia, S.-I.; Nishidea, K. Onob, K.; Okuyamab, K.; Fudesakaa, M.; Komanaa, S.; 
Node, M. Tetrahedron, 2003, 59, 8393-8398. 
 
15 Keck, G. E.; Welch, D. S. Org. Lett. 2002, 4, 3687-3690. 
16 Fukuyama, T.; Lin, S. C.; Li, L. J. Am. Chem. Soc. 1990, 112, 7050. 
 381
17 Jung, M. E. Synlett 1999, 843. 
18 (a) Juaristi, E. Enatnioselective Synthesis of β-Amino Acids, Wiley-VCH, Wiley, New 
York 1997. (b) Cardillo, G.; Tomasini, C. Chem. Soc. Rev. 1996, 117. (c) Cole, D. C. 
Tetrahedron 1994, 50, 9157. 
 
19 (a) Gellman, S. H. Acc. Chem. Res. 1998, 31, 173. (b) Salzmann, T. N.; Ratcliffe, R. 
W.; Christensen, B. G.; Bouffard, F. A, J. Am. Chem. Soc. 1980, 102, 6161. (c) 
Mayachi, N.; Shibasaki, J. Org. Chem. 1990, 55, 1975.  
 
20 Juaristi, E.; Quintania, D.; Escalante, J. Aldrichimica Acta 1994, 27, 3. 
 
21 (a) Fülöp, F. Chem. Rev. 2001, 101, 2181. (b) Harmat, N. J. S.; Di Bugno, C.; 
Criscuoli, M.; Giorgi, R.; Lippi, A.; Martinelli, A.; Monti, S.; Subissi, A. Bioorg. Med. 
Chem. Lett. 1998, 8, 1249. (c) Knapp, S. Chem. Rev. 1995, 95, 1859. (d) Forter, E. A.; 
Wang, X.; Lee, H.-S.; Weisblum, B.; Gellman, S. H. Nature 2002, 404, 565. (e) Cheng, 
R. P.; Gellman, S. H.; DeGrado, W. F. Chem. Rev. 2001, 101, 3219. 
 
22 Kim, J. N.; Lee, H. J.; Lee, K. Y.; Gong, J. H. Synlett 2002, 173-175. 
23 Kim, J. N.; Lee, H. J.; Gong, J. H. Tetrahedron Lett. 2002, 43, 9141-9146.  























Jongrock was born in Changnyung, South Korea on September 23, 1972, the last son of 
Jaehee Kong and Jungkee Noh. After graduating from Changshin High School, Masan, 
South Korea in 1991, he pursued his Bachelor’s degree at Sungkyunkwan University 
majoring in chemistry. Then he served in the Korean military from 1993 to 1995. Upon 
earning B.S. degree in chemistry, he enrolled at Pohang University of Sicence and 
Technology (POSTECH) for Master’s degree in organic chemistry and joined Byeang-
Hyean Kim’s research group to study bioorganic medicinal chemistry in 1998. In 2000, 
he earned his M.S. degree upon writing his thesis entitled “Oligonucleotides with Novel 
Linkage: Design, Synthesis, and Application”. In August of 2002, he entered the 
Graduate School of the University of Texas at Austin and started a Ph.D. program in 
organic chemistry under the direction of Professor Michael J. Krische. In 2006, he was 
awarded the Dorothy B. Banks Fellowship from the Department of Chemistry and 
Biochemistry. In 2006, he was awarded the University Tuition Fellowships from 
University of Texas at Austin. He is going to work as a postdoctoral fellow under the 
direction of Professor David MacMillan at Princeton University in September of 2007.  
 
 
Permanent address: 175 Sanglee, Yeebangmyun, Changnyunggoon, Kyungsangnamdo, 
Republic of Korea  
This dissertation was typed by the author. 
